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Abstract
The multicopy and specific insertion element IS6110 provide a good target for 
the detection of M. tuberculosis complex by amplification techniques such as 
Polymerase Chain Reaction (PCR). However, the emergence of IS6110-negative strains 
suggests that false negative results may occur if only IS 6110 is used as the target for 
detection. In this report, a multiplex PCR system was established using primers derived 
from the insertion sequence IS 6110 and a recently discovered IS-like element, 
designated as B9 (accession number 78639) which has been shown to be potentially 
useful for the detection of M. tuberculosis including IS6110-negative strains (Musa, 
1996). The multiplex PCR was then evaluated using adult and paediatric clinical 
samples. The results shows that the multiplex system is both sensitive (93.1% and 76% 
in adult and paediatric cases respectively) and specific (89.6% and 72.1% % in adult and 
paediatric cases respectively) and exceeds that of the conventional methods of 
microscopy and culture.
The discovery of IS6770 single copy strains has triggered many questions 
regarding transposability of the IS element in these strains, their relationship to BCG and 
their epidemiological significance. The lack of transposability in these strains and in 
BCG are hypothesised to be due to mutation or mutations within this element 
particularly in the region designated as ORFa which is thought to regulate the expression 
of the transposase protein. In order to examine this hypothesis, the element in 8 single 
copy strains, chosen at random from clinical isolates were characterised. The sequence 
results indicated that the insertion sequence of the single copy strains of M  tuberculosis 
were identical to ISP#7 which was isolated from a single copy BCG strain. However 
data of a recently transposed element and a resequence of the original ISP#<5 cloned 
copy showed that all the sequences were identical (B. Plikaytis and J. Dale, personal 
communications) and the differences between the published sequences of ISPSd and 
ISPS7 were due to sequencing errors. This implies that the mobility of the IS elements is 
dependent on the transcriptional activity of the flanking chromosomal region and not 
within the IS itself. Further research in the evolutionary relationship of the strains and 
variants is needed to understand the transposability of IS6770 in these strains.
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Chapter 1
Chapter 1
In troduction
Tuberculosis, caused by the bacterium M y c o b a c t e r i u m  t u b e r c u l o s i s  ( M .  t u b e r c u l o s i s ), 
has been a plague of humanity for centuries, especially in populations suffering from 
malnutrition and poor living conditions. The clinical features as well as the 
communicable nature of this infectious disease have been known since at least 1000 B.C.
» Examination of a skeleton dating from the fourth millennium B.C., excavated from the
Arene Candide Cave in Liguria, Italy, demonstrated evidence of spinal tuberculosis 
(Formicola et. al., 1987). With the advent of the polymerase chain reaction technique, 
more precise evidence will be obtained from D N A  extracted from infected sites in 
ancient corpses. Both Aristotle and Hippocrates described tuberculosis. Ancient Hindu 
recognised this dreadful disease as “the king of diseases and the disease of kings” 
(Collins et al., 1985b). In 1882, Robert Koch said “ if the number of victims which a 
disease claims is the measure of its significance, then all diseases, particularly the most
* dreaded infectious diseases such as bubonic plague, Asiatic cholera and others, must
rank far behind tuberculosis” (Ellner et al., 1993). At the turn of the century, there are 
still more deaths from tuberculosis than are due to any other single infectious agent. The 
important landmark in the eradication of tuberculosis was the discovery of bacillus 
Calmette-Guerin (BCG) vaccine by Calmette and Guerin in 1921. D u e  to the universal 
vaccination programme with BCG, together with the availability of specific anti- 
tuberculous drugs (beginning with streptomycin in 1945 and later isoniazid in 1952), and 
better living conditions in the Western world, there has been a steady decline in the
i
incidence of tuberculosis in the developed countries. However, it still remains a major 
health problem in the Third World, especially in countries with poor public health and 
limited medical facilities (Murray et al., 1990). In the last few years, a revival of
1.1 History of tuberculosis
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tuberculosis cases has been reported in the developed countries, prompting fears of a 
trend of increase in tuberculosis world wide (Kochi, 1991; Bloom and Murray 1992; 
Brown 1992; Enarson 1992; Snider and Roper 1992; Collins, 1993; Hart et a l., 1996). 
Three factors were thought to contribute to the increase of tuberculosis cases in the 
world, i) immigration from endemic countries, ii) reactivation or co-infection of 
tuberculosis with increasing cases of H u m a n  Immune Deficiency Virus (HIV) infection, 
and iii) outbreak of tuberculosis in congregrative facilities such as hospitals, nursing 
homes, shelter for the homeless, residential facilities for Acquired Immune Deficiency 
Syndrome (AIDS) patients and correctional institutions (Ellner and Wallis 1989).
Although immigrant populations have long been recognised to be at high risk of 
developing tuberculosis (Davies, 1995), deteriorating social conditions appear to have a 
stronger link than migration in the recent increase in United Kingdom (UK) tuberculosis 
notification (Bhatti et al., 1995 and Mangtani et al., 1995).
In 1991, eight million new cases of tuberculosis were reported. It has been estimated 
that one third of the world’s population is infected with an annual death count of about 
three million, particularly in the developing countries (Murray et al., 1990).
In Malaysia, 10,000 to 12,000 cases were registered annually from 1985 to 1995. The 
data also shows an increasing trend in the number of cases detected beginning in 1984 
with the majority of cases detected being pulmonary (Table 1.1) (Annual Report, 
Ministry of Health Malaysia, 1995).
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Table 1.1 Annually registered tuberculosis cases in Malaysia from 1985-1995
Year Number of Tuberculosis cases detected
1985 10,569
1986 10,735
1987 11,068
1988 10,944
1989 10,686
1990 10,873
1991 11,059
1992 11,420
1993 12,075
1994 11,708
1995 11,778
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1.2 Mycobacteriaceae
The family Mycobacteriaceae, consisting of one genus, Mycobacterium, is a name 
assigned by Lehmann and N e w m a n  in 1896, in the Atlas of Bacteriology. The genus 
originally consisted of two species; M. tuberculosis (tubercle bacillus), first described by 
Robert Koch in 1880, and the leprosy bacillus (Mycobacterium leprae), observed by 
Armauer Hansen in 1874. The name Mycobacterium means fimgus-bacterium arising 
from the characteristic fungus-like pellicle produced by the tubercle bacillus when grown 
in liquid media. Apart f r o m M  leprae, the genus Mycobacterium has been dominated by 
the species M. tuberculosis because of the widespread disease it causes. With the 
emergence of HIV, the pathogenic potential of other mycobacterium species has n o w  
been recognised. Mycobacterial species such a s M  kansasii and M. avium-intracellulare 
cause disseminated infections in immunocompromised patients (Wayne, 1986). This 
suggests that the atypical mycobacterium can also be clinically significant, which 
stimulated changes in attitudes and interest towards mycobacterial species other than M. 
tuberculosis (Grange, 1980).
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1.3 Properties of Mycobacteriaceae
1.3.1 Acid fastness
The characteristic and most well known property of mycobacteria is its acid fastness 
(Grange, 1988). This is referred to as the capacity to resist decolorisation by weak 
mineral acids (such as acid or acid-alcohol), when stained with an arylmethane dye (such 
as carbol fiichsin). Most of the staining procedures that are used to demonstrate this 
property are modifications of the methods derived by Ziehl and Neelsen whose name the 
method n o w  bears (Bishop and Newmann, 1979). Some other micro-organisms such as 
some strains of Nocardia, Corynebacterium and Rhodococcus can sometimes be weakly 
acid-fast.
1.3.2 Morphology and cell wall structure
M. tuberculosis are classified as Gram-positive non-spore forming rod shape organisms 
apart from being acid-fast. It is about 1 to 10|dm long and 0.5 to l[im in width. M. 
tuberculosis usually, but not always, forms characteristic serpentine cord structures 
under the microscope. Mycobacterial species all have a complex lipid rich ceil wall. This 
cell wall structure is probably responsible for the acid fastness. Studies revealed that the 
sphaeroplasts of M. tuberculosis obtained in pure culture seemed to be non pathogenic 
unless they reverted to the wild type bacilli (Ratnam and Chandrasekhar, 1976), thus 
indicating the virulence of M. tuberculosis is closely associated with the cell wall 
component. Cellular morphology ranges from rods ( M  tuberculosis), curved rods ( M  
microti), and coccobacillary ( M  avium) although ovoid and filamentous forms may also 
be seen.
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1.4 Transmission of tuberculosis
The disease caused by M .  t u b e r c u l o s i s is normally transmitted via the lung although rare 
portals of entry, such as through broken skin do exist. Ingestion is the main route of 
transmission in the case of M .  b o v i s infection. Some predisposing factors for the 
development of the disease include acquired or congenital immunodeficiency, 
alcoholism, use of immunosuppressive drugs, diabetes, malnutrition, stress and old age. 
Aerosolised pulmonary secretions are expelled through coughing or sneezing. The bacilli 
subsequently migrate to the alveoli in the lung. In the alveoli, the bacilli are 
phagocytosed by macrophages. However, they resist killing by the phagocytes and 
multiply within the macrophages. The macrophages subsequently lyse resulting in the 
release of bacilli which may trigger the disease. Milk contaminated with M .  b o v i s may 
lead to infection in the tonsils and intestine. Close contact with a “smear positive” 
patient poses a maximum risk of infection with 25-50% of those exposed becoming 
infected (Steady, 1981) but most of these do not develop the disease. The bacterium can 
remain dormant for many years; as a consequence, a decline in immunity later in life can 
allow reactivation of the infection, which then progresses to active tuberculosis. Of 
those initially infected, the normal lifetime risk of reactivation is estimated to be about 
10%  (Styblo, 1991). The advent of AIDS is causing a dramatic change in this figure. 
The likelihood of patient previously infected with tuberculosis and subsequently infected 
with H I V  developing active tuberculosis is 5 0 %  (Horsburg and Selik, 1989) which 
would have significant impact in a tuberculosis endemic country such as Malaysia. Not 
only is tuberculosis the actual cause of death of a high proportion of A I D S  patients 
(especially in the tuberculosis endemic area), but the increasing numbers of active 
tuberculosis amongst AIDS patients also causes an increased risk for the population as a 
whole. M .  t u b e r c u l o s i s could also be a factor in the progression from H I V  positive 
status to A I D S  (Selwyn et a l , 1989).
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1.5 Growth Characteristics
M. tuberculosis (and probably all other mycobacteria), is a strict aerobe although the 
growth is enhanced by incubating in an atmosphere of 5-10% carbon dioxide (Beam and 
Kubica, 1986). The addition of a low percentage of glycerol to the liquid culture media 
such as 7H9 medium, encourages the growth of M. tuberculosis but might inhibit 
growth of the bovine strains. Tubercle bacilli will grow on top a of a liquid medium as a 
wrinkled pellicle if the inoculum is carefully floated on the surface and the flask left 
undisturbed. Otherwise they will grow as floccules throughout the medium. Addition of 
Tween 80 to a concentration of 0.05% in the liquid medium also facilitates a dispersed 
growth. O n  solid medium such as Lowenstein Jensen medium (LJ), the colonies are of 
irregular shape with dry wrinkled or mamellated surface, tough and tenacious 
consistency with a creamy white colour which later becomes buff.
1.5.1 Conditions of growth
Members of the genus Mycobacterium are commonly classified as slow or fast growers. 
M. fortuitum has a doubling time of 2.5 hours, M. tuberculosis is about 18 hours a n d M  
paratuberculosis is even slower. M. leprae is a unique member of the mycobacteria in 
that it is an obligate parasite. So far, it only can be propagated on living tissue. It has an 
estimated generation time of about 12 days with optimum growth at about 30°C. The 
optimum growth temperature f o r M  tuberculosis is 37°C with p H  6.0-6.5. Some strains 
of mycobacteria produce pigment in the presence of light (photochromogens) while 
others produce pigment in the dark (scotochromogens) or do not produce pigment at all. 
Bovine serum albumen (BSA) is usually added to media for growth of many 
mycobacterial species. It improves growth by neutralising free fatty acids which might 
be toxic to the cell. It also serve as a source of amino acids hence benefiting nitrogen
7
metabolism of the cell. Primary cultures from clinical samples usually yield visible 
colonies after 2-5 weeks of incubation.
1.6 Mycobacterial Genetics
Mycobacterial species have large genome sizes (3.1xl09 to 4.5xl09 daltons) compared 
to most other prokaryotes (Bradley, 1973; Baess and Mansa, 1978; McFadden et al., 
1987a), but the pathogenic mycobacterial species seems to have smaller genomes than 
other mycobacteria (Clark-Curtiss et al., 1985). Genomic sizes of M. tuberculosis, M. 
leprae and M. bovis B C G  are 2.5xl09, 2.2xl09 and 2.8x 109 respectively (Bradley, 
1973). Generally, mycobacterial species have a high G C  content which ranged from 
6 4 %  to 7 1 %  (Baess and Mansa, 1978) whereas M. leprae and M. lufu have lower G C  
contents of 5 8 %  and 6 1 %  respectively (Clark-Curtiss et. al, 1985). D N A  from t h e M  
tuberculosis complex were shown to have 78-97% homology to M. tuberculosis H 3 7  
chromosomal D N A .  Chromosomal D N A  of M. fortuitum, M. phlei, M. smegmatis and 
M. vaccae have homology of 4 to 2 6 %  with that of M. tuberculosis (Athwal et al., 
1984; Grosskinsky et al., 1989).
1.7 Plasmids in mycobacteria
There have been notable advances in the past few years in understanding the biochemical 
and genetic basic of antibiotic resistance in M. tuberculosis. M a n y  laboratories have 
attempted to detect plasmids in M. tuberculosis that could be responsible for antibiotic 
resistance, but with very little success. A n  early report by Alberghina, et al, (1973), 
claimed that aminoglycoside resistance in M. tuberculosis was extrachromosomally 
mediated and Zainuddin and Dale (1990), showed apparently extrachromosomal bands
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in some strains of M. tuberculosis by gel electrophoresis, but the data was not 
conclusive.
The general belief is thatM tuberculosis does not naturally contain plasmids. Resistance 
to several anti-tuberculosis drugs such as isoniazid, rifampicin and streptomycin, is n o w  
known to be due to mutation in chromosomal genes and not to the presence of plasmids 
(Telenti et al., 1993; Zhang, 1993, Banerjee et al., 1994), The reason for this is not 
clear, especially as plasmids are com m o n  in some other mycobacterial species, such as 
M. avium complex. Artificially constructed plasmids have been successfully introduced 
into M. tuberculosis and BCG, by electroporation and are stably maintained (Stover et 
al, 1991; Norman et al., 1995; M c A d a m  et al., 1995). The most likely hypothesis is that 
M. tuberculosis is normally parasitic and has little contact with other bacteria for it to 
acquire plasmids from them, whereas M. avium is widespread in the environment with 
the consequent opportunity to acquire plasmids from other bacteria.
In fact, mycobacterial plasmids were first demonstrated in strains of the M. avium 
complex (Crawford and Bates, 1979), and the occurrence of plasmids in M. avium, M  
intracellulare and M. scrofulaceum (MAIS) complex has since been reported (Crawford 
and Falkinham, 1990). Plasmids have also been reported in isolates of M. fortuitum 
(Labidi et al, 1984 and Hull et al, 1984), including the most thoroughly studied 
mycobacterial plasmid designated as pAL5000. The sequence of this plasmid has been 
determined, and it provides the basis for the construction of many shuttle plasmids that 
are used as cloning vectors for mycobacteria. The presence of plasmids in mycobacteria 
is significant for several reasons. In other bacteria, plasmids frequently encode drug 
resistance, virulence factors, antigens, and various functions that promote survival in the 
environment. Plasmids are excellent markers for epidemiological studies in such bacteria.
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1.8 M tuberculosis complex
The M. tuberculosis complex is actually a group of very closely related mycobacteria 
but can be differentiated using a number of biochemical and antigenic markers. The 
differentiation is distinct enough for division into actual species or variants but for 
convenience they are usually referred to as the M  tuberculosis complex. Some 
authorities prefer to regard the M  tuberculosis complex as a single species, which 
molecular analysis would support, and the ‘species’ within it as variants. In diagnostic 
laboratories an acid fast bacillus is identified as M. tuberculosis complex or atypical 
mycobacteria. This information is usually adequate for therapeutic purposes. Further 
differentiation of M. tuberculosis complex into the species level is only done for 
epidemiological or research purposes. In neonates and immunocompromised patients, 
isolates identified as M  tuberculosis are usually further determined as B C G  or 
otherwise.
The M. tuberculosis complex consists of M  tuberculosis, M afiicanum, M. bovis, M. 
bovis B C G ,  and M. microti. Collins, et al, (1982) further subdivided the M  
tuberculosis complex into species and variants. The most c o m m o n  causes of 
tuberculosis in man are the Classical, Asian and the two African variants. M. bovis is an 
important pathogen causing tuberculosis in cattle but occasionally infects man. B C G  is 
an attenuated vaccine strain used world wide in the control and prevention of 
tuberculosis (and relatively recently, leprosy). It occasionally causes disease in neonates 
and immunocompromised hosts. Recent developments in the identification of genetic 
markers have allowed even further differentiation of members of this complex into 
specific strains, thus allowing more sensitive epidemiological studies.
1.9 Methods for identifying the M. tuberculosis complex
In most bacterial infections, there are substantial numbers of bacteria present, and 
detection of only a few organisms would not be regarded as significant (cerebral spinal 
fluid (CSF) and blood excepted), but in the case of tuberculosis infection, a single 
organism detected can be considered diagnostic.
M a n y  methods are currently used for the detection of the M .  t u b e r c u l o s i s complex, 
including microscopy, culture, biochemical assays, immunological assays, gene detection 
systems, physical identification based on pigmentation and colonial morphology, 
assessment of growth on nutrient agar and growth at different temperature. Methods for 
the detection of M .  t u b e r c u l o s i s can be divided in three parts, namely;
i) Detection methods
ii) Identification methods
iii) Typing methods
It
1.9.1 Methods for detection
1.9.1.1 Microscopy by staining method
This method demonstrate the presence of tubercle bacilli by direct microscopy. One such 
technique is the Ziehl-Neelsen staining method, which uses a strongly acting dye (carbol 
fuchsin), together with heat application to facilitate impregnation; this is followed by 
1 decolourization with acid alcohol and then counter staining with methylene blue or
malachite green. The tubercle bacillus stains red with a bluish background if methylene 
blue is used as the counter stain. Most samples can be stained using this method. It is 
done mostly for samples collected from patients with open pulmonary lesions.
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A n  alternative staining method is by auramine-rhodamine stains, followed by detecting 
the bacillus under a fluorescence microscope, but this is more expensive compared to 
Ziehl-Neelsen as the fluorescence microscope is expensive and also requires well trained 
personnel to interpret the results. This method is therefore not widely used in a 
developing country like Malaysia.
Staining methods are rapid but a negative result does not exclude tuberculosis infection 
as at least some 104 bacilli must be present in 1 ml of specimen for a positive 
microscopic finding. Sensitivity is reported as ranging from 22-78% of culture proven 
cases (Pfaller, 1994). Although the acid-fast bacilli detected does not distinguish M  
t u b e r c u l o s i s from other mycobacteria, nevertheless, the rapidity in obtaining results 
compared to the weeks required for culture makes it the most widely used screening 
method. In Malaysia, a sample would be reported as A F B  positive at this stage and if the 
clinical picture shows signs and symptoms of tuberculosis infection, treatment would be 
started without waiting for culture results.
1.9.1.2 Tuberculosis culture
Samples are usually cultured on Lowenstein-Jensen (LJ) medium. The LJ medium is an 
egg-based medium which contains asparagine, glycerol and mineral salts. The dye, 
malachite green, is also incorporated to serve both as an inhibitory agent to some 
bacteria and fungi as well as to give a better background against which the colonies can 
be easily observed.
In order to carry out culturing of the bacilli from a specimen, decontamination 
procedures have to be carried out (Grange, 1988). This is vital as the presence of 
contaminants which include fungi and other bacteria will rapidly grow on the medium, 
hence suppressing the growth of the mycobacterial species. The culture is then incubated
for 6 to 8 weeks before a culture result is dispatched. Samples grown on LJ medium will 
then be further examined by tests which can differentiate up to the species level.
Culture is recognised as the “gold standard” for the diagnosis of M  t u b e r c u l o s i s; 
however, it has a detection limit of 100 viable bacilli/ml. Subsequent biochemical 
analysis for species identification requires a further 2-3 weeks. The definitive diagnosis is 
the identification of the organism in the specimen. The introduction of new culture based 
methods such as B A C T E C  radiometric system (Becton Dickenson Diagnostic 
Instrument Systems, Sparks, Maryland) has reduced these times, but are often too 
expensive for use in many laboratories and are still considerably slower than 
conventional bacteriological methods for diagnosis of many other diseases.
1.9.1.3 Immunological detection methods
A  variety of serological tests have been developed to detect antibodies against 
tuberculosis; however most of these tests lack the specificity and sensitivity required to 
make them clinically useful.
E L I S A  measures antigen-antibody binding in a solid phase. The antigen used will 
determine the specificity of the E L I S A  system developed. Both crude and purified 
antigen have been employed but as expected highly purified antigens are more specific 
with sensitivities of between 65-85% for culture positive specimens of extrapulmonary 
tuberculosis (Daniel and DeBanne, 1987). Mathai et a l., (1991), also developed a Dot 
Enzyme Immunoassay (Dot EIA) for the detection of M .  t u b e r c u l o s i s antibodies in 
cerebrospinal fluid using M .  tub e r c u l o s i s antigen 5 isolated from M .  t u b e r c u l o s i s  
H37Ra. They claimed the Dot EIA has a sensitivity of 7 0 %  and a specificity of 100% in 
detecting tuberculous meningitis patients.
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Serological methods are believed to be more useful in detecting extrapulmonary 
tuberculosis. Despite the sensitivity of serological tests for tuberculosis, there is the 
problem of specificity to be solved. N o  single species-specific antigen o f M  t u b e r c u l o s i s  
has been shown to be able to elicit significantly elevated levels of antibodies in all cases 
of the disease. There is also the problem of antigenic cross reactions among 
mycobacterial species and with species of other genera (Grange, 1989).
1.9.1.4 BACTEC detection system
d
This radiometric method was developed for the detection, identification and drug 
susceptibility testing of mycobacteria. The procedure involves growing the bacilli in 
7H12 broth and growth is detected by measuring the release of 14C 0 2 from 14C-palmitic 
acid. The positive attribute of this method is that it is faster with an average detection 
time of 10 days compared to 17 days for conventional culture technique (Anargyros et 
a l., 1990).
I
1.9.1.5 The BacT/Alert detection system
The BactT/Alert System was developed by Organon Teknika Corp, Durham, N e w  
York. It is a fully automated, non-radiometric blood culture detection method. Growth 
is indicated by an increase in C 0 2 production, and is monitored by the changing colours 
of the growth media. Preliminary studies using clinical specimens showed that this is a 
good system for detecting mycobacteria (Wilkins and Thorpe, 1992). The method and 
the Middlebrook 7H9 broth are being modified to improve mycobacterial detection 
(Wellstood, 1993)
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1.9.1.6 The Septi-Chek AFB
This is a biphasic culture system for the rapid isolation of mycobacteria introduced by 
Roche Diagnostics. It consists of a bottle of Middlebrook 7H9 broth and a three-sided 
paddle coated with Middlebrook 7H11 agar, modified egg media and chocolate agar. 
After adding antibiotic and growth supplements, the broth is inoculated with an aliquot 
of the specimen. The paddle is then screwed onto the vial, which is inverted to 
subculture the broth onto the agar paddle. Culture can be examined for up to 8 weeks. 
Although the sensitivity of the Septi-Chek AFB system is comparable to the BACTEC 
system (94.2% and 93%, respectively), the detection time for the Septi-Chek system is 
19 days compared with 13 days for the BACTEC system (Abe et al 1992). However, 
the use of a specific DNA probes for M. tuberculosis to test the Speti-Chek broth 
sediment will reduce the time of detection to 8 days (Drummer and Szabo, 1992).
1.9.1.7 Gas Liquid Chromatography detection method
This method detects fatty acid of the mycobacterial cell walls. The type and amount of 
fatty acids are species-specific (Buesching et al., 1991). The Microbial Identification 
System (MIS) is a commercially available gas-liquid chromatography system for the 
rapid identification of mycobacteria and other organisms. The MIS, based on the unique 
fatty acids profiles of various micro-organisms, consists of a gas chromatograph with 
capillary columns, a flame ionisation detector, an autosampler, an integrator, a computer 
and a printer. The extracted sample containing the fatty acid methyl esters are injected 
into the chromatograph column and as they elute from the column, the fatty acid is 
detected by a flame ionisation detector which then send a signal to the integrator for 
processing. It will then be analysed using a computer with databases containing cell wall 
fatty acid profiles for well characterised species of mycobacteria.
The MIS has a sensitivity of 94% in identification of mycobacteria isolates compared 
with conventional biochemical methods (Buesching etal., 1991).
1.9.1.8 Gene probe detection systems
Probe methods utilise nucleic acid hybridisation with specific labelled sequences in the 
test sample. One of the tests was developed by GEN-PROBE and involved the 
hybridisation of single stranded 125I-labelled DNA probes with complementary ribosomal 
RNA giving a DNA-RNA hybrid. The double stranded hybrid is then separated from the 
single stranded molecules and the amount of radioactivity emitted by the DNA-RNA 
hybrid is measured. The results are calculated as percentage of input probe that has 
hybridised. A hybridisation of 10% is regarded as positive.
Another gene probe based detection system (SNAP), developed by Synegene, San 
Diego, California, utilises an alkaline phosphates-labelled probe that is directed towards 
a portion of the rRNA gene. The target is immobilised on a membrane and hybridisation 
is detected by a calorimetric assay.
Probes are available for several mycobacterial species including M. tuberculosis, M  
avium, M. intracellulare, M. kansasii, and M. gordonae. The advantages of gene probe 
methods includes automation and high specificity for the members of the M  tuberculosis 
complex (>95%). But they do not differentiate between the members of the M  
tuberculosis complex. The target sequences for these probes are also often too short, in 
the case where there is an occurrence of a mutation or natural variation, it may lead to 
failure to identify that organism (McFadden et al., 1990).
The sensitivity of both nucleic acid probes and immunoassay is at about 105 organism 
per millilitre of sample (Daniel, 1989) , whereas the number of bacilli in many clinical
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samples is much lower than this. Gene probes therefore are not sufficiently sensitive for
* the direct detection of mycobacteria in clinical specimens. Nevertheless, gene probe 
hybridisation is the method of choice for the speciation of mycobacteria after isolation 
and growth in culture. Despite the success of these detection methods, there are some 
inherent problems such as high cost of machinery and training of manpower, instability 
of reagents and low specificity in some cases. It should be noted that some strains of M  
terrae complex cross react with DNA probes (Syngene, Inc., and Gen-Probe, Inc) for 
M. tuberculosis complex (Ford et al, 1993).
1.9.1.9 Polymerase Chain Reaction (PCR)
PCR provides rapid methods for detecting mycobacterial DNA or RNA directly from 
clinical samples. A number of investigators have reported the usefulness of PCR (De Wit 
et al, 1990; Brisson-Noel et al, 1991; Kolk et al, 1992; Clarridge et al, 1993; Forbes 
etal., 1993; Nolte etal., 1993; Kox., 1994; Miller et al., 1994; Pfyffer et al., 1994) but 
its ability for direct detection of mycobacteria varies according to not only the
* operational skills of the laboratory, but also the PCR techniques, including lysis 
methods, the target region of nucleic acid, and the systems employed for detecting the 
amplified products (Pierre et al., 1991; Clarridge et al., 1993; Kox et al., 1994; 
Noordhoek et al., 1994,.). Simplified and standardised amplification systems are, 
therefore, needed to fit into the work flow of a clinical laboratory. In this thesis, a 
multiplex PCR system for the direct detection of M. tuberculosis in clinical samples was 
used. The PCR system will be further discussed in the later chapter.
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1.9.1.10 Other amplification systems
Other amplification techniques have been developed to avoid the restrictions of the 
patented PCR process and payment of licence. These amplification techniques include 
strand displacement amplification (SDA) by Becton Dickenson and transcription 
mediated amplification (TMA) by Gene Probe Incorporated.
1.9.1.10.1 Strand Displacement Amplification (SDA)
SDA is an isothermal amplification process which utilises the ability of the Klenow 
fragment of E. coli DNA polymerase, starting at the site of a single stranded nick 
(created by the enzyme HincII) in a double stranded DNA, to extend one strand from 
the 3’ end, and displace the downstream strand of DNA. The process is repeated and it 
is estimated to produce 107-108 fold amplification in about 2 hours, which is similar to 
figures claimed for PCR. Since SDA is an isothermal technique, it has the advantage of 
not requiring the use of thermal cycler. This method is veiy sensitive and has been 
shown to detect as few as oneM tuberculosis genome containing 10 copies of IS 6110 
target sequence (Spargo etal., 1993)
1.9.1.10.2 Transcription Mediated Amplification (TMA)
TMA is also an isothermal target based technique. Jones et al., (1993), combined this 
method with a homogeneous detection method to detect M. tuberculosis in clinical 
samples. This test amplifies rRNA from lysed mycobacteria. The rRNA target sequences 
are copied into a transcription complex by using reverse transcriptase and RNA 
polymerase is used to make numerous RNA transcripts of the target sequence from the
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transcription complex. The process is then repeated automatically. Three or four hours 
is needed for the entire assay.
1.9.2 Methods for identification
1.9.2.1 Biochemical Techniques
Biochemical assays for identification of M. tuberculosis include tests for niacin 
production, catalase or peroxidase activity, nitrate reduction, tellurite reduction and 
arylsulphatase test. The biochemical activities are usually detected as the production of 
gas or colour. Growth in 5% NaCl or failure to grow in thiopene-2-carboxylic hydrazide 
(TCH) test is usually recommended for organisms resembling M. tuberculosis as some 
M. bovis strains will produce small amounts of niacin and could be mistaken for M. 
tuberculosis. M  tuberculosis will grow in 5% NaCl and medium containing TCH while 
M. bovis will not grow. The number of different tests needed for the full confirmation of 
a species is laborious and expensive.
1.9.2.2 Molecular techniques
As mentioned in the earlier section, gene probes are useful in particular for speciation.
PCR is also increasingly used not only for the detection of tuberculosis but also for the 
identification of mycobacteria generically.
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1.9.3 Methods for typing of mycobacterial species
The objectives of the typing scheme are to group isolates according to similarities they 
share. This typing scheme will generate data which can be applied in fields such as 
epidemiology and nomenclature. The grouping defined by one typing scheme will 
usually differ to that defined by another scheme. The implication of the scheme of choice 
will mostly depend on the specific needs of the researcher.
1.9.3.1 Serotyping
Serotyping has been widely used in characterising members of the M. avium complex 
(Schaefer, 1968). Other more specific typing schemes have shown that some strains 
classified as M. intracellulare are actually M avium (McFadden et al, 1987b). 
Immunological techniques like enzyme-linked immunosorbant assay (ELISA) (Grange, 
1989) and latex agglutination has been employed in serotyping. It involves serodiagnosis 
of the antigenic components and also detection of the tubercle bacilli in other specimens. 
However most of these tests lack the specificity and sensitivity required to make them 
clinically useful.
1.9.3.2 Phage typing
Phage typing relies on the ability of certain bacteriophages to lyse members of the M. 
tuberculosis complex or other mycobacteria. These phages are called 
mycobacteriophages and they are known to be common in the environment. They differ 
in host range, morphology, antigenic structure and plaque morphology. For the cell 
infection to occur, there must be suitable phage receptors on the cell wall for the phages 
to adhere, and the host cell must lack systems that will restrict the phage DNA. M.
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tuberculosis can be divided into 4 phage types, namely A, I, B and C, while BCG form 
a separate phage type (Grange, 1982). Phage typing is also seen to be related to the 
geographical origin of the bacilli. For example phage type I is common to Asia. Most of 
the strains from Hong Kong, Japan and Central Africa are of phage type A. Phage type 
B is common in Europe and America.
Despite its proven ability to type strains of tuberculosis, phage typing is not widely used 
due to lack of discriminating power and reproducibility.
1.9.3.3 Genomic typing
This scheme relies on the generation of unique restriction length polymorphism (RFLP) 
patterns for different strains using a DNA probe. The RFLP will depend on the 
distribution of the enzyme restriction sites for the endonuclease in the genome. 
Employing appropriate restriction enzyme will yield characteristic patterns for different 
strains and species. Collins and De Lissle (1985a) has revealed patterns which 
distinguish between members of M. tuberculosis complex by digesting total genomic 
DNA with BstE II enzyme. The Collins’s method does not use any probe, just stained 
gel. It needs a lot of DNA for the digestion and a very careful standardisation of 
electrophoresis. So, despite its power (it is still the most successful way of typing M. 
bovis), it is not widely used.
Cooper et al., (1989), showed that although M. tuberculosis and M. bovis are closely 
related, they are genetically distinct. Some species harbour unique sequences which are 
repeated many times in the genome with the number and location of the repeated 
sequence varying with different isolates, thus providing a suitable target site for 
generating RFLP.
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Some of these repeated sequences have been identified as insertion sequences. The 
insertion sequences are capable of replicating and inserting at various sites within the 
genome. They may show species specificity. The ability of these insertion elements to 
replicate and translocate in the genome varies among strains in the same species, hence 
creating an ideal situation for generating RFLPs. RFLPs studies have been conducted 
among members of theM tuberculosis complex (Eisenach et al., 1988; Hermans et al., 
1990; McAdam et al., 1990), the M. paratuberculosis-M. avium group (McFadden et 
al., 1987a; McFadden et al., 1987b; Hernandez et al., 1994) and among isolates of M  
leprae (Clark-Curtiss and Docherty, 1989; Williams et al., 1990). These insertion 
sequences will be discussed in more detail in the later section.
1.10 Control and treatment of tuberculosis
Control and prevention of tuberculosis in many countries often involves vaccination 
programmes using M. bovis BCG and specific chemotherapy in patients with confirmed 
tuberculosis.
1.10.1 Vaccination
The vaccine is an attenuated mutant of M. bovis developed by two French scientists, 
Calmette and Guerin. This organism, BCG, is a live vaccine. The vaccine BCG was 
produced between 1908 and 1921 at the Institute Pasteur by passaging a strain of M. 
bovis through 239 consecutive transfers in potato-glycerol bile medium. Although BCG 
is the only tuberculosis vaccine currently in use, yet the effectiveness of the vaccine is 
still a matter of controversy. There have been many trials carried out to determine the 
effectiveness of the vaccine, but have provided conflicting results. The British MRC trial 
among school leavers (14-15 years old of age) in industrial areas in England, showed a
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protection level of 70-80% during a follow-up period of 15 years (MRC report 1972). 
Relative protection levels vary from 80% in North American Indians to 0% in Madras, 
South India. A meta-analysis of data from a number of such trials concluded that BCG 
showed an overall protective effect of 50% (Colditz et al., 1994). Various reasons may 
account for the differences including;
i) Variations in the potency and immunogenicity of the BCG strain used.
ii) Regional differences in the tubercle bacilli causing infection.
iii) Difference in host response due to genetic and nutritional factors.
iv) Prior immunisation by strains of M. tuberculosis of low virulence.
v) Prior immunisation by contact with environmental mycobacteria.
It is most likely that the failure of certain trials is due to several factors rather than one 
factor alone.
1.10.2 Tuberculin skin testing
The tuberculin skin test evaluates a delayed-type hypersensitivity response to 
mycobacteria using a substance called purified protein derivative (PPD). PPD is a crude 
mixture prepared from filtrates of heat sterilised cultures of M. tuberculosis. The PPD 
skin test, normally called the Mantoux test or tuberculin test, is carried out by 
intradermal injection of 0.1ml of the prepared solution of tuberculin (or 5 tuberculin 
units of PPD). The exact mechanism of the PPD skin test is not totally known. The PPD 
injection is thought to cause an influx of sensitised T cells into the areas as well as the 
release of lymphokines from these T cells. The release of the lymphokines will result in 
local vasodilatation, oedema, and also stimulates other inflammatory cells migrating to 
the area. The result is determined from the size of the induration and erythema of the 
skin area after 48 to 72 hours. The range of the responses are 1 to 5 mm, (negative); 5
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to 9 mm, (doubtful); and 10 to 33 mm, (previous or possible current infection). Reports 
from many parts of the world indicate a relationship between the size of the skin reaction 
and the risk of developing active tuberculosis: the larger the reaction, the greater the 
possibility of active disease. Skin reactivity to the introduction of skin-testing material 
may be suppressed by several factors or conditions. These include advanced age, 
terminal or severe acute diseases (such as cancer) and immune defects (AIDS and 
related conditions).
The PPD skin test is neither specific nor sensitive as tuberculin contains many antigens 
that are shared with non-tuberculous environmental mycobacteria and sensitisation with 
these organisms can yield a positive skin test in the absence of tuberculosis infection. On 
the other hand, some recently infected patients and some active tuberculosis patients 
may show a negative PPD skin test (Ellener and Wallis, 1989).
1.10.3 Chemotherapy
Drugs now commonly used for previously untreated cases are isoniazid (INH), 
rifampicin, pyrazinamide, streptomycin, ethambutol, thiacetazone and para-amino 
salicylic acid (PAS). The reserves, or second line drugs, are ethionamide, prothionamide, 
cycloserine, kanamycin and capreomycin.
Rifampicin, and isoniazid together with either streptomycin, ethambutol or pyrazinamide 
are used in “short course” regimes, and they are given for 6 to 9 month duration. The 
rationale behind these multidrug therapies, is based on the experience with the 
development of anti-tuberculosis regimens, in that the few mutants that emerge which 
are resistant to a single drug will be killed by the other two components.
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With the emergence of MDR strains ofM tuberculosis, new drugs were also developed. 
* Among rifamycin derivatives, rifabutin is more effective than rifampicin in vitro and in
experimental animals (Grassi and Peona, 1995). Rifapentine is more active than rifampin 
in vitro and has a longer half-life, but it is not active against rifampicin resistant strains 
(Mor et al., 1995). Fluoroquinolones, e.g. Ciprofloxacin, concentrate within 
macrophages and are effective against M tuberculosis. They also act synergistically with 
rifampicin and isoniazid (Grassi and Peona, 1995).
Patient non-compliance with drug regimes will lead to partially treated infections re­
establishing in patients. These patients may be a source of emergence of the multidrug- 
resistant strains (MDR) of tuberculosis.
A summary of clinical characteristics of first line anti-tuberculosis agents with their 
mechanism of action as well as the side effects they may have, is shown in Table 1.2.
1.10.4 Multi Drug Resistant (MDR) Strains of Tuberculosis
The most ominous aspect of the current tuberculosis epidemic is the appearance of 
MDRM tuberculosis strains. Many MDR cases have been reported in the United States 
(Beck-Sague et al., 1992; Centres for Disease Control Report 1990; 1991; 1992; Edlin 
et al., 1992, Pearson et al., 1992). Occurrence of the MDR tuberculosis have also been 
j reported elsewhere (Snider et al 1992; Annual Report, Ministry of Health Malaysia,
1995; Carpels et al., 1995; Kritski et al., 1996; Morbidity Mortality Weekly Report 
1996). Although they also occur in normal populations, MDR strains are more common 
in the HIV patients. HIV and tuberculosis are a virulent combination as HIV infected 
persons are particularly susceptible to infection with MDR strains of M. tuberculosis 
which give rise to a rapidly fatal disseminated disease. In Malaysia, the drug resistance
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Table 1.2 Summary of clinical characteristics of antimycobacterial agents.
Agents Mechanism of action Comments
Isoniazid
(INH)
Mycobactericidal. Inhibits mycolic acid 
synthesis
Majority strains still susceptible to INH. 
Side effects include hepatitis
Rifampicin Mycobactericidal. Inhibits DNA-dependent 
RNA polymerase
Effective when used with INH. 
Penetrates tissue. Most susceptible. Side 
effect range from mild gastrointestinal 
upset, anaemia, thrombocytopenia, 
leukopenia, to hepatotoxicity.
Streptomyicn Mycobactericidal. Inhibits protein synthesis. Most effective against actively 
replicating cells. Major side effect 
include ototoxicity, renal toxicity.
Pyazinamide Mycobactericidal. Mechanism of action 
unknown.
Effective against dividing intracellular 
organisms. Side effects include hepatitis 
and nausea.
Ethambutol Mycobacteristatic or mycobactericidal, 
depending on concentration. Inhibits mycolic 
acid synthesis.
Only effective against replicating cells. 
Toxicity minimal.
( A d a p t e d  f r o m  C o n n i e  a n d  W i l l i a m  1 9 9 3 )
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rate for rifampicin and combination of isoniazid with rifampicin is less than 1%. (Annual 
Report, Ministry of Health Malaysia, 1995). Malaysia has recently been selected by 
WHO to be one of the regional centres for MDR surveillance.
1.11 Insertion sequences and transposons
Transposition was first observed by Barbara McClintock in 1956 in an eucaryotic 
system, namely maize. Transposition, is now known to take place in prokaryotic 
chromosomes as well. The elements involved in the transposition process are known as 
insertion sequences (IS) or transposons. One such element known as IS 6110, was 
initially discovered in the genome of M. tuberculosis as a repetitive sequence (Thierry et 
al, 1990a, Thierry et al., 1990b). An almost identical element designated as IS936 was 
independently identified and characterised by McAdam et al., 1990.
1.11.1 Prokaryotic Transposable elements
Prokaryotic transposable elements are capable of duplicating and inserting as discrete, 
unchanged segments of DNA at different sites in the genome. Some transposable 
elements are capable of duplicating and inserting a daughter copy at a new location in 
the genome, while in others transposition activity result in the deletion of the donor 
replicon. The enzyme transposase is involved in the insertion of a transposable element 
at a new site.
Transposable elements can be divided into insertion sequences and transposons.
Insertion sequences (IS). IS are the simplest known transposable elements with sizes 
ranging from 800 to 2500 base pair (bp). They can be found in the genome of many
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bacteria varying from a few to more than a hundred copies per genome. Because they 
encode only functions involved in transposition, they have been branded as selfish genes. 
They do not carry any selectable markers and preliminary knowledge about an IS usually 
derived from its effect on surrounding genes. The presence of IS in large numbers in the 
genome might have a strong influence on the structure and stability of the genome. In 
addition to their transposition properties, IS can also be detected at the recombination 
junctions of two replicons, where they are seen to provide homologous sites for 
recombination (Galas and Chandler, 1989).
Transposons. Transposons are larger and more complex IS elements. The simplest type 
of transposon is very similar in structure to IS in that they have the transposase gene 
flanked by inverted repeats (IR). However, in contrast to IS, this type of transposon also 
carries additional genes in addition to the transposase gene. A good example of the 
transposon is Tn3. Tn3 are similar in structure to an IS, containing a transposase gene 
and inverted terminal repeats.
More complex transposons are called composite transposons. These consist of a central 
region containing usually several genes (such as antibiotic resistance genes) and flanked 
on both sides by IS. An example of composite transposon is TnlO which consists of a 
region of DNA carrying a tetracycline resistance genes, flanked at both ends by a copy 
ofIS 10.
1.12 Mechanism of transposition
There are two group of transposition models: Conservative (cut and paste) and 
replicative.
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1.12.1 Conservative transposition /Non replicative
Conservative transposition is also known as non replicative or cut and paste mechanism. 
In this process the transposon is excised from its original position by a double strand 
break at each end. The transposon is then joined to the asymmetrically cut target 
sequence. The single stranded gap is then repaired, generating a repeat of the target 
flanking the transposon. In this type of transposition, there will be loss of the transposon 
at original site and the acquisition of the transposon at a new site.
1.12.2 Replicative transposition
In this mechanism, one copy of the IS element is retained at the original site and a copy 
is inserted at the second site. In this process, a single stranded cut at each 3’ end of the 
transposon is made, the loose ends of the transposon are then joined to free DNA ends, 
at the target sequence, generated by asymmetric cleavage. This intermediate form has 3’ 
OH ends which are used as primers by DNA polymerase to make new copies of the 
transposon leading to two DNA molecules combined into what is known as a co- 
integrate structure. The co-integrate structure is resolved by a homologous 
recombination process involving two copies of the transposons (or in some cases by site 
specific recombination by enzyme resolvase, such as in Tn3) resulting in a copy of the 
transposon at the original site and a second copy at the second site.
Although it might be thought that transposons and IS follow either conservative or 
replicative pathway, it is likely that they use both mechanisms to different extents.
1.13 Insertion elements in mycobacteria
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1.13.1 ISP#6 and related elements
The insertion sequence ISP#6 was discovered during an attempt to demonstrate the 
presence of plasmids in M  tuberculosis DNA with probes derived from a M. fortuitum 
plasmid (Zainuddin and Dale 1989). Sequence data (accession number X52471) shows 
that IS9#6 is 1358bp in size with a 30bp inverted repeat sequence at the ends.
In addition to IS9#6, two other nearly identical elements have been published, namely 
IS6770 (Thierry et al., 1990a, Thierry et al., 1990b) (accession number M29899) and 
IS9#7 (Hermans et al., 1991) (accession number X57835). IS986 and IS6110 were 
isolated from multicopy M. tuberculosis strains while ISP# 7 was obtained from a strain 
of BCG carrying a single copy of the element.
The designation IS 6110 was accepted for describing these elements, except where 
specific copies are referred to (van Embden et ah, 1993).
The polymorphic nature of the banding pattern detected with probes derived from this 
insertion sequence confer advantages in its use as an epidemiological tool (Hermans et 
al., 1990). Most M. tuberculosis strains have multiple copies of IS6770 (from 5 to 20 
copies), but there are a significant minority of strains with only one or two copies of 
IS6770 (Das et al., 1993, Yuen et al., 1993, van Soolingen et al., 1993, Fomukong et 
al., 1994, Musa et al., 1994) and some IS6110-negative strains have also been reported 
(Das etal., 1993; van Soolingen etal., 1993; Yuen etal., 1993, Musa etal., 1994).
These IS elements belong to the IS3 family of insertion sequences and show similar 
organisation of their coding regions. All three elements contain two main open reading 
frames (ORF) designated as ORFa and ORFb in which the translation of ORFb appears 
to depend on ribosomal frame shifting in the overlap region between ORFa and ORFb 
(Fig. 1.1).
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IS 3
F u s i o n  P r o t e i n
F i g u r e  1 . 1  Structure of IS3 family of insertion sequences. IS3 and related elements, 
including IS956 and IS6/70, have two regions coding for product thought to be 
involved in transposition, known as ORFa and ORFb. The two overlapping genes are in 
different reading frames. ORFb is probably not translated independently, but may be 
expressed by a ribosomal frameshifting event in the region of overlap of ORFa and 
ORFb, resulting in a fusion protein. ORF: Open reading frame.
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Although the published sequences of these three elements are virtually identical, there 
are several base differences between all three elements particularly in the ORFa region 
which affects the organisation of ORFa and hence the ribosomal frameshifting from 
ORFa to ORFb. In IS987, ORFa is continuous (Hermans et al, 1991) whereas in both 
IS9#d and IS 6110 ORFa is split into two smaller overlapping ORFs designated as 
ORFal and ORFa2 (McAdam et al, 1990; Thierry et al., 1990b) suggesting that another 
frame shifting event is required in the latter two elements. However, the structure of 
ORFal and ORFa2 are not identical in IS9#d and 186110.
The mobility of IS9#d has been demonstrated in BCG (Fomukong et al., 1993) using 
artificially constructed composite transposons on a non-replicating vector. However, 
Mendiola et al., (1992), were unable to demonstrate transposition of IS6110 by 
essentially the same procedure. Since BCG has only one or two copies of the element it 
follows that IS987 is also likely to lack transposibility. The variation in transposibility 
between these three elements has been suggested to be due to the differences in the 
organisation of ORFa.
However, as will be discussed later, the published sequences of IS986 and IS6110 
contain errors, and each is actually identical to IS9<5?7, in which ORFa is continuous.
1.13.2 IS900 and related elements
IS900 and other related elements such as 18901, IS902 and 181110, form another major 
group of insertion sequences. There is extensive variation among members of the IS900 
family, apart from 18901 and IS902, which show 98% identity and are effectively the 
same element (Green et al., 1989, Kunze et al, 1991, Moss et al., 1992, Hernandaz et 
al., 1994). IS901 shows greater similarity to IS 116 (from Streptomyces clavuligerus)
than to the mycobacterial sequence IS900 (Kunze et al., 1991). This group of insertion 
sequences is unusual for not having inverted repeat ends.
IS900 has very little polymorphism in human strains of M. paratuberculosis (McFadden 
et al., 1990), but Collins et al., (1990), have shown polymorphism in animal isolates 
using IS900 as a probe.
IS907 is confined to isolates of M. avium from animals and birds, generally, and is rarely 
found in isolates from AIDS patients or in environmental strains (Kunze et al., 1992)
IS/7/0 is a further member of the IS900 family characterised by Hernandez et al., 
(1994), IS/770 was identified because of its exceptional mobility in the strain (M avium 
LR541) in which it was found. Using an IS/770 derived probe is expected to be useful 
as a molecular tool in the epidemiological study ofM. avium infection in AIDS patients.
1.13.3 IS 1081.
IS7081 was isolated from a library ofM bovis, using genomic probes ofM tuberculosis 
and M. bovis DNA (Collins and Stephens, 1991). It is present in most strains of th eM  
tuberculosis complex and is capable of distinguishing BCG from other members of M. 
tuberculosis complex. In contrast to IS<5770, IS7057 has only a very low degree of 
polymorphism (van Soolingen et al, 1992; van Soolingen et al, 1993).
1.13.4 Other IS elements
A number of other IS elements have been isolated from mycobacteria and are shown in 
Table 1.3.
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Table 1.3: Other IS elements in Mycobacteria
IS Family Host Size Inverted
repeat
Direct
repeat
Reference
IS1 0 9 6 ? M .  s m e g m a t i s 2260 25 8 C i r i l l o  e t a l .  1991
IS 6 1 2 0 IS 2 5 6 M .  s m e g m a t i s 1486 24 9 G u i l h o t  e t  a l  1992
IS 1 6 5 2 ? M .  k a n s a s i i 947 - 3 Y a n g e t a l .  1993
IS 6 1 0 0 IS6 M .  f o r t u i t u m 880 14 - M a r t i n  e t  a l .  1990
IS 1 1 4 1 IS3 M .  s m e g m a t i s 1361 32 3 F a l k i n h a m  a n d  
C r a w f o r d  1994
IS1 2 4 5 IS256 M .  a v i u m - - - G u e r r e r o  e t  a l .  1995
U n n a m e d IS 4 2 7 T B  c o m p l e x 969 17 4 R o i z  e t  a l .  1995
T h e  t a b l e  w a s  a d a p t e d  f r o m  D a l e  ( 1 9 9 5 )  I S :  I n s e r t i o n  s e q u e n c e ;  b p :  B a s e  p a i r
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Chapter 2
C hapter 2
M ateria ls and Methods
2.1 Materials
2.1.1 Chemicals, Reagents, K its and other consumables
All chemical used were ANALAR grade unless otherwise stated.
Alpha-Innotech Corporation 
Digital Imaging System
BIO-RAD
Power supply for agarose electrophoresis and sequencing 
BDH Chemicals Ltd.
Ammonium acetate, boric acid, glycine, sodium acetate anhydrous, phenol, chloroform, 
acetic acid, ethanol (absolute), isopropanol, ammonium persulphate, calcium chloride, 
sodium dihydrogen orthophosphate dihydrate, disodium hydrogen orthophosphate, 
trisodium citrate, Tween 80, sodium hydroxide (pellets)
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Boehringer Manheim Biochemica
Taq DNA polymerase, positively charged nylon membrane, digoxigenin (DIG) DNA 
labelling and non-radioactive detection kit, restriction enzymes and their respective 10X 
buffers.
Difco
Bacto Middlebrook 7H9 broth (dehydrated), Bacto Middlebrook 7H11 agar 
(dehydrated), Middlebrook OADC Enrichment, Lowenstein-Jensen Medium Base.
Gibco BRL
lOObp DNA ladders, Sequencing gel unit, 
restriction enzymes and their respective 10X buffers.
Hoefer Scientific Instruments 
Agarose gel units
Invitrogen 
TA cloning kit
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Kodak Photo Co. Ltd.
X-ray film (Type RX), Polaroid film type 667 (positive/negative) and type 665 (positive 
only)
Northumbria Biologicals Ltd.
Isopropyl p-D-thiogalactopyranoside (IPTG), 5-bromo-4-chloro-3-indolyl-b-d- 
galactopyranoside (X-gal)
Oxoid
Bacteriological agar, nutrient broth, nutrient agar, tryptone, yeast extract.
Perkin Elmer
GeneAmp PCR system 9600 
Promesa
Agarose (ultra-pure), DNA molecular weight markers (X Hindlll, (|)X174 Haelll), Urea 
(ultra-pure), proteinase K, deoxynucleotide triphosphates (dNTPs), restriction enzymes 
and their respective 10X buffer.
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Sigma Chemicals Co.
Ampicillin, ethidium bromide, ethylene diaminotetracetic acid (EDTA), 8 
hydroxyquinoline, maleic acid, spermidine, Proteinase K, Tween 20, N,N,N’N’ 
tetramethylenediamine (TEMED).
United States Biochemicals (USB)
Sequenase version 2.0 DNA sequencing kit.
US Bio-Svnthesis
100 bp DNA Ladder.
HPLC purified primers for PCR
USBIO 101 Inc.
Geneclean II kit.
Whatman Laboratories Ltd.
Whatman 3M filter paper.
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2.1.2 Culture Media
All media were sterilised by autoclaving at 121 °C and 15psi for 15 minute unless 
otherwise stated. Liquid media were allowed to cool to room temperature before 
addition of antibiotics or other substances if required and aliquoting into the appropriate 
containers. Agar-based solid media were cooled to 50-55°C in a water bath before 
adding the required substances and plating out onto the appropriate containers.
Luria-Bertani (LB) broth
Bacto tryptone lOg
Bacto yeast extract 5g
NaCl lOg
Deionised water to 1 litre
Luria-Bertani (LB) agar
Bacto tryptone lOg
Bacto yeast extract 5g
NaCl lOg
Agar 15g
Deionised water to 1 litre
Middlebrook 7H9 broth
Dehydrated 7H9 powder 4.7 g
Deionised water 900ml
Tween 80 0.9ml
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After autoclaving the media was allowed to cool before OADC Enrichment was added 
to 10%.
Middlebrook 7H11 agar
Dehydrated 7H11 agar 21 g
Deionised water 900 ml
After autoclaving the media was allowed to cool before OADC Enrichment was added 
to 10%.
Lowenstein-Jensen Medium (Difco)
Dehydrated LJ Base 37.2g
Glycerol 12ml
Deionised water 600ml
The mixture was heated to boiling with constant agitation and then autoclaved. A 
uniform suspension of fresh egg was prepared, added to the sterile base to 1 litre and 
mixed under aseptic conditions. It was then dispensed into sterile universal bottles. The 
media were inspissated in a slanting position at 85°C for 45 minutes. The media were 
tested for sterility in a 37°C incubator overnight and were kept at 4°C prior to use.
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2.1.3 General buffers and solutions
3M Sodium acetate pH 5.2
The appropriate amount of sodium acetate was dissolved in deionised water. pH was 
adjusted with glacial acetic acid and the solution was autoclaved before using.
Phenol/Chloroform solution
Phenol:Chloroform was prepared as a 1:1 (v:v) mixture, saturated with TE buffer and 
stored in the presence of the antioxidant 8-hydroxyquinoline (0.1% w/v).
Distilled water was added to 100ml and the solution was autoclaved at 121°C for 15 
minutes. The solution was kept at room temperature. For the preparation of IX TE, the 
solution was diluted 1:10 with sterile distilled water.
The lysozyme was dissolved in distilled water. The lysozyme solution was used fresh or
IPX TE buffer (Tris lOOmM. EDTA lOmM)
Tris, pH 8.0 
EDTA
12.lg 
3.7g
Lvsozvme solution (10 mg/mll
stored in aliquots at -20°C for not longer than 1 year.
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10% SDS
10 gm SDS in 100ml distilled water. The SDS was dissolved by heating at 65°C for 20 
minutes. It was stored at room temperature for not longer than 1 month.
Proteinase K (lOmg/ml)
Proteinase K lOmg
Distilled water 1ml
Proteinase K was added in 1ml of distilled water. They were then stored in small 
aliquots at -20°C for not longer than one year.
SD S/Proteinase K mix
Proteinase K (10 mg/ml) 5 pi
SDS (10%) 70pl
Both solution were mixed prior to use.
5M Sodium Chloride (NaCB
NaCl 29.2g
Distilled water to 100ml
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The solution was autoclaved and stored at room temperature for not longer than one 
year.
CTAB/NaCl solution
NaCl 4.1gm
Distilled water 80ml
CTAB lOgm
(N-acetyl-N,N,N-trimethyl ammonium bromide)
NaCl was dissolved first with 80ml of distilled water. CTAB was then added while 
stirring. The solution was heated to 65°C and adjusted to 100ml with distilled water. It 
was stored at room temperature for not longer than 6 months.
Chloroform/isoamvl alcohol (24:1)
Chloroform 24 volume
Isoamyl alcohol 1 volume
The solution was mixed and kept at room temperature for not longer than one year. 
Isopropanol (100%)
The isopropanol solution (Analar Grade) was stored at room temperature for not longer 
than 1 year
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Ethanol (70% v/v)
Ethanol (Analar Grade) 
Distilled water
70ml
3 0 m l
The solution was kept in room temperature for not longer than one year.
2.1.4 Bacterial Species and Strains
All Mycobacterium species and strains were obtained from the National Tuberculosis 
Centre (NTBC), Kuala Lumpur, Malaysia. All other bacterial species and strains used 
were obtained from the Diagnostic Microbiology Laboratory, Department of Medical 
Microbiology and Parasitology, School of Medical Sciences, University Sains Malaysia 
(USM). The bacterial species and strains used are listed in Table 2.1.
Clinical isolates of M tuberculosis used in this study, which were all from National 
Tuberculosis Centre, Malaysia, are not listed in Table 2.1.
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Table 2.1 Bacterial species and strains used in this study.
Bacteria Source
M. tuberculosis Mt 14323 j The Netherlands *
M  simiae NTBC
M. chelonei NTBC
M. phlei NTBC
M. avium NTBC
M. intracellulare NTBC
M. fortuitum NTBC
M  triviale NTBC
M. xenopi NTBC
M. vaccae NTBC
M. kansasii NTBC
M. chelonei NTBC
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Table 2.1 Continue.
Pseudomonas aeruginosa USM
Klebsiella pneumonia USM
Streptococcus pneumonia USM
Streptococcus gtvup B USM
Staphylococcus aureus USM
Enterobacter species USM
Haemophilus influenzae USM
Klebsiella aeruginosa USM
Escherichia coli USM
Candida albicans USM
Branhamella catarrhalis USM
*  M .  t u b e r c u l o s i s  r e f e r e n c e  s t r a i n  M t l 4 3 2 3  w a s  o b t a i n e d  f r o m  R i j k i n s t i t u t  v o o r  
V o l k g e z o n d h e i d e n  M i l i e u h y g i e n e ,  B i l t l i o v e n ,  T h e  N e t l i e r l a n d s
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2.2 M ethods
2.2.1 Extraction of Nucleic Acid with Phenol-chloroform
Solutions containing nucleic acids was added with an equal volume of phenol- 
chloroform and mixed. The two phases were separated by centrifugation at lOOOOg for 5 
minutes in a microcentrifuge. The aqueous phase was transferred to a fresh tube. The 
extraction procedure was repeated until the interphase was clear of debris. A final 
extraction was performed using an equal volume of chloroform in isoamyl alcohol. The 
DNA was then precipitated by ethanol or isopropanol.
2.2.2 Precipitation of DNA bv ethanol or isopropanol
DNA precipitation was carried out using either method A or B as described below:
A. 3M sodium acetate (pH 5.2) was added to the DNA solution to 0.1 volume 
followed by 2 volumes of ice-cold absolute ethanol.
B. 3M sodium acetate (pH 5.2) was added to the DNA solution to 0.1 volume 
followed by 1 volume of ice-cold isopropanol.
After addition of ethanol or isopropanol, the solution was mixed by inversion several 
times and incubated on ice for 30 minutes (or in the case of isopropanol, at room 
temperature, 5 minutes) or for shorter time periods at -20°C or -70°C. The DNA was 
then precipitated by centrifuging at lOOOOg for 20 minutes. The pellet was washed with 
70% (v/v) ethanol and dried in vacuum prior to resuspending in sterile deionised water 
or TE buffer (pH 8.0).
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2.2.3 Quantitation of DNA in aqueous solution
The concentration and purity of nucleic acid was estimated by measuring the U.V. 
absorbance of the solution at the range of 260-280nm. A pure DNA solution has a 
260nm/280nm ratio of >1.8 (Sambrook et al, 1989). The concentration of DNA was 
calculated by employing the formula A26O of 1 = 50 pg/ml of double stranded DNA or 
33pg/ml of single stranded oligonucleotides (Sambrook et al, 1989).
2.2.4 Agarose-gel Electrophoresis
Buffers used:
IX TAE (Tris-acetate) 
Tris 400mM
EDTA 2mM
pH to 8.0 with glacial acetic acid.
Made as a SOX stock solution which was diluted to IX prior to use.
0.5X TBE (Tris-borate)
Tris 89mM
Boric acid 89mM
EDTA 2mM
Made as a 20X stock solution which was diluted to 0.5X before use.
DNA loading buffer (6X) 
Bromophenol blue 0.25% (w/v)
Xyelene cyanol 0.25% (w/v)
Sucrose 40% (w/v)
The concentration of agarose-gel used ranged between 0,8% to 2%, depending on the
#
size of the DNA to be visualised. Ethidium bromide to 0.5pg/ml was added to the gel 
before casting. One microlitre of 6X DNA loading buffer was added to each 5 pi of 
sample before loading onto the gel. The gel was run in 0.5X TBE or IX TAE 
(according to requirement) at 100 volts for 30-60 minutes depending on the gel 
dimension and agarose concentration.
2.2.5 Extraction of DNA from Agarose Gel
♦
DNA bands separated on agarose gels were extracted using the Geneclean II kit (BIO 
101) according to the manufacturer’s instructions.
2.2.6 Restriction Enzymes Digest
Restriction enzyme digestion were performed according to the manufacturer’s 
• instruction. Restriction digests were performed using the appropriate buffers supplied
with the enzyme and approximately 1 microgram of DNA and 1-5 units of enzyme in a 
volume of 10-20 pi
2.2.7 Cloning of PCR products
The amplified fragment was extracted using Geneclean II kit, ligated to the pCRII™ 
vector and then transformed into the One Short™ (INVaF’) strain provided in the TA 
Cloning Kit (Invitrogen) according to the manufacturer’s instructions. Recombinant 
plasmid were characterised by restriction digest, PCR and subsequently by sequencing of 
the inserts.
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2.2.8 Miniprep Plasmid DNA Preparation
1.5ml of an overnight (17 hours) culture, grown in 10ml of L-broth, was centrifuged at 
7000g for 5 minutes at room temperature. The supernatant was discarded and pellet was 
resuspended in 50pl of TEN buffer. Fifty microlitres of Phenol [Chloroform was added, 
the mixture was vigorously vortexed for 30 seconds and centrifuged at 7000g for 6 
minutes at room temperature. Sixty microlitres of the supernatant was carefully 
collected and 6pl of 5M ammonium acetate was added, followed by 2 volumes of
absolute ethanol (-20°C). The solution was well mixed by inversion and incubated on ice 
for 15 minutes. It was then centrifuged at 7000g for 10 minutes at room temperature. 
The supernatant was discarded and the pellet was washed with 70% cold ethanol, 
desiccated under vacuum for 5 minutes, and resuspended in 20pi sterile deionised water 
or IX TE. The solution was stored at 4°C (or -20°C for long term storage).
2.2.9 Isolation of Total Genomic Mycobacterial DNA
Mycobacterial total genomic DNA were extracted using a protocol described by van 
Soolingen et. al. 1991.
A loopful of cells from a culture grown on Lowenstein-Jensen was transferred into a 
microcentrifuge tube containing 500pl of IX TE. It was then heated for 20 minutes at 
80°C to kill the cells and cooled to room temperature. 50pl of lOmg/ml lysozyme was 
added, vortexed and incubated for 1 hour at 37°C. 75pl of 10% SDS/proteinase K 
solution was then added, mixed and vortexed briefly, before the mixture was incubated 
for 10 minutes at 65°C. lOOpl of a 5M NaCl solution was added followed by lOOpl of 
CTAB/NaCl solution, which was prewarmed to 65°C. The mixture was vortexed until it 
turned white (milky) followed by an incubation at 65°C for 10 minutes. An equal volume
50
(750pi) of chloroform/isoamyl alcohol was added, followed by vortexing for at least 10 
seconds, and centrifugation at room temperature for 5 minutes at 12,000g. 180pl of the 
aqueous supernatant was transferred to a fresh microcentrifuge tube and 180pl of 
isopronanol was added to precipitate the nucleic acids. After incubating for 30 minutes 
at -20°C, it was spun for 15 minutes at room temperature in a microcentrifuge at 
12,000g. The supernatant was discarded leaving about 20pl above the pellet. 1ml of ice 
cold 70% ethanol was added and the tube was inverted gently several times. After 
centrifugation for 5 minutes at room temperature, the supernatant was discarded, 
leaving about 20pl above the pellet. It was spun again for 1 min in a microcentrifuge and 
the supernatant was discarded using a micropippetter. The pellet was allowed to dry at 
room temperature for about 10 minutes. The pellet was re-dissolved in 2pl of IX TE 
buffer and stored at 4°C.
2.2.10 Detection of DNA by Southern Blotting and Hybridisation
2.2.10.1 Buffers and solutions used:
Southern blot DNA transfer solution
0.4N Sodium hydroxide (NaOH)
20X SSC
NaCl 3.0M
Tris-sodium citrate 0.3M
Prehvbridisation/hybridisation solution
The hybridisation solution for Chemiluminescent contained 5X SSC,
2.5% blocking reagent, 0.1% N-laurosarcosine sodium salt, 0.02%
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SDS and lOOug/ml herring sperm DNA, The herring sperm DNA was 
denatured by heating prior to use.
Wash buffer
0.3% (w/v) Tween 20 in Buffer 1.
Buffer 1
Maleic acid 0.1 mol per litre
NaOH 0.15 mol per litre
pH was adjusted to 7.0
Buffer 2 (2% blocking solution)
Made by diluting 10% Blocking stock solution 1:5 with Buffer 1.
pH was adjusted to pH 9.0.
10% Blocking stock solution
lOg of blocking reagent was dissolved in 100ml of Buffer 1, 
autoclaved and stored at 4°C.
Antibody conjugate
Anti-dioxigenin-AP Fab fragment was diluted 1:10,000 in Buffer 2. 
Herring sperm DNA
A solution of 10 mg/ml of herring sperm DNA was prepared in IX 
TE. The DNA was denatured by heating at 95°C before use.
Buffer 3
Tris-HCL 0.1 mol per litre 
0.1 mol per litre 
50 mol per litre
NaOH
Magnesium chloride
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AM PPD [ 3 ~(2’ spiroadamantaneV4-f 3 -phosphoryloxvV phenvl-1.2- 
dioxetanel
AMPPD is a chemiluminescent substrate for alkaline phosphotase 
which comes as a lOmg/ml stock solution. The working solution of 
0.235mM, was derived by diluting the stock solution 1:100 in Buffer 
3
2.2.10.2 Southern Blotting
The DNA to be probed was run on a electrophoresis gel (1% gel) which 
was then stained in ethidium bromide (0.5pg/ml) solution for 15 minutes. The DNA on 
the gel was transferred onto a nylon membrane (Hybond-N, Amersham) by Southern 
blotting technique using 0.4 N NaOH as the transfer buffer and the blotting was carried 
out overnight. The membrane was carefully rinsed in 6X SSC for few seconds and it was 
then baked at 120°C for 30 minutes to fix the DNA firmly onto the membrane. The 
membrane was kept at room temperature before further use.
2.2.10.3 Hybridisation and Non-radioactive Detection
The membrane was placed into a hybridisation bottle sandwiched by 
nylon gauzes. The membrane was pre-hybridised using 20ml of hybridisation solution for 
at least 1 hour at 68°C .
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Probes were labelled with digoxigenin using the DIG kit (Boehringer Mannheim) 
according to the manufacturer’s instructions. The probe was denatured at 95 C for 10 
minutes and immediately placed on ice for 5 minutes before being used.
The pre-hybridisation buffer was replaced with fresh hybridisation solution and the 
denatured probe was added. The membrane was then incubated at 68°C overnight in a 
hybridisation oven. The membrane was washed twice for 5 minutes in 2X SSC, 0.1X 
SDS (100ml) at room temperature, followed by two washings, 15 minutes each time, in 
pre-warmed 0.1X SSC, 0.1X SDS (100ml) at 68°C.
«
The hybridisation solution containing the probe was stored in a sterile bottle at -20°C 
and was re-used for up to 5 times before discarding.
2.2.10.4 Chemiluminescent detection method
The chemiluminescent detection method was carried out at room
► . . . .temperature in the hybridisation bottle. The membrane was washed briefly for 3 minutes
in the washing buffer and was then incubated in Buffer 2 for 30 minutes. Buffer 2 was
discarded and the membrane was incubated for 30 minutes with Buffer I containing anti-
DIG-AP conjugate at 1: 10,000. The membrane was then washed twice, 20 minutes
each time, with washing buffer. After the last wash, the membrane was equilibrated in
20ml of Buffer 3 for 2 minutes followed by incubation in AMPPD solution for 5
minutes. Excess AMPPD was removed and the damp membrane was then sealed in
Saran wrap, incubated at 37°C for 5 minutes and exposed to X-ray film for up to 20
minutes. Further exposures were done when necessary.
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2.2 .10 .5 Removal of probe from membrane for reprobing
The membrane was not allowed to dry out if probe stripping is to be 
carried out. The membrane was rinsed in distilled water for 3 minutes, followed by 
washing in a solution containing 0.2M NaOH, 0.1% SDS (w/v) at 37°C for 20 minutes. 
The membrane was finally washed in 2X SSC for 3 minutes. The membrane was then re­
hybridised with other probe(s) or were stored air-dried.
2.2.11 Polymerase Chain Reaction (PCR)
All PCR experiments were performed using the Perkin Elmer Cetus (PEC) Thermal 
Cycler Model 9600. The basic reaction mixtures and initial PCR parameters were based 
on the recommended methods by PEC and modifications were introduced if and when 
necessary (and are described in the appropriate sections). Briefly:
The four deoxynucleotide triphosphates (dNTPs) were mixed to a final concentration of 
1.25mM. To make up a Master Mix enough for ten PCR reactions, 320pi of sterile 
deionised water, 80pl of dNTP mix, 50pl 10X buffer containing 1.5mM of Magnesium 
chloride. The PCR Master Mix was used on the same day or stored at -20°C for up to 2 
weeks.
To each 45pl of Master Mix were added lpl of each primer (100-200ng/ul), lpl of Taq 
DNA polymerase enzyme (1 unit/pl), and 2pl of template DNA (1-100 ng/pl ) in a 
200pl microtube. This was then spun briefly in a microcentrifuge and slotted into the 
heating block. Oil overlay was not used with the 9600 model.
2.2.11.1 Heating Block Program
Each cycle of thermal cycling comprises of three steps: Denaturation of the 
template DNA (usually at 94°C), annealing of the primer to the template DNA 
(temperature used is dependent on the Tm of the primers) and an extension reaction 
(usually at 72°C). However the actual temperature used, the time that the reaction is 
held at each step, the number of cycle and other additional steps are determined by the 
actual primers used and are optimised empirically.
2.2.11.2 Precautionary Procedures in Preparing and Running a PCR 
Reaction
To prevent contamination by extraneous DNA material from sources which include 
aerosols, gloves, or contaminated stocks like buffer, primers, deoxyneuclotides, some 
basic guidelines were observed:
All preparative work was carried out in laminar flow cabinet. The cabinet was regularly 
cleaned with 70% ethanol and the air flow system was switched on 15 minutes before 
commencing work. All the manipulation involving stock solutions were carried out to 
completion before template DNA are handled. Gloves used were changed from time to 
time during PCR work. Positive and negative control reactions (including extraction 
controls when clinical samples were processed for PCR) were always included in each 
run.
2.2.11.3 Primers for PCR 
Primers were obtained commercially (US Bio-Synthesis) and were all HPLC purified.
2 .2 .1 2  Sequencing
2.2.12.1 Preparation of the sequencing gels
The sequencing gel consisted of the following: Urea (31.5g), 10X Tris-borate 
buffer (7.5 ml), 50% Long Ranger gel solution (FMC BioProducts) (9 ml) and sterile 
deionised water to 75ml. The urea was dissolved by heating the mixture in a 37°C water 
bath, with occasional stirring, for 20 minutes. Just before pouring the gel, 420}il of 10% 
ammonium persulphate (AMPS), and 75pi of TEMED were added and the gel 
preparation was mixed with a 60ml syringe and immediately poured.
2.2.12.2 Preparation of sequencing glass plates
Two glass plates were used in the preparation of the sequencing gel. A large 
glass plate with a sticky surface to which the gel adhered to and a smaller plate with a 
non adhesive surface. Both plates were thoroughly washed with a non-scratch detergent, 
rinsed in distilled water followed by a final rinse in ethanol. The gel facing side of the 
small plate was coated with a commercial product for automobile windscreen called 
“Rain X” (which contain ethyl alcohol, ethyl sulphate, isopropyl alcohol and siloxanes) 
and allowed to dry. The plate was then gently wiped with ethanol. The large plate was 
cleaned with ethanol and air dried. Rain X provided a non-adhesive surface for the gel, 
hence the gel will only stick to the larger plate. Spacers were placed between both 
plates, lengthwise. Both plates were then bound together with plastic tapes along their 
length and bottom. This provided a perfect seal between which the liquid gel mixture 
was poured. Combs were inserted in the opposite direction and the gel was allowed to 
set. The sealing tapes were removed and the gel was mounted onto an electrophoresis 
tank. The combs were then taken out and placed in the right orientation of the gel. The
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tank was filled with IX Tris-borate buffer and the gel was pre-run at 75watts for 20 
minutes before loading. The pre-run was to heat up the gel to the running temperature. 
Both long run and short run were done for each sample. At the end of the run, the 
combs and spacers were taken off and the small plate was taken out. The gel was then 
transferred to a blotting paper and dried using a heated vacuum chamber. Finally, the 
dried gel was exposed to an X-ray film.
2.2.12.3 Sequencing PCR products [direct DNA sequencing) using 
Sequenase version 2.0.
The direct sequencing method was adopted from Me Pherson et. al 1991 and the 
Sequenase Version 2.0 kit (United States Biochemicals) was used. Double stranded 
PCR products were sequenced directly using the PCR primers as sequencing primers. 
DNA was recovered from agarose gels using the Geneclean II kit. 0.2 to 2pg of PCR 
DNA recovered from the gel was mixed with 2pmol of the appropriate primer in a total 
volume of 8 pi made up with distilled water. The solution was heated to 100°C for 5 
minutes and the tubes were then rapidly transferred to a cold Ethanol bath (-70°C) until 
the solution was frozen (1-2 minutes). 2pl of 10X sequencing reaction buffer was added 
for annealing at room temperature for 20 minutes to allow annealing. While annealing, 
the Labelling reaction was prepared using diluted Labelling Mix (1:5), [35S]dATP, DTT,
0.1M and diluted sequenase polymerase. Sequencing Reaction and preparation of the 
reaction for loading onto the sequencing gel were then performed according to the 
manufacturer’s instruction.
In addition to a dilution of 1:5 of the labelling mix, in some cases a dilution of 1:20 was 
also used to allow sequencing close to the primer. In such cases, lp of Manganese (Mn) 
buffer (provided by the sequencing kit) would be added to the sequencing reaction. The
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addition of Mn buffer to the reactions will decrease the extensions in the termination 
reactions. Thus will also improves the ability to read the sequence close to the primer.
2.2.13 Method for examination and reporting of a direct smear for A F B
The direct smear examination for AFB was carried out using Ziehl-Neelsen staining 
according to the method recommended by the National Tuberculosis Centre of Malaysia 
which was based on the WHO/Tuberculosis/Technical Guide 67.7 (1967).
In this method , after appropriate treatment of the specimen if necessary, a smear was 
made covering an area equal to about two-thirds of the slide. Ziehl-Neelsen staining was 
performed according to standard protocols (Collins et a l 1985b). The slide was then 
examined under the microscope at lOOx objective magnification with oil immersion.
The top part of the smear was first examined along the whole length of the smear. Each 
length of the smear was equal to approximately 100 fields (Collins et al., 1985b). If 
more than 50 AFB were observed the examination was terminated and the slide was 
recorded as having >50 AFB/length (L).
If between 10 to 50 bacilli were observed at the end of one length, the actual number of 
AFB was recorded. For example 36 AFB/L.
If 0 to 10 bacilli were observed at the end of one length, the examination was continued 
for a further two lengths (giving a total of 3 lengths which was equivalent to 
approximately 300 fields). Three possibilities can occur:
a. If 50 or more bacilli were observed, the result was recorded as 
>50 AFB/3L
b. If less than 50 AFB were observed the actual number was recorded for 
example: 29 AFB/3L or 8 AFB/3 L
c. If no bacillus were observed the result was recorded as 0/ 3L.
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C h a p t e r  3
C h a p t e r  3
C h a r a c t e r i s a t i o n  o f  I S 6110  i n  M a l a y s i a n  S t r a i n s  o f  M .  tuberculosis
3.1 Introduction
IS6 1 1 0  was originally thought to be present in 10 to 15 copies in M .  t u b e r c u lo s i s  and 
one copy in BCG. Studies in University of Surrey have however demonstrated that some 
BCG strains possess two copies of IS6 1 1 0  (Fomukong e t  a l . ,  1992). A collaborative 
study by University Sains Malaysia and the University of Surrey also found M  
t u b e r c u lo s i s  isolates carrying only a single copy of 1 8 6 1 1 0 .  Single copy strains were also 
later detected amongst Omani and Tanzanian isolates (See Chapter 1.13.1).
Earlier experimental work carried out in the University of Surrey has shown that IS6 1 1 0  
in these single copy strains appears to be inserted in the first BCG site which had been 
shown to be a preferred site of integration of 1 8 6 1 1 0  (Fomukong e t  a l . ,  1993, Hermans 
e t  a l . ,  1991). The variation in band sizes seen when probing these single copy strains 
with an ISd/70-based probe is thought to be due to mutation of the flanking sequence, 
which could either be deletions or insertions (Fomukong e t  a l . ,  1993). Further questions 
have been raised concerning the epidemiological significance of the unusual M  
t u b e r c u lo s i s  isolates and their relationship to BCG.
3.2 DNA fingerprinting of the M .  t u b e r c u lo s i s  complex
Analysis of the M  t u b e r c u lo s i s  genome was first done by digesting the DNA with 
restriction enzymes, separating the resultant fragments by agarose electrophoresis and 
the gel was then stained with ethidium bromide (Collins e t  a l . , 1984; Collins e t  a l . ,
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1985a; Patel e t  a l ,  1986). These methods gave results which were difficult to interpret 
because the numerous fragments generated were not easily differentiated .
Later, cloned species-specific DNA fragments were employed as probes, including 
repetitive sequences (Eisenach e t  a l ,  1988; Reddi e t  a l ,  1988; Hermans e t  a l ,  1990). 
The advantage of employing these repetitive sequences is their sensitivity, due to the 
multiple copy number of the target in the genome. Some repetitive sequences, however 
are not highly species specific despite their capability for strain differentiation (Reddi e t  
a l ,  1988) whereas others show high species specificity such as IS6 1 1 0  (Hermans e t  a l ,  
1990; Thierry e t  a l . ,  1990a).
I S 6 J 1 0  shows highly polymorphic banding patterns with M .  t u b e r c u lo s i s  isolates. The 
degree of polymorphism is well suited to epidemiological analysis. A standard protocol 
allowing comparison of IS 6 1 1 0  fingerprints from different laboratories has been devised 
(van Embden e t  a l ,  1993). This is to enable a central database of banding patterns of 
strains from different countries to be maintained and analysed using a computer 
programme such as GELCOMPAR.
Using the standard protocol 476 M .  t u b e r c u lo s is  Malaysian isolates were typed using a 
DNA probe derived from IS 6 1 1 0 . The full analysis of the epidemiological data is 
continuing and will be presented elsewhere. This thesis concentrates on those strains 
with one or zero copies of IS 6 1 1 0 .
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3 . 3  E x p e r i m e n t a l  p r o c e d u r e s  a n d  r e s u l t s
3.3.1 Extraction of M  t u b e r c u lo s i s  DNA from clinical isolates
Chromosomal DNA was extracted using the method recommended by van Embden et 
al (1993) as described in Chapter 2.
3.3.2 IS 6 1 1 0  derived probe
The probe (BX probe) was derived by PCR of a recombinant plasmid DNA carrying a 
copy of IS6110 using primers derived from the restriction enzyme site Acc III 
(designated as API primer) and Xho I site (designated as BX2 primer) [Fig 3.1][Table 
3.3]. The 376bp PCR product generated by these primers was purified from agarose gels 
using the Geneclean kit (BIO 101), and labelled with digoxigenin-dUTP as described in 
Chapter 2.
S B  S X  A
IR
API
IR
BX2
PCR amplified fragment using API and BX2 primers (1240bp)
A= Acc III X=Xhol
P= Pvu II IR= Inverted repeats
S= Sal I AP 1= Primer from Acc III site
B= BamH  I BX2= Primer from X110 I site
Figure 3.1 Schematic diagram of IS6//0 and location BX probe. BX probe is located 
at the right-hand end of IS6J10 corresponding to the BamHl  and Xho\ sites. The PCR 
fragment for cloning and sequencing was amplified using primers derived from the 
restriction enzyme site^cc III (designated as API primer) and Xho I site (designated as 
BX2 primer).
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3 .3 .3  The hybridisation
Chromosomal DNA ofM tuberculosis was digested with Pvu II restriction enzyme and 
probed with the BX probe. A M  tuberculosis reference strain (Mtl4323) was included 
in the digestion as control for correct cleavage by Pvu II restriction enzyme (fig. 3.2, 
lane 6) and also for normalisation of gels by GELCOMPAR. Hybridisation was 
performed at 68°C for 18-24 hours followed by high stringency washing as described in 
Chapter 2.
3.3.3.1 Hybridisation Results
Seventy six of the 476 (15.9%) isolates typed were shown to be single copy strains. The 
majority of these strains presented with a band of approximately 1.45kb in size (IS Type 
A) (Fig. 3.2, lane 7) while the rest show a band of approximately 5kb in size (IS Type B) 
(Fig 3.2, lane 8). Ten isolates were found to be 186110 negative. Two of these IS 
negative strains are shown in Fig. 3.2, lanes 3 & 4).
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Lane 1: US 84 (multicopy strain) Lane 7: US 10l(single copy strain)
Lane 2: US 186 (multicopy strain) Lane 8: US 102(single copy strain)
Lane: 3 US 15 (IS-negative strain) Lane 9: US 201 (multiple copy strain)
Lane 4: US 17 (IS-negative strain) Lane 10: US 202(multiple copy strain)
Lane 5: US 196 (multicopy strain) Lane 11: US 203 (multiple copy strain)
Lane 6: Mt 14323 (control strain)
Figure 3.2: DNA probing of Malaysian M tuberculosis clinical isolates using BX probe. 
Number at left indicate the sizes of the standard DNA fragment (lambda Hind III) in 
kilobase pairs
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Isolates which are negative with IS6110 probes present a problem because these isolates 
could either be genuine M  tuberculosis complex or are atypical mycobacteria. In order 
to resolve this problem, IS<5//0 negative and single copy strains were hybridised further 
with two additional probes, BP and 9kb. The BP sequence (Genebank accession number 
U78639) was derived from an EMBL4 recombinant clone designated as EMBL4/A-3, 
which was previously described by Zainuddin and Dale (1989). Although present only in 
a single copy in the M. tuberculosis genome, the BP sequence has been shown to be 
potentially useful for detection of M. tuberculosis as it is present in all M  tuberculosis 
strains tested including IS6110-negative strains (Musa, 1996). The 9kb probe is a 
second sub-fragment from the same EMBL4/A-3 clone, which was shown to give RFLP 
patterns when used to probe PvuII digested chromosomal DNA of M. tuberculosis 
(Zainuddin and Dale, 1989). Figure 3.3(a), 3.3(b) and 3.3(c) show the results of probing 
an IS negative (lane 4) and IS single copy (lanes 5 and 6) strains with the IS 6110, BP 
and 9kb probes respectively. One BCG strain (lane 1), 2 atypical Mycobacterium (lanes 
2 and 3) and 3 IS multiple copyM tuberculosis strains (lanes 7, 8 and 9) are included in 
Fig. 3.3 for comparison. IS negative and IS single copy strains are confirmed as M. 
tuberculosis if the strain is positive with BP and show the typical band pattern with the 
9kb probe.
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Lane 1: B C G  Sweden Lane 6: KB29 (IS single copy strain)
Lane 2: M. fortuitum (atypical mycobacterium) Lane 7: NTBC28 (IS multiple copy strain)
Lane 3: AS 178 (Mycobacterium spp.) Lane 8: NTBC45 (IS multiple copy strain)
Lane 4: US 15 (IS-negative strain) Lane 9: NTBC20 (IS multiple copy strain)
Lane 5: AS80 (IS single copy strain)
Figure 3.3a: Results of probing IS negative and single copy M  tuberculosis strains with 
BX probes. One BCG strain, 2 atypical Mycobacterium species and 3 IS multiple copy 
M  tuberculosis strains were included for comparison. Numbers at left indicate sizes of 
the standard DNA(Lamda Hind III) marker in kilobase pairs.
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Lane 1: B C G  Sweden
Lane 2: M  fortuitum
Lane 3: AS 178 (Mycobacterium spp.)
Lane 4: US 15 (IS-negative strain)
Lane 5: AS80 (IS single copy strain)
Lane 6: KB29 (IS single copy strain)
Lane 7: NTBC28 (IS multiple copy strain)
Lane 8: NTBC45 (IS multiple copy strain)
Lane 9: NTBC20 (IS multiple copy strain)
Figure 3.3b: Results of probing an IS negative and IS single copy M tuberculosis 
strains with the B9 probe. One BCG strain, 2 atypical Mycobacterium and 3 IS multiple 
copy M  tuberculosis strains were included for comparison. Numbers at left indicate 
sizes of the standard DNA(Lambda Hind III) fragment in kilobase pairs.
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Lane 1: B C G  Sweden Lane 6:
Lane 2: M. fortuitum Lane 7:
Lane 3: AS 178 (,Mycobacterium spp.) Lane 8:
Lane 4: US 15 (IS-negative strain) Lane 9:
Lane 5: AS80 (IS single copy strain)
Figure 3.3c: Results of probing an IS negative (lane 4) and IS single copy (lanes 5 and 
6) strains with 9kb (3.3c) probes. One BCG strain (lane 1), 2 atypical Mycobacterium 
(lanes 2 and 3) and 3 IS multiple copy M tuberculosis strains (lanes 7, 8 and 9) are 
included for comparison. Number at left indicate sizes of standard DNA(Lambda Hind 
III) fragment in kilobase pairs.
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Twenty six single copy strains of IS Type A, four single copy strains of IS Type B and 
three IS6110-negative strains chosen at random were further subjected to the 
Spoligotyping assay by Zainuddin Z.F. at Rijkinstitut voor Volkgezondheiden 
Milieuhygiene, Bilthoven, The Netherlands. The band patterns obtained were scanned 
and analysed using the GELCOMPAR programme (Schouls et al., 1995 and Mangiapan 
et ah, 1996) and the results (Fig. 3.4) further confirmed the identity of these isolates. 
Furthermore, the twenty six IS Type A strains and the four IS Type B strains could be 
further divided into 14 and 3 different Spoligotypes respectively. The three IS6770 
negative strains (US 15, US 17, and US263) were divided into two Spoligotypes as 
determined by the GELCOMPAR programme. However, a visual analysis of the band 
patterns (Fig. 3.4) suggests that these three strains should be grouped together under 
one Spoligotype. This error is likely to be due to the slightly weaker signals of the bands 
in strain US 17. Table 3.1 summarises the results of the strain typing of Malaysian single 
copy strains using the IS6770 RFLP and the Spoligotyping assays.
The results from the strain typing study show the significant presence of IS6770 single 
copy and IS negative strains in Malaysia. The differentiation of the IS single copy strains 
into 2 different IS types which can then be differentiated further into a number of 
spoligotypes suggests that the single copy strains are fairly heterogeneous. This raises 
the question of why only one copy of IS6770 is present in these strains. In order to 
answer this question, it would be necessary to characterise the IS elements, by 
sequencing, in some of these strains for comparison with each other and with other 
copies of the element from multicopy strains that have been characterised previously.
71
Spoligotype
\S6110 R F L P  Type
Figure 3.4:
t u b e r c u lo s i s
programme.
n
Z L
c c c c c g c P c c c c c c  cr cr cr cr cr ^  c r J J -c r c r c r c r c r c r
O O O O O c o O r j O O O O O OA  A  ft r» t£t f t \ / f t f t f t Q Q Q
3 3 3 -0^ .-0
CD CD CD XXX
o  o  o  6  o  o  o  W o  o  o  3 3 3 3 3 £ 3 § 3 3 3
D U T J T 3 T 3  T3 r f  TJ  TJ  T3
CD CD CD CD CD CD —-  (D <D CD
X X X X X  X  f v X  X  X
c c c c c c c c c c c c c c c c c c c ccrcrcrcrcrcrcrcrcrcrcrcrcrcTcrcrcrcrcro-
O O O O O O O O O O O O O O O O O O O Oo o o o o o o o o o o o o o o o o o o o3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3.^rf.lLH'S.'D'OTO'O'a-o'O'O'a'o^ .Ta-o'D-o
t D C D C D t D C D C D C D C D t T S C D C D C D r D t l )  CD Ct> <5” CI> <© CB
x x x x x x x x x x x x x x x x x x x x
C C C C C T J C I C C C C C C C C C C C C C C C C C C C C C C C C C CMM(flMCflWMUM(/)(/)CO(flMMMCOMM£flCn(flMMtOCflC/)(rtM(/)MWCntfl
coM-vioicn ■^ ;0-Nj-*c£)uiivJa>KJ<go^ i-'l-4a>-*-*(o.D»4£<j>-»oocr>a>ooco ro in co cn < o o o i - * o ) ^ o w a ) - ‘ O M W - ‘ s u - ‘ W N i o - i a ! c n w - * M
►
—►
Spoligotyping band patterns of Malaysian single copy IS6//0 M  
strains obtained by scanning and analysing using the GELCOMPAR
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Table 3.1 Summary of strain typing of Malaysian single copy strains using 1 8 6 1 1 0  
RFLP and Spoligotyping assays.
Strain
number
IS6 1 1 0  j 
R FLP  
type
Spoligotype Strain
number
IS 6 1 1 0  
R FLP  type
Spoligotype
US93 A 1 US101 B 8
US102 A 1 US496 B 8
US301 A 1 US323 A 9
US383 A 1 US680 A 10
US385 A 1 US124 A 11
US488 A 1 US756 A 12
US711 A 1 US315 A 13
US260 A 2 US678 A 14
US347 B 3 US176 B 15
US343 A 4 US191 B 16
US491 A 4 US325 A 19
US713 A 4 US332 A 19
US317 A 5 US545 A 19
US481 A 5 US263 IS negative 17
US773 A 5 US15 IS negative 17
US772 A 6 US17 IS negative 18
US470 B 7
3 .3 .4 Selection of IS6110 single copy strains for Sequencing Study
Eight 1S6110 single copy strains of M. tuberculosis were chosen for this study. The 
1S6110 type and spoligotype (if available) of the strains are shown in Table 3.2.
Table 3.2 IS6110 single copy strain and the respective spoligotype
Single copy 
strains
IS6110 RFLP 
type
Spoligotype
US 176 B 15
US199 B ND
US101 B 8
US278 A ND
US 102 A 1
US191 B 16
US301 A 1
US774 A ND
* ND =  Not Done
3.3.5 Preparation of PC R  product for sequencing and cloning
Analysis of the IS6110/986 sequence suggests that expression of the transposase coded 
by ORFb is controlled by ribosomal frameshift during translation of ORFa in the ORFa- 
ORFb overlap region (McAdam et al, 1990). Base changes in the overlap region or in 
the region coding for the transposase may influence transposability of the element. In
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order to study the element from the chosen strains, templates for sequencing were 
prepared from each strain by PCR employing the API and BX2 primers (see Table 3.3). 
which gave a product of 1240bp ( Fig. 3.5) containing most of the IS 6110 element (Fig.
3.1) Amplification was performed using lOOng of each primer and 10-100ng of 
template. Other parameters are as described in Chapter 2, Section 2.2.11. The PCR 
product was purified from agarose gels using the Geneclean II kit (BIO 101) before 
sequencing was performed.
Table 3.3 Sequence data of primers derived from 186110 for PCR and 
sequencing.
Primers sequence Position in 
IS6110 (bp)
Usage
API 5’ G A C T C C A G T T C T T G G A A A G G  3’ 27-46 P C R  and 
sequencing
B X 2 5’ T T C G A C C G G C G G G A C G T C  G C  3’ 1267-1248 P C R  and 
sequencing
BX1 5’ C T G G C G G G T C G C T T C C A C G A  3’ 891-910 sequencing
B X 3 5’ T C G G A G C G G T C G G A A G C T C C  3’ 1077-1096 sequencing
B X 4 5’ C C T G C C T C G G C G A G C C G C T C  3’ 1062-1043 sequencing
TB1 5 ’G G A C A A C G C C G A A T T G C G A A G G 3  ’ 295-318 sequencing
TB2 5 ’T A G G C G T C G G T G A C A A A G G C C A 3  ’ 851-826 sequencing
TB3 5 ’ A C G A C C A C  A T C A A C C G G G A G 3  ’ 505-524 sequencing
TB4 5’ C C T G T C C G G G A C C A C C C G C  3’ 689-707 sequencing
AP2 5 ’T G T G C A G A T C G A C T C G A C A C 3 ' 457-438 sequencing
AP3 5 ’C T G G C G C A C C C A C T T A C G C A  3’ 222-203 sequencing
AP4 5’T C C G C G G T C A G C A C G A T T C G  3’ 125-144 sequencing
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Figure 3.5 PCR result of a single copy strain using API and BX2 primers and 
visualised using a preparative agarose gel. This amplification procedure resulted in a 
1,240 bp product. Numbers at left indicate sizes of the standard DNA marker (lOObp 
DNA ladder) fragment.
3 .3 .5 .1 Sequencing the amplification product
The sequencing of the PCR amplification product was based on the method described by 
McPherson et al., (1991). Sequencing was performed using Sequenase V2.0 (USB) 
employing either 35S or 32P as labels. Both strands were sequenced using primers derived 
from the IS6770 sequence and are listed in Table 3.3. Sequencing with each primer was 
performed at least twice to ensure accuracy of the sequence. Ambiguities were resolved 
by repeating the sequencing procedure until a consensus was achieved. The sequencing 
strategy is also depicted in Fig. 3.6.
A PI  ^ B X 2
region where ORFa and O R F b  overlaps
IS6110
TBF
AP4
TB3
BX1
BX3 -
TB4
"AP2
AP3
TB2
■BX4
Figure 3.6 Schematic diagram of the position and direction of the derived primers, for 
PCR and/or sequencing.
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3 .3 .6 Cloning P C R  fragm ent using the Invitrogen TA  cloning kit
In addition to direct sequencing of PCR products, the Apl/BX2 product from two 
strains, US301 and US774, were also cloned.
3.3.6.1 Ligation of the purified PC R  amplified product
The extracted product was ligated to the pCR™ II vector provided by the TA Cloning 
kit (Invitrogen). One to two pi of PCR product (corresponding to approximately 20 ng 
of DNA) was ligated with 50 ng (20 fmoles) of pCR™ II vector. A map of the pCRII™ 
vector (Invitrogen) is shown is figure 3.9. Each ligation reaction was set up as follows:
Reagent Amount
Fresh PCR product 
10X ligation buffer 
pCRTM II vector (25ng/pl) 
Sterile water
T4 DNA ligase (4 Weiss units)
1-2 pi
1 pi
2 pi 
to 9 pi
lpl
The ligation reaction was incubated at 14°C overnight.
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M13 Reverse Primer _________ Sp6 Promoter___________
GAGgZTTcZ1Z7-ATG~Ac]c ATG ATT ACG CCA AGC TiAT TTA GOT GAC ACT ATAl GAA GTC CTT TGfT CGA TAC TGlGTAC TAA TGC GOT TOG AIT A AAT CCA CTG TGA TATI CTT
Nail Hindi 1 Kpnl Sacl BarmH I Sp«lTAC TCA AGC TAT GCA TCA AGC TTG GTA CCG AGC TOG GAT CCA CTA OTA ACG GCC ATG ACT TOG ATA OCT ACT TOG AAC CAT GQC TCG AGC CTA OCT GAT CAT TGC CGG
BstXI EcoRI   EcoRI EcoRV
GCC ACT CTG CTG GAA TTC GGC GOC GAA TTC TGC AGA TATCGG TCA CAC GAC CTT AAG CCG /’dAiAAAMIllH T T CGG CTT AAG ACG TCT ATA
Aval 
PaaRTI
BstXI Notl Xhol Nail Xbal Apal
CCA TCA CAC TGG CGG OCG CTC GAG CAT GCA TCT AGA GGG CCC AAT TCG I CCC TATGOT ACT CTG ACC GOC GQC GAG CTC CTA CCT AGA TCT CCC GGG TTA AGC Inra ATA
T7 Promoter
ACT GAG TCG TAT JA C AAT TCA TCA CTC AGC ATA AT GTTA ACT
M13 (-20) Forward Primar M13(-40) Forward Primer
CTG GCC CTC GTT TTA C AA CG T CCT GAC TGG GAA AAC GAC COG CAG CAA AAT aTT GgA OCA CTG ACC CTT TTG
Figure 3.7 The map of the PCR™ II vector (Invitrogen). The site of insertion of the 
PCR product is shown in the multiple cloning site.
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3 .3 .6 .2  Transform ation of the ligation reaction
Transformation was carried out using the competent cells provided by the manufacturer 
(One Shot™ INVaF’ competent cells). The transformation process was started by 
thawing a vial of 0.5 M p-mercaptoethanol (|3-ME) (provided by the manufacturer) and 
one 50pl vial of frozen One Shot™ INVaF’ competent cells. Two microlitres of 0.5 M 
P-mercaptoethanol was pipetted into each vial of the competent cells and mixed by 
gently stirring with the pipette tip. Two microlitres of each ligation reaction was pipetted 
directly into the competent cells and mixed by stirring gently with the pipette tip. The 
^  vials were then incubated on ice for 30 minutes. The vials were heat shocked for exactly
30 seconds in a 42°C waterbath without mixing or shaking. Four hundred and fifty 
microlitres of SOC medium (provided by the manufacturer) was added at room 
temperature. The vials were then shaken at 37°C for 1 hour at 225 rpm in a rotary 
shaking incubator. Fifty microlitres and 200pl from each transformation were spread on 
separate, labelled LB agar plates containing 50pg/ml of ampicillin and X-Gal (40pi of 
20mg/ml X-Gal solution overlaid on agar plates, and let the agar plate dried in incubator 
before use). The plates were then incubated in a 37°C incubator over night. The plates 
*  were then transferred to 4°C for 2 to 3 hours to allow for colour development.
3.3.6.3 Analysis of the recombinant clone
Colonies most likely to carry the desired insert (white colonies) were picked from the 
LB plates and plasmid isolation was performed (plasmid extraction protocol in Chapter 
2). The plasmid extracted were digested withEcoRl restriction enzyme and were run on 
i a 0.8% TBE gel. Plasmids showing inserts of approximately 1.2kb (Fig. 3.8) were
subjected to PCR using the API and BX2 primers to confirm that the plasmids carry the 
correct insert. Two clones, designated pTT301 (Fig. 3.8, lane 3) and pTT774 (Fig. 3.8, 
lane 4) carrying the PCR product from strains US301 and US774 respectively, were 
selected for sequencing.
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»2  3  4  5
• Lane 1: 0X174HaeIII D N A  marker
Lane 2: Uncut pTT301 Lane 5: pTT301/l
Lane 3: pTT301 Lane 6: pTT774/l
Lane 4: pTT774 Lane 7: pTT301/2
Figure 3.8 Digestion of recombinant plasmids with EcoR I restriction enzyme and 
electrophoresis on a 0.8% TBE gel. Number at left indicate the sizes of standard DNA 
marker (0X174 Hae III) fragment in base pairs.
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3 .3 .7 Sequencing of the insert
Two approaches were carried out to determine the sequence of the recombinant clone. 
First, the recombinant clones were sequenced using the standard manual method 
employing Sequenase V2.0 and the same set of primers used for direct sequencing of 
PCR products as described previously. In addition, pTT301 was independently 
sequenced by automated sequencing (ABI Model 373) by Susan Wall and Steve Dyer at 
the University of Surrey.
3.3.8 Sequence results and assembly
Sequences obtained from each template were assembled using the Microgenie program 
(Beckman). The final sequences, of which eight were produced by direct sequencing of 
PCR products of the strains listed above (Table 3.2) and two by sequencing of the 
recombinant plasmids pTT301 and pTT774, were aligned using the same program and 
found to be identical. The insert sequence of pTT301 obtained by using automated 
sequencing independently performed at the University of Surrey was also in complete 
agreement with the results of this study. The consensus sequence, which will be referred 
to as TH101 was then compared to the published sequences of IS956, IS6770 and 
IS9#7.
3.3.9 Comparison of sequences of TH101, IS9#6, IS6 1 1 0  and IS9 8 7
Sequences of IS9#6, IS9#7 and IS6770 were obtained from the EMBL/GenBank/DDBJ 
Nucleotide Sequence Databases under the accession numbers X52471, X57835 and 
M29899 respectively.
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TH101 is 1234 bp in length. A multiple alignment of the corresponding regions of the 
four sequences was performed using the Microgenie program. The results of this 
alignment is shown in Fig. 3.9. The significance of this result will be discussed further.
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Figure 3.9 Sequence alignment of TH101, IS9S7, 18986 and IS6110 showing that the 
sequence of TH101 is identical to that of IS987.
Region showing base differences are marked by bold characters or ( - ) symbol.
1 0  2 0  3 0  4 0  5 0  6 0
C A G T T C T T G G  A A A G G A T G G G  G T C A T G T C A G  G T G G T T C A T C  G AG G AG G TAC C CG CC G G AG C  T H 1 0 1
C A G T T C T T G G  A A A G G A T G G G  G T C A T G T C A G  G T G G T T C A T C  G AG G AG G TAC C CG CC G G AG C  I S 987
C A G T T C T T G G  A A A G G A T G G G  G T C A T G T C A G  G T G G T T C A T C  G AG G AG G TAC C CG CC G G AG C  I S 986
C A G T T C T T G G  A A A G G A T G G G  G T C A T G T C A G  G T G G T T C A T C  G AG G AG G TAC C CG CC G G AG C  I S 6110
*****************************************************************
#  7 0  8 0  9 0  1 0 0  1 1 0  1 2 0
T G C G T G A G C G  G G C G G TG C G G  A T G G T C G C A G  A G A TC C G C G G  TC A G C A C G A T TC G G A G TG G G  T H 1 0 1
T G C G T G A G C G  G G CG G TG CG G  A T G G T C G C A G  A G A TC C G C G G  TC A G C A C G A T T C G G A G TG G G  IS987
TG C G T G A G C G  G G CG G TG CG G  A T G G T C G C A G  A G A TC C G C G G  TC A G C A C G A T T C G G A G TG G G  I S 986
T G C G T G A G C G  G G CG G TG CG G  A T G G T C G C A G  A G A TC C G C G G  T C A G C A C G A T  T C G G A G TG G G  I S 6110
'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'kik'k'k'k'k'k'k'k'k'k'k'k'fe'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'if
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
C A G C G A T C A G  TG A G G TC G C C  C G T C T A C T T G  G T G T T G G C T G  C G C G GAGACG G T G C G T A A G T  T H 1 0 1
C A G C G A T C A G  TG A G G TC G C C  C G T C T A C T T G  G T G T T G G C T G  CGCGGAGACG G T G C G T A A G T  IS98 7
C A G C G A T C A G  T G A G aT C G C C  C G T C T A C T T G  G T G T T -G C T G  C G C G GAGACG G T G C G T A A G T  IS986
*  C A G C G A T C A G  TG A G G TC G C C  C G T C T A C T T G  G T G T T G G C T G  CG CG G AG ACG  G T G C G T A A G T  X S 6110
************************************** **************************
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
G G G TG C G C C A  G G CG CA G G TC  G A TG C C G G C G  CAC G G CC C G G  G A C CA C G A CC  G A A G A A T C C G  T H 1 0 1
G G G TG C G C C A  G G CG CA G G TC  G A TG C C G G C G  C AC G G CC C G G  G A C CA C G A CC  G A A G A A T C C G  I S 987
G G G TG C G C C A  G G CG CA G G TC  G A TG C C G G C G  C AC G G CC C G G  G A C CA C G A CC  G A A G A A T C C G  IS 986
G G G TG C G C C A  G G CG CA G G TC  G A TG C C G G C G  C AC G G CC C G G  G A C CA C G A CC  G A A G A A T C C G  I S  6110
*****************************************************************
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
C T G A G C T G A A  G C G C T T  GCGG C G G G AC A AC G  C C G A A T T G C G  A AG G G C G A A C  G C G A T T T T A A  T H 1 0 1
C T G A G C T G A A  G C G C T T  GCGG C G G G AC A AC G  C C G A A T T G C G  A AG GGC GAAC G C G A T T T T A A  I S  P S  7
C T G A G a T G A A  G C G C T T  GCGG C G G G AC A AC G  C C G A A TT G C G  AAG GGC GAAC G C G A T T T T A A  I S  98 6
C T G A G C T G A A  G C G C T T aG C G G  C G G G AC A AC G  C C G A A T T G C G  AAG GGC GAAC G C G A T T T T A A  I S  6110
***** *********** ************************************************
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3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
A G A C C G C G T C  G G C T T T C T T C  GCGG CCGAGC TC G A C C G G C C  A G C A C G C T A A  T T A C C C G G T T  T H 1 0 1  
A G A C C G C G T C  G G C T T T C T T C  GCGG CCGAGC TC G A C C G G C C  A G C A C G C T A A  T T A C C C G G T T  I S 987 
A G A C C G C G T C  G G C T T T C T T C  GCGG CCGAGC TC G A C C G G C C  A G C A C G C T A A  T T A C C C G G T T  I S 9 5 6
A G A C C G C G T C  G G C T T T C T T C  GCGG CCGAGC TC G A C C G G C C  A G C A C G C T A A  T T A - a C G G T T  I S  6110 
********************************************************** *****
3 7 0  3 8 0  3 9 0  4 0 0  4 1 0  4 2 0
C A T C G C C G A T  C A TC A G G G C C  A C C G C G A G G G  C C C C G A TG G T T T G C G G T G G G  G T G T C G A G T C  T H 1 0 1  
C A T C G C C G A T  C A T C A G G G C C  A C C G C G A G G G  C C C C G A TG G T T T G C G G T G G G  G T G T C G A G T C  I S 987 
C A T C G C C G A T  C A TC A G G G C C  A C C G C G A G G G  C C C C G A TG G T TT G C G G T G G G  G T G T C G A G T C  I S 986 
C A T C G C C G A T  C A TC A G G G C C  A C C G C G A G G G  C C C C G A TG G T TT G C G G T G G G  G T G T C G A G T C  IS 6110
'k'k'k'kicic-k'k'k'k'k'k'k'k'k-k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k^'k'k'k'k'k'k'k
4 3 0  4 4 0  4 5 0  4 6 0  4 7 0  4 8 0
G A T C T G C A C A  C A G C T G A C C G  A G C T G G G T G T  G C C G A TC G C C  C C A T C G A C C T  A C T A C G A C C A  T H 1 0 1  
G A T C T G C A C A  C A G C T G A C C G  A G C T G G G T G T  G C C G A TC G C C  C C A T C G A C C T  A C T A C G A C C A  I S 987 
G A T C T G C A C A  C A G C T G A C C G  A G C T G G G T G T  G C C G A TC G C C  C C A T C G A C C T  A C T A C G A C C A  I S 986
G A T C T G C A C A  C A G C T G A C C G  A G C T G G G T G T  G C C G A TC G C C  C C A T C G A C C T  A C T A C G A C C A  I S  6110 
******** *•* *******************************************************
4 9 0  5 0 0  5 1 0  5 2 0  5 3 0  5 4 0
C A T C A A C C G G  G A G C C C A G C C  G C C G C G A G C T G C G C G A TG G C  G A A C TC A A G G  A G C A C A T C A G  T H 1 0 1  
C A T C A A C C G G  G A G C C CA G C C  G C C G C G A G C T G CG CG ATG G C G A A C T C A A G G  A G C A C A T C A G  IS987 
C A T C A A C C G G  G A G C C CA G C C  G C C G C G A G C T G CG CG ATG G C G A A C T C A A G G  A G C A C A T C A G  I S 986 
C A T C A A C C G G  G A G C C CA G C C  G C C G C G A G C T GC G C G A TG G C  G A A C TC A A G G  A G C A C A T C A G  I S  6110
'k'k'k'k'k'k'k-k'k'k'k'k'k'k'k'k’k'k'h'k'k'k'k'k'k-^'k'k'k'k'k'h'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
5 5 0  5 6 0  5 7 0  5 8 0  5 9 0  6 0 0
C C G C G T C C A C  G C C G C C A A C T A C G G T G T T T A  C G G TG C CC G C  A A A G T G TG G C  T A A C C C T G A A  T H 1 0 1  
C C G C G TC C A C  G C C G C C A A C T A C G G T G T T T A  C G G TG C CC G C  A A A G T G TG G C  T A A C C C T G A A  IS987 
C C G C G T C C A C  G C C G C C A A C T A C G G T G T T T A  C G G TG C CC G C  A A A G T G TG G C  T A A C C C T G A A  I S 986 
C C G C G T C C A C  G C C G C C A A C T A C G G T G T T T A  C G G TG C CC G C  A A A G T G TG G C  T A A C C C T G A A  I S  6110
■k-^'k'k’k-k-k'k'k-k'k-k'k-k'k'k'k-k-k'k-k'k'k-k-k-h'k'k'k'k'k'k'k'k^^^k'k'k'k'k'k'k^e'k'k'k'k'k'k'lt'k'k'kic'k'k'h'k'k'k'k'k'k'k
6 1 0  6 2 0  6 3 0  6 4 0  6 5 0  6 6 0
CC G TG A G G G C  A TC G A G G T G G  C C A G A TG C A C  C G TC G A A C G G  C T G A T G A C C A  A A C T C G G C C T  T H 1 0 1  
C C G TG A G G G C  A TC G A G G T G G  C C A G A TG C A C  C G TC G A A C G G  C T G A T G A C C A  A A C T C G G C C T  I S 987 
CC G TG A G G G C  A TC G A G G T G G  C C A G A TG C A C  C G TC G A A C G G  C T G A T G A C C A  A A C T C G G C C T  I S 986 
C C G TG A G G G C  A T C G A G G T G G  C C A G A TG C A C  C G TC G A A C G G  C T G A T G A C C A  A A C T C G G C C T  IS 6110
'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'kie'k'k'k'k'k'k'k'k'k'k'k'k-kK-k'k-kicrk'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
I 85
6 7 0  6 8 0  6 9 0  7 0 0  7 1 0  7 2 0
GTCCGGGACC ACCCGCGGCA AAGCCCGCAG GAC CAC GAT C GCTGATCCGG CCACAGCCCG T H 1 0 1  
GTCCGGGACC ACCCGCGGCA AAGCCCGCAG GACCACGATC GCTGATCCGG CCACAGCCCG I S 9 8 7  
GTCCGGGACC ACCCGCGGCA AAGCCCGCAG GACCACGATC GCTGATCCGG CCACAGCCCG IS986 
GTCCGGGACC ACCCGCGGCA AAGCCCGCAG GACCACGATC GCTGATCCGG CCACAGCCCG IS 6 1 1 0
7 3 0  7 4 0  7 5 0  7 6 0  7 7 0  7 8 0
T C C C G C C G A T  C T C G T C C A G C  G C C G C T T C G G  A C C A C C A G C A  C C TA A C C G G C  T G T G G G T A G C  T H 1 0 1  
T C C C G C C G A T  C T C G T C C A G C  G C C G C TTC G G  A C C A C C A G C A  C C TA A C C G G C  T G T G G G T A G C  I S 9 8 7  
T C C C G C C G A T  C T C G T C C A G C  G C C G C T T C G G  A C C A C C A G C A  C C TA A C C G G C  T G T G G G T A G C  I S 9 8 6
T C C C G C C G A T  C T C G T C C A G C  G C C G C TTC G G  A C C A C C A G C A  C C TA A C C G G C  T G T G G G T A G C  I S 6 1 1 0  
********************************************************************
7 9 0  8 0 0  8 1 0  8 2 0  8 3 0  8 4 0
A G A C C T C A C C  T A T G T G T C G A  C C TG G G C A G G  G T T C G C C T A C  G T G G C C T T T G  T C A C C G A C G C  T H 1 0 1  
A G A C C T C A C C  T A T G T G T C G A  C C TG G G C A G G  G T T C G C C T A C  G T G G C C T T T G  T C A C C G A C G C  I S 9 # 7  
A G A C C T C A C C  T A T G T G T C G A  C C TG G G C A G G  G T T C G C C T A C  G T G G C C T T T G  T C A C C G A C G C  I S 9 8 6  
A G A C C T C A C C  T A T G T G T C G A  C C TG G G C A G G  G T T C G C C T A C  G T G G C C T T T G  TC A C C G A C G C  I S  6 1 1 0  
*****************************************************************
8 5 0  8 6 0  8 7 0  8 8 0  8 9 0  9 0 0
C T A C G C T C G C  A G G A T C C T G G  G C TG G C G G G T C G C T T C C A C G  A T G G C C A C C T  C C A T G G T C C T  T H 1 0 1  
C T A C G C T C G C  A G G A T C C T G G  G C TG G C G G G T C G C T T C C A C G  A T G G C C A C C T  C C A T G G T C C T  I S P S 7 
C T A C G C T C G C  A G G A T C C T G G  G C TG G C G G G T C G C T T C C A C G  A T G G C C A C C T  C C A T G G T C C T  I S 986 
C T A C G  TC G C  A G G A T C C T G G  G C TG G C G G G T C G C T T C C A C G  A T G G C C A C C T  C C A T G G T C C T  I S  6 1 1 0  
*****************************************************************
9 1 0  9 2 0  9 3 0  9 4 0  9 5 0  9 6 0
C G A C G C G A T C  G A G C A A G C C A  T C T G G A C C C G  C C A A C A A G A A  G G C G TA C T C G  A C C T G A A A G A  T H 1 0 1  
C G A C G C G A T C  G A G C A A G C C A  T C T G G A C C C G  C C A A C A A G A A  G G C G TA C T C G  A C C T G A A A G A  I S 9 8 7  
C G A C G C G A T C  G A G C A A G C C A  T C T G G A C C C G  C C A A C A A G A A  G G C G TA C T C G  A C C T G A A A G A  I S 986 
C G A C G C G A T C  G A G C A A G C C A  T C T G G A C C C G  C C A A C A A G A A  G G C G TA C T C G  A C C T G A A A G A  I S  6 1 1 0
(^/klelt'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k-k'k'k'k'k-klt'k-k'k'k'k'k'k'k+t-k'k'k-k-k-k-k'k’k-k'k'k-k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
9 7 0  9 8 0  9 9 0  1 0 0 0  1 0 1 0  1 0 2 0
C G T T A T C C A C  C A T A C G G A T A  G G G G A T C T C A  G T A C A C A T C G  A T C C G G T T C A  G C G A G C G G C T T H 1 0 1  
C G T T A T C C A C  C A T A C G G A T A  G G G G A T C T C A  G T A C A C A T C G  A T C C G G T T C A  G C G A G C G G C T I S 9 8 7  
C G T T A T C C A C  C A T A C G G A T A  G G G G A T C T C A  G T A C A C A T C G  A T C C G G T T C A  G C G A G C G G C T I S 9 8 6  
C G T T A T C C A C  C A T A C G G A T A  G G G G A T C T C A  G T A C A C A T C G  A T C C G G T T C A  G C G A G C G G C T I S  6 1 1 0
'kic'k'k'k-k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
> 86
1 0 3 0  1 0 4 0  1 0 5 0  1 0 6 0  1 0 7 0  1 0 8 0
C G C C G A G G C A  G G C A TC C A A C  C G TC G G TC G G  A G C G G T C G G A  A G C T C C T A T G  A C A A T G C A C T  T H 1 0 1  
C G C C G A G G C A  G G C A TC C A A C  C G TC G G TC G G  A G C G G T C G G A  A G C T C C T A T G  A C A A T G C A C T  I S  P S  7 
C G C C G A G G C A  G G C A TC C A A C  C G TC G G TC G G  A G C G G T C G G A  A G C T C C T A T G  A C A A T G C A C T  I S  986 
C G C C G A G G C A  G G C A TC C A A C  C G TC G G TC G G  A G C G G T C G G A  A G C T C C T A T G  A C - A T  GC A C T  I S  6110 
********************************************************* *******
1 0 9 0  1 1 0 0  1 1 1 0  1 1 2 0  1 1 3 0  1 1 4 0
A G C C G A G A C G  A T C A A C G G C C  T A T A C A A G A C  C G A G C TG A TC  A A A C C C G G C A  A G C C C T G G C G  T H 1 0 1  
A G C C G A G A C G  A T C A A C G G C C  T A T A C A A G A C  C G A G C TG A TC  A A A C C C G G C A  A G C C C T G G C G  I S  P S  7 
A G C C G A G A C G  A T C A A C G G C C  T A T A C A A G A C  C G A G C TG A TC  A A A C C C G G C A  A G C C C T G G C G  I S  P S 5  
A G C C G A G A C G  A T C A A C G G C C  TA T A C A A G A C  C G A G C TG A TC  A A A C C C G G C A  A G C C C T G G C G  I S  6110 
*****************************************************************
1 1 5 0  1 1 6 0  1 1 7 0  1 1 8 0  1 1 9 0  1 2 0 0
G T C C A T C G A G  G A T G T C G A G T  TG G C C A C C G C  G C G C TG G G TC  G A C T G G T T C A  A C C A T C G C C G  T H 1 0 1  
G T C C A T C G A G  G A T G T C G A G T  TG G C C A C C G C  G C G C TG G G TC  G A C T G G T T C A  A C C A T C G C C G  I S P S 7 
G T C C A T C G A G  G A T G T C G A G T  TG G C C A C C G C  G C G C TG G G TC  G A C T G G T T C A  A C C A T C G C C G  I S 986 
G T C C A T C G A G  G A T G T C G A G T  TG G C C A C C G C  G C G C TG G G TC  G A C T G G T T C A  A C C A T C G C C G  I S  6110 
*****************************************************************
1 2 1 0  1 2 2 0  1 2 3 0
C C T C T A C C A G  T A C T G C G G C G  A C G TC C C G C C  G G TC  T H 1 0 1  
C C T C T A C C A G  T A C T G C G G C G  A C G T C C C G C C  G G TC  I S P S 7 
C C T C T A C C A G  T A C T G C G G C G  A C G T C C C G C C  G G TC  I S P S 6  
C C T C T A C C A G  T A C T G C G G C G  A C G TC C C G C C  G G TC  I S  6110 
*************************************
Note:
1. The sequences shown in Figure 3.9 span the region between the AccIII and Xhol 
sites of the insertion sequence (corresponding to position 31 to 1264 of the 
insertion sequence IS 6110)
2. Bases 1 to 15 and 1218 to 1234 shown in Figure 3.9 are actually derived from 
the primers used to prepare the sequencing template.
3 . 4 D i s c u s s i o n
Several studies (including this one) have shown that a significant minority of M  
tuberculosis strains has only one or two copies of IS6110 (Fomukong et al., 1994, 
Musa et al., 1994). Analysis of a selection of single copy strains has established that in 
most strains the insertion sequence is located at the same position on the chromosome, 
which corresponds to the site of insertion inM bovis BCG (referred as the BCGi site by 
Fomukong et al., 1994). A logical explanation of this phenomenon is that in these 
organisms the element is defective in transposition and that the loss of transposability 
may have occurred in a strain at an early stage in the evolution of the M  tuberculosis 
complex and the single-copy M. tuberculosis strains are the direct descendants of this 
“ancient strain”.
Studies have shown that some BCG strains have two copies of this element while the 
majority have one copy (Fomukong et al., 1992). Identical results were obtained from 
BCG strains of various sources and lineages (van Soolingen et al., 1991; Cave et al 
1992; Musa et al., 1994) suggesting that the element in BCG is defective in 
transposition. Consequently the identical nature of the sequence of the element in 
IS 6110 single copy M. tuberculosis strains and that of IS957 tend to suggest that the 
element in these strains are also defective in transposition.
Comparison of the published sequences of 1S987 and IS9£<5 (which has been shown to 
be transposable, Fomukong and Dale, 1993) appeared to show that the fundamental 
difference between the two is that in IS9#<5 the ORFa is split into two reading frames, 
designated as ORFal and ORFa2 (McAdam et al., 1990) whereas ORFa is in a single 
reading frame in IS987 (Hermans et al., 1991). It is possible that proper expression of 
ORFa (which is thought to regulate expression of the transposase coded by ORFb) 
require translational frameshifting as seen in IS986 and a mutation which results in 
realignment of ORFal and ORFa2 into a single reading frame such as seen in IS987 (and
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TH101) would result in lost of transposibility. This hypothesis is indirectly supported by
§
the fact that IS6110 also differs from IS9#6 in the ORFa region and has also been shown 
to be non-transposable (Mendiola et al 1992).
However, this hypothesis may not be correct in the light of results obtained from another 
study. In that study a copy of the insertion sequence (from a variant of the IS 6170- 
multicopy W strain, Pablo et al., 1996) which was shown to have recently transposed, 
were sequenced and also found to be identical to ISP#7 (B, Plikaytis, personal 
communication) and thus to TH101.
This result therefore suggests that ISP# 7 and the elements in the IS single copy strains 
used in this study actually are capable of transposition. This raises the question that the 
difference in the ORFa region between ISP#7 and IS9#<5 may be due to sequencing 
error. In the light of this study, a cloned copy of the original IS9#<5 element was re­
sequenced at the University of Surrey and confirms that the sequence of IS9#6 and 
ISP#7 are identical (J, Dale, personal communication).
t  A cloned copy of IS6770 has not been available for re-sequencing; however, this
originated from theM tuberculosis strain H37Rv, which is also the source of DNA for 
the M  tuberculosis genome sequencing project. One of the cosmids (Y339) has been 
sequenced and shown to contain an IS with sequence that is identical to IS987 
(Badcock, K., Churcher, C.M., Barrell, B.G., Rajandream, M.A., Walsh, S.V.,(1996); 
unpublished; accession number Z77163) indicating that the differences in the published 
sequence of IS6770 are also due to sequencing errors, and that all copies of this element 
in theM tuberculosis complex are identical.
These results therefore suggest that the element in most if not all low copy number 
strains of the M  tuberculosis complex are fully capable of transposing and the low copy 
number in these strains requires a different explanation.
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ORFa in IS95<5 has been shown to contain a potential initiation codon preceded by a 
region showing a good match with the consensus Shine-Dalgarno sequence. However, 
examination of the sequence further upstream does not show the presence of a potential 
promoter region suggesting that transcription of ORFa is driven exogenously. The 
mobility of the element therefore will be dependent on the transcriptional activity of the 
flanking chromosomal region.
A study by Fomukong et al (1994) indicated that in most single copy M  tuberculosis 
strains, the element is located in the region designated as the DR region by Herman et al 
(1991). The structure of the DR region suggests that it is unlikely to be transcribed, and 
hence any IS inserted into this region will be of low mobility. The ancestral strain of the 
M  tuberculosis complex may have originally acquired IS956 into this region before 
diverging into the various variants of the M. tuberculosis complex hence resulting in the 
presence of this element in the same site within the DR region in almost all strains and 
variants that have been studied. The multicopy strains may have arisen by a rare event 
which resulted in the insertion of a copy of IS956 from the DR region into a 
transcriptionally active site. Alternatively, the multicopy strains may have arisen from 
acquisition of a second copy of IS95<5 directly into a transcriptionally active site.
The DR region is postulated to be a “hot spot” for integration of IS956 (Herman et al 
1991) and regardless of the original site of integration almost all strains would 
eventually have a copy of IS956 in this region. It is then possible that the low copy 
number strains may have evolved by the loss of the elements from multicopy strains 
except the copy inserted into the DR region which as a consequence of its low mobility 
is also of greater stability and is not easily lost.
The evolutionary relationships of the strains and variants of the M  tuberculosis complex 
requires further research. However the data generated from this study may provide some 
clues towards the final answer and at the very least have resulted in a re-examination and
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correction of the basic structure of IS9#d which has been and continues to be an 
important tool in mycobacterial research and diagnosis.
»
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C h a p t e r  4
I C h a p t e r  4
Establishm ent and Evaluation of a Multiplex P C R  for the Rapid  
Diagnosis of M. tuberculosis
4.1 General Introduction
The use of PCR for diagnosis of tuberculosis is not new. Many PCR assays have been 
developed for detection of mycobacterial DNA which uses different strategies and target 
sequences. Some of the targets used are able to detect mycobacteria in general (Hance 
et al, 1989; Boddinghaus et al., 1990; Patel et al, 1990;), while others are more 
specific such as for M  tuberculosis (Shankar et al, 1991; Cousins et al., 1992) or M  
leprae (Williams et al., 1990). Table 4.1 list some examples of the targets commonly 
used for the detection of mycobacteria by PCR. Some primers are designed to amplify 
species-specific target, for example, primers derived from the mtpAO protein gene (Table
4.1) for the detection of M. tuberculosis, whereas some primers were derived for 
multiple species amplification which will be further followed by a second amplification 
or by a DNA probe step to detect the specific species. An example of this is the 
detection of the 65kDa protein gene (Table 4.1), in which the primers for the first PCR 
amplification allow detection of the mycobacteria genus, followed by a nested PCR or a 
DNA probe using internal sequences for identification to species level. Recently, 
multiplex PCR has also been designed to amplify two or more target sites using two or 
more pairs of primers. Portillo et al., (1996), described a multiplex PCR for the 
detection and differentiation of tuberculosis and non tuberculosis infection using three 
pairs of primers. The first set of primers amplifies a 506bp fragment of the 32kDa 
antigen gene, which is present in most mycobacterium species. The second set of 
primers amplifies a 984bp fragment from 186110 which belongs to theM tuberculosis
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complex. The third primer pair, derived from an M. tuberculosis species-specific 
sequence named mtp40, amplifies a 396bp fragment. It should be noted however that a 
recent paper suggests that the mtp40 gene may not be present in some M. tuberculosis 
strains (Weil et al., 1996). Other multiplex PCR methods for the detection of M. 
tuberculosis were also reported by Sinclair et al., (1995) and Totsch et al., (1994).
Table 4.1 Some common PCR targets and primers for the detection of Mycobacterium 
species.
Target gene Primers Specificity Reference
mtp 40
Primers:
PT1: 5* CAACGCGCCGTCGGTGG 3’ 
PT2: 5’ CCCCCCACGGCACCGC 3’
M tuberculosis Portillo et al 
1991
65 KDa protein
Primers
TB-1: GAGATCGAGCTGGAGGATCC(sense)
TB-2: AGCTGCAGCCCAAAGGTGTT(antisense)
Primers (nesting)
TB28: CCATCGATCCGAGACCCTGCTCAAGGGC(sense) 
TB29:TGCTCTAGACTCCTCGACGGTGATGACG(antisense)
Probes
TB3: 5 ’GCGGCATCGAAAAGGCCGTG3'
TB4: 5 ’CGAAATCGCTGCGGTGGCCG3 ’
TB5: 5 ’CTGCCACCGCGGCCATCTCC3 ’
TB6: 5 ’ CTGCCACCGCCGGTATCTCC3 ’
Genus
M. tuberculosis
M. tuberculosis 
M. tuberculosis 
M. avium 
M. fortuitum
Hance et al 
1989,
Lecossier et al 
1991.
Repetitive
element
Primers
MtbA: GGGTCGGTGACTCCGGGGGCT(sense) 
MtbB: CGGTGGGAACGGGGGCGCT(antisense) 
Primers
MtbC: TACGGATTCCGTCCACCGTCAT(sense) 
MtbD: CACCGGCGGAACACT(antisense) 
Primers
5 ’GCGGCTCGGGCGGCGTCGGTGGCTT3 ’
5 ’GCC AGAACCGACC AACCCGCCGATA 3 ’
Genus
Genus
Genus
Genus
M. tuberculosis
Patel et al 
1990
De Wit et al 
1990
MPB 64 protein
Primers
1: 5 ’TCCGCTGCCAGTCGTCTTCC3 ’ 
2: 5 ’GTCCTCGCGAGTCTAGGCCA3 ’
M. tuberculosis complex Shankar et al 
1991
38 kDa protein
rimers
MT1: ACCACCGAGCGGTTCGCCTGA(sense) 
MT2: GATCTGCGGGTCGTCCCAGGT(antisense)
M  tuberculosis complex Sjobring et al 
1990
MPB 70 antigen
Primers
TB1A: 5 ’ GAAC A AT CCG G AGTT G AC AA3 * 
TB1B: 5 ’AGCACGCTGTCAATCATGTA3 ’
M. tuberculosis complex Cousins et al 
1992
Table 4.1 continue.
Target gene Primers Specificity Reference
18kDa protein
Primers
A T T C G T C G T C G A G T T C G A C C T T C C T  (sense) 
TG A C A A C A A A C G C G T T G T T C G A T T C  (antisense)
M. leprae 
M. leprae
Williams et al 
1990
16SrRNA
Primers
246: AGAGTTTG A TC C TG G CTC A G (sense) 
264: TGCACACAGGCCACAAGGGA(antisense) 
Primers
246: AG AG TTTG ATCCTG G CTCAG (sense) 
260: GTCCTGTGCATGTCAAACCC(antisense) 
Primers
246: AG AG TTTG ATCCTG G CTCAG (sense) 
266: CACGCCCACAGTTAAGCTGT(antisense)
Probes
5 ’TT TC A C G A A C A A C G C G A C A A 3 ’
5 * A CC A C  A AG AC  A TG C A TC C C G 3 ’
5 * A C C  A G A A G  A C  A TG C G T C T TG 3 ’
5 ’ A C C TA A A G A C A TG C G C C TA A 3 ’
Genus
Genus
Genus
Genus
M. tuberculosis 
M.avitim/paratuberculsis 
M. mtracellulare
Boddinghaus 
et al 1990
IS 6110
Primers
TB 294  5 ’G G AC A A C G C C G A A TTG C G A A G G G C  3 ’ 
TB 850 5 ’TA G G C G TC G G TG A C A A A G G C C A C G  3 ’ 
Nested Primers
TB 505 5 ’ A CG A C C A C A TC A A C C  3 ’
TB 670  5 ’ A G TT T G G T C A T C A G C C  3 ’
M. tuberculosis complex
Wilson et al 
1993
4.2 Development of a multiplex P C R  for detection of M.
tuberculosis in clinical specimens.
4.2.1 Choice of targets for amplification.
Among the targets used in amplification, primers derived from IS6110 have been the 
most commonly used for PCR (Clarridge et al., 1993; Wilson et al., 1993, Kox et al., 
1994; Noordhoek et al., 1994). IS6110 has been shown to be a powerful tool in 
epidemiological studies of M  tuberculosis. (Hermans et al., 1990; Otal et al., 1991; van 
Soolingen et al., 1991). It was originally thought that all strains of M  tuberculosis 
contain multiple copies of 186110 providing a good target site for PCR. Figure 4.1 
shows a schematic representation of IS 6110 indicating the regions commonly targeted 
for amplification. Table 4.2 shows the sequences of the primers used to amplify the 
regions depicted in Figure 4.1.
However, it was subsequently shown that there are some strains ofM  tuberculosis that 
possess only a single copy of IS6110, while others do not carry any copy of \86110 
(IS6110-negative strains). Yuen et al, (1993) reported four 186110 negative strains 
from Vietnamese patients, van Soolingen et al., (1993) reported one ISM 70-negative 
strain from India and Das et al., (1993) reported three IS6110-negative strain in Hong 
Kong. In the recent restriction length polymorphism (RFLP) epidemiological study in 
Malaysia, using IS6//0 as a probe, 491 M  tuberculosis isolates were screened and out 
of that, five IS6110-negative strains were also detected (unpublished data). The 
distribution of these IS 6110-negative strains seems to be geographically restricted, to 
some extent to the Asian region. The data suggest that false-negative results may occur 
when only IS6/70 is used as the target for detection particularly when screening 
tuberculosis samples from the Asian region.
96
*Eisenach et al 1990 
Kolk et al 1992
S ha war et al 1993
Wilson et al 1993
Portillo et al 1996
Kox et al 1994
ISM70
P B X
study)
amplified region
P: PvwII enzyme restriction site 
B : BamRl  restriction enzyme and primer BX1 site 
X  : Xhol restriction enzyme and primer BX2 site
i
Figure 4.1 Schematic diagram showing IS 67 70 regions commonly targeted for 
amplification.
97
§Table 4.2: Primer sequences and expected amplification product sizes with reference to 
Figure. 4.1
i
References Primers sequences based on 
186110(18986
position(bp) 
186110/18986 
5* to 3 ’
size
(bp)
Eisenach et al 
1990 (186110)
CCTGCGAGCGTAGGCGTCGG
CTCGTCCAGCGCCGCTTCGG
865-883
762-781
123
Kolk et al 1992 
(IS9S6)
INS1 CGTGAGGGCATCGAGGTGGC 
INS2 GCGTAGGCGTCGGTGACAAA
641-660
866-885
245
Shawar et al 
1993 (IS 6110)
41: CCTGCGAGCGTAGGCGTCGG 
43: TCAGCCGCGTCCACGCCGCCA
865-883
568-588
317
Wilson et al 
1993 (186110)
TB1
GGAC AACGCCGAATT GCGAAGGGC 
TB2
TAGGCGTCGGTGACAAAGGCCACG
TB3 ACGACCACATCAACC 
TB4 AGTTTGGTCATCAGCC
295-318
51-874
505-519
669-685
586
165
Portillo et al 
1996 (186110)
155 CGGAGACGGTGCGTAAGTGG
156 GATGGACCGCCAGGGCTTGC
194-213
1158-1177
984
Kox etal 1994 
(J.86110)
PT8 GTGCGGATGGTCGCAGAGAT 
PT9 CTCGATGCCCTCACGGTTCA
106-125
627-647
541
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MostM tuberculosis strains contain multiple copies of IS 6110 which makes this target 
still an excellent choice for detection of PCR because the multiple targets would make 
the test less vulnerable to mutations that might affect PCR targeting single copy genes. 
However, the existence of IS6110-negative and IS6770 single copy strains also suggest 
that it would be prudent to include a second different target to avoid missing such 
strains due to the absence of the target or in the case of the single copy strains 
mismatches at the priming sites that could have arisen from mutations.
For reasons already described above, the first choice as target is the insertion element 
IS6110. The selected region in IS6770 was amplified using primers designated as BX1 
and BX2 (see Fig. 4.1). The second target is another insertion sequence-like element 
designated as BP (Musa et al., 1994). The BP sequence, was derived from the A3/2 
fragment (Fig. 4.2) previously described by Zainuddin and Dale (1989). Although 
present only in single copy in the M  tuberculosis genome, the BP sequence has been 
shown to be potentially useful in for detection ofM. tuberculosis as it is present in all M  
tuberculosis strains tested including in IS6770-negative strains (Musa, 1996). The 
primers used to amplify a region within the BP sequence were designated as MM1 and 
MM2.
(amplified region)
Figure 4.2 Schematic diagram of the A3/2 fragment (Zainuddin and Dale, 1989). The 
position of the BP sequence and the region that is amplified using the MM primers.
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4 .2 .2  Choice of Prim ers
The following criteria were taken into account in selecting primers for multiplex PCR:
a) The sizes of the amplified products should be different enough to allow easy 
discrimination in agarose gels.
b) The primers should not have potential priming sites with each other.
c) The optimal parameters for PCR for both pairs of primers should be equal or 
nearly equal.
In this study the IS 6110 primers used were derived from the region of IS 6110 between 
the BamEl  and Xhol restriction sites (see Fig. 3.1, Chapter 3) designated as the BX  
region. The BX region has previously been used as a probe to generate RFLP from M  
tuberculosis complex isolates (Fomukong et al., 1992). The BX primers used in this 
study are:
BX1: 5’ CTG GCG GGT CGC TTC CAC GA 3’ (891-910)
BX2: 5’ TTC GAC CGG CGG GAC GTC GC 3’ (1266-1247)
The number in brackets refer to the base pair position according to the IS9#6 sequence 
previously reported by McAdam et. al., (1990). Amplification with the BX primers 
(both 20bp in length) will give a 376bp amplification product.
Primers for amplification of the BP element are based on the sequence of this element 
previously reported by Musa et al., 1994. The sequence of the primers, designated as 
MM1 and MM2 are:
MM1: 5’ GGC CTG GAC TCC CGT AGC CT 3’ (1007-988) 
MM2: 5’ TCT CGT GGC GAC TGT TAT GAC A 3’ (830-851)
The numbers in the brackets refer to the base position according to the sequence 
reported by Musa, (1996). The MM1 and MM2 primers are 20bp and 21bp in length 
respectively. Amplification with the MM primers will give a 178bp amplification 
product.
4 .3  Optimisation of the multiplex P C R  reaction condition
4.3.1 Annealing temperature
To begin optimisation of the PCR test, the initial amplification parameters adopted were 
as follows:
Template DNA =  lOng
dNTPs (each) =  200pmol
MgC12 =1 .5  mmol
Taq =  1.25U
Primers =  200ng each
The reaction was done in a total volume of 50pi.
The amplification parameters used in the initial set up were as follows:
1. One cycle consisting of an initial denaturing step of 95°C for 2 minutes.
2. Twenty nine cycles consisting of denaturation at 95°C for 1 minute, annealing at 
68°C for 1 minute and extension at 72°C for 1 minute.
3. One cycle consisting of 95°C for 1 minute, annealing at 68°C for 1 minute and 
extension at 72°C for 2 minutes.
4. The reaction was then held at 4°C before further analysis.
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The BX primers were previously used at an annealing temperature of 65°C by 
Fomukong and Dale (1993) whereas the MM primers were previously shown to work 
well at 68°C by studies done at this laboratory (Musa, 1996). Since the higher 
temperature would minimise the chances of non-specific binding and amplification, it 
was decided to begin the optimisation process by using 68°C as the initial annealing 
temperature. It was subsequently shown that both pairs of primers worked well at this 
annealing temperature (see results shown later).
The Tm of each primer, calculated using a simple formula (Sambrook et. al., 1989), Tm 
= 2(A+T) + 4(G+C) shows that the Tm of the primers used are 68°C (BX1), 70°C 
(BX2), 68°C (MM1) and 66°C (MM2). Although the annealing temperature that was 
used is actually 2°C above the Tm of MM2, the experimental results obtained (see 
below) proved that it is suitable for this PCR test. This annealing temperature and the 
thermal cycling programme described above were maintained throughout this study.
4.3.2 Optimisation of primer
Primer concentration is a critical parameter for successful multiplex PCR and should be 
determined for each type of reaction. To establish the optimal concentration of each 
primer multiplex PCR was carried out using a fixed amount of template DNA (lOng) 
and variable amounts of BX and MM primers. Other PCR parameters were as described 
above. The results in Figure 4.3 shows that the best results were obtained using lOOng 
and 200ng of each BX and MM primer respectively (lane 3). These primer amount were 
used as parameters for optimisation of other PCR.
■BX(ng) MM(ng) BX(ng) MM(ne)
Lane 1: 100 50 Lane 6: 200 100
Lane 2: 100 100 Lane 7: 200 200
Lane 3: 100 200 Lane 8: 200 300
Lane 4: 100 300 Lane 9: Negative control
Lane 5: 200 50 Lane M 1 OObp D N A  marker
I
Figure 4.3: Optimisation of PCR using different combinations of B X  and MM primers 
amount. The template DNA was lOng of chromosomal DNA of an IS6 1 1 0  single copy 
strain
M 1 2 3 4 5 6 7 8 9
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4 .3 .3  Optimisation of MgCIz concentration
A number of publications describes the effect of various MgCl2 concentration (Erlich, 
1989; Saiki, 1989; McPherson et al., 1991; Mullis et al., 1994) on PCR. The MgCl2 
concentration is important as excess MgCl2 will result in the accumulation of non­
specific amplification product and insufficient MgCl2 will reduce the yield. However, the 
exact concentration of MgCl2 has to be empirically determined as the optimal 
concentration has been found to vary from primer to primer. Figure 4.4a shows the 
results of amplification using BX primers at various MgCl2 concentration. The results 
#  show that the best MgCl2 concentration is in the range of 1 to 6mM. The MgCl2 range
for the MM primers are from 1.5mM to 8mM [Fig. 4.4b]. The results suggest that the 
optimum MgCl2 concentration is in the range of 1.5-6mM. To determine the optimum 
MgCl2 concentration when the primers are used together in one tube, multiplex PCR 
was then performed using MgCl2 in the range of 0.5-10mM (Fig. 4.5a). The results 
shows that 1.5mM of MgCl2in the multiple PCR gave the best yields of both products. 
Specificity of the amplified fragment was verified using BX and MM probes (results not 
shown)
i
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(a) (b)
Lane 1: lOObp ladder DNA marker
MeCl? concentration used MeCl? concentration used
Lane 2: 0.5 mM Lane 7: 3 mM
Lane 3: 1.0 mM Lane 8: 4 mM
Lane 4: 1.5 mM Lane 9: 6 mM
Lane 5: 2.0 mM Lane 10: 8 mM
Lane 6: 2.5 mM Lane 11: 10 mM
Figure 4.4 : Results of amplification using B X  primers (a) and MM primers (b) at 
various MgCl2 concentration. The template DNA was lOng of chromosomal DNA of an 
1 8 6 1 1 0  single copy strain
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Lane 1: lOObp ladder DNA marker
MeCL concentration used MeCl? concentration used
Lane 2: 0.5 mM Lane 7: 3 mM
Lane 3: 1.0 mM Lane 8: 4 mM
Lane 4: 1.5 mM Lane 9: 6 mM
Lane 5: 2.0 mM Lane 10: 8 mM
Lane 6: 2.5 mM Lane 11: 10 mM
Figure 4.5 : Multiplex PCR using various concentration of MgCl2. The template DNA 
was lOng of chromosomal DNA of an IS6 1 1 0  single copy strain
i
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4 .3 .4  Optimisation of Taq polymerase enzyme
The most commonly used DNA polymerase in PCR is Taq DNA polymerase isolated 
from Thermus aquaticus, Alternative heat stable enzymes are also available such as 
Thermus thermophilus (United State Biochemicals), Bacillus stearothermophilus (Bio- 
Rad) and Thermococcus litoralis which is also referred to as the ‘Vent” polymerase 
(New England Biolabs).
Taq DNA Polymerase was the only heat stable enzyme used in this study. To ensure 
consistency of results Taq polymerase from only one manufacturer (Boehringer 
Mannheim) was used throughout this study. To determine the optimum amount of 
enzyme required, vaiying amounts of Taq DNA polymerase were tested using purified 
chromosomal DNA from an IS<5770 single copy MTB strain in a total volume of 50ql 
reaction. The results (Fig. 4.6) show that an enzyme amount as low as 0.25 units gave 
sufficient yield of products for observation on agarose gels. 1 unit of Taq per 50pl 
reaction was chosen as standard throughout this study. This amount of enzyme should 
ensure that the enzyme is slightly but not grossly in excess while at the same time is 
sufficiently economical for large scale usage. Consistent results were obtained in a 
number of preliminary tests using 1.0 unit of enzyme for each 50pl PCR reaction (results 
not shown)
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Lane 1: lOObp ladder D N A  markers
Amount of Tag used (units) Amount of Tag used (units)
Lane 2: 0.25 Lane 5: 4
Lane 3: 1 Lane 6: 8
Lane 4: 2 Lane 7: 10
Note: The template D N A  was 10ng of chromosomal D N A  of an IS6110 single copy strain
Figure 4.6 : Optimisation of Taq DNA polymerase enzyme.
4.3 .5 Final optimised P C R  param eters
Based on the results of the optimisation procedures described above further work using 
multiplex PCR were performed using the following protocol:
Template DNA =10ng or 16pl of processed clinical sample
(see below) 
dNTPs (each) =  200|±mol
MgCl2 =1 .5  mmol
Taq DNA polymerase =  1U  
@ BX 1 primer =  lOOng
BX 2 primer =  lOOng
MM 1 primer =  200ng
MM 2 primer =  200ng
The PCR reaction was done in a total volume of 50fil.
The thermal cycling programme described in Section 4.3.1 was used throughout the rest 
of this study.
0
4.4 Sensitivity and specificity of the multiplex PC R  test
To determine the sensitivity of the test, multiplex PCR was performed using different 
amounts of template DNA (IS6110 single copy MTB strain) ranging from lOOng to lfg 
and the results are shown in Fig. 4.7. The results indicated that the limit of detection of 
this PCR test is lpg of template DNA. Although the detectable level is lower than that 
reported by some workers (Manjunath et al, 1991; Shawar et al, 1993) this sensitivity 
level is comparable to that reported by others (Andersen et al., 1993; Portillo et al, 
1996). The PCR products, after running on agarose gels, were then transferred to a
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^ nylon membrane and probed consecutively with the BX and MM probes as previously
described (Chapter 3). The results shown in Fig. 4.7 (a) and (b) confirms that the 
respective targets were correctly amplified.
The next step in the developmental process is to determine the specificity of this 
multiplex PCR. Recently, Kent et al., (1995), demonstrated that the IS<5770-derived 
primers reported by Wilson et a l (1993), were able to amplify DNA from other 
mycobacterium species such as M. fortuitum, M. kansasii, M  chelonei, M. xenopi, M. 
avium-intracellulare complex and M. malmoense. This is believed to be due to the 
^  presence of other elements of the IS3 family in atypical mycobacteria, and that these
primers were derived from a conserved region of the IS3 family (Kent et al, 1995). The 
data suggested that false-positive results may be obtained if primers derived from this 
region (which is thought to code for the transposase protein of IS 6110) are used, and 
should be avoided.
The IS6110 primers used in this multiplex PCR were derived from an area which is not 
within the region reported by Kent et al (1995) (Fig. 4.1). To determine the specificity 
$  of this test, PCR were performed using lOng of chromosomal DNA from various
atypical species of mycobacteria as templates. Fig 4.8a shows that the BX and MM 
primers did not amplify any of the atypical mycobacteria tested. This was then verified 
by Southern hybridisation using both BX and MM probes (Fig. 4.8b). The results show 
that no products were seen in the lanes where atypical mycobacterial DNA were used as 
templates.
I l l
Lane M: lOObp ladder DNA marker
Amount of template Amount of template
Lane 1: lOOng Lane 6: Ipg
Lane 2: 10ng lane 7: lOOfg
Lane 3: lng Lane 8: 10fg
Lane 4: lOOpg Lane 9: Ifg
Lane 5: lOpg Lane 10: negative control
Note: The template DNA was chromosomal DNA of an IS6110 single copy strain
Figure 4.7(a) Multiplex PCR result with amounts of template DNA.
Lane M: lOObp ladder DNA marker
Amount of template Amount of template
Lane 1: lOOng Lane 6: Ipg
Lane 2: 10ng lane 7: lOOfg
Lane 3: lng Lane 8: 10fg
Lane 4: lOOpg Lane 9: Ifg
Lane 5: lOpg Lane 10: negative control
Figure 4.7(b) Hybridisation results of multiplex PCR (Fig. 4.7a) with BX and MM 
probes.
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Lane 1: lOObp ladder DNA marker Lane 7: M. kansasii
Lane 2: M. xenopi Lane 8: M. simiae
Lane 3: M. vaccae Lane 9: M. avium
Lane 4: M. triviale Lane 10: M. fortuitum
Lane 5: M. phlei Lane 11: Negative control
Lane 6: M. intracellulare Lane 12: M. tuberculosis (positive control)
Figure 4.8(a) Multiplex PCR results using atypical mycobacteria chromosomal DNA.
Lane 1: lOObp ladder DNA marker Lane 7: M. kansasii
Lane 2: M. xenopi Lane 8: M. simiae
Lane 3: M. vaccae Lane 9: M. avium
Lane 4: M. triviale Lane 10: M. for tui turn
Lane 5: M. phlei Lane 11: Negative control
Lane 6: M. intracellulare Lane 12: M. tuberculosis (positive control)
Figure 4.8(b) H ybrid isa tio n  result o f m u ltip lex PCR (F ig. 4 .8a).using B X  and M M  
probes.
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The PCR were then tested with various normal flora and pathogenic organisms of the 
respiratory tract. The PCR results (Fig. 4.9a) were also verified by DNA probes (Fig 
4.9b). The results obtained with atypical mycobacteria and other bacteria confirmed the 
specificity of the B X  and MM primers to M. tuberculosis complex.
Finally, to determine that the test that has been developed will actually work with 
clinical specimens, PCR was carried out using sputum specimens containing high, 
medium and low numbers of AFB. For the purpose of this study, the definitions of high, 
medium and low numbers of organism are >50 AFB/L, 20-30 AFB/3L and <10 AFB/3L 
respectively (the method for scoring the bacterial counts is described in Section 2.2.13). 
These definitions were chosen deliberately to include the centre and extreme ends of the 
range.
The available specimens were screened and the ones with the appropriate AFB loads 
were chosen. Specimens from non-TB cases were also included in the study. The results 
shown in Fig. 4.10 (a) suggest that the test was equally efficient in detecting the 
organism in all three types of specimens. Note that on one of seven specimens with 
microscopy results of 0/3 length was positive by PCR (Fig. 4,10a, lane 12) which was 
also verified by hybridisation (Fig. 4.10b, lane 12). This specimen was later shown to be 
AFB positive by culture. The other 6 AFB negative specimens (by both microscopy and 
culture)(Lane 3, 4, 9, 10, 11, 14) came from patients not suspected as having 
tuberculosis.
During this initial preparatory period it was also noticed that occasionally, bands with 
different sizes (other than the B X  and MM amplification products) were observed on the 
agarose gel. However, these bands did not hybridise with either the B X  or MM probe 
(results not shown).
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Lane 2: Pseudomonas aeruginosa Lane 10: Neisseria meningitides
Lane 3: Streptococcus gp. B Lane 11: Candida albicans
Lane 4: Haemophilus influenzae Lane 12: Neisseria catarrhalis
Lane 5: Enterobacter species Lane 13: Extraction Negative Control
Lane 6: Klebsiella aeruginosa Lane 14: Reagent control
Lane 7: Staphylococcus aureus Lane 15: M. tuberculosis KB29
Lane 8: Escherichia coli Lane 16: M. tuberculosis AS80
Lane 9: Streptococcus pneumoniae Lane 17: lOObp ladder DNA marker
i
Figure 4.9(a) M u ltip le x  PCR using lOng o f chrom osom al D N A  fro m  various norm al 
and pathogenic organism s o f the resp ira tory tract.
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Lane 2: Pseudomonas aeruginosa Lane 10: Neisseria meningitides
Lane 3: Streptococcus gp. B Lane 11: Candida albicans
Lane 4: Haemophilus influenzae Lane 12: Neisseria catarrhalis
Lane 5: Enterobacter species Lane 13: Extraction Negative Control
Lane 6: Klebsiella aeruginosa Lane 14: Reagent control
Lane 7: Staphylococcus aureus Lane 15: M. tuberculosis KB29
Lane 8: Escherichia coli Lane 16: M. tuberculosis AS 80
Lane 9 . Streptococcus pneumoniae Lane 17: lOObp ladder DNA marker
Figure 4.9(b) H ybrid isa tio n  o f m u ltip lex  PCR (F ig. 4.9a) using M M  and B X  probes.
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Lane M : 0X 174H aeIII DNA marker Lane 10: 0/3 L
Lane 1: 15 /3 Length (L ) Lane 11: 0/3 L
Lane 2: 30/3L Lane 12: 0/3 L
Lane 3: 0/3 L Lane 13: 3/3 L
Lane 4: 0/3 L Lane 14: 0/3 L
Lane 5: > 5 0 /L Lane 15: Positive extraction control
Lane 6: >50/L Lane 16: Extraction reagent control
Lane 7: >50/L Lane 17: PCR reagent negative control
lane 8: 45/3L Lane 18: PCR reagent positive control
lane 9: 0/3L
Figure 4.10(a) Multiplex PCR of AFB positive and AFB negative .
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*Lane M: 0X 174H aeIII D N A marker Lane 10: 0/3 L
Lane 1: 15 /3 Length (L) Lane 11: 0/3 L
Lane 2: 30/3L Lane 12: 0/3 L
Lane 3: 0/3 L Lane 13: 3/3 L
Lane 4: 0/3 L Lane 14: 0/3 L
Lane 5: > 5 0 /L Lane 15: Positive extraction control
Lane 6: >50/L Lane 16: Extraction reagent control
Lane 7: >50/L Lane 17: PCR reagent negative control
lane 8: 45/3L Lane 18: PCR reagent positive control
lane 9: 0/3 L
Figure 4.10(b) Hybridisation of multiplex PCR (Fig. 4 .10a) with MM and B X  probe.
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4.5 Controls for the Multiplex PCR
Four controls were ran for each set of PCR reaction: 1). extraction positive (using AFB- 
positive sputum specimens); 2). extraction buffer negative (extraction buffers and 
reagents run in parallel with actual test specimens), 3). PCR positive (using lOng of 
purified DNA from an IS 6110 single copy MTB strain) and 4). PCR negative controls.
4.6 Evaluation of the Multiplex PCR test Using Clinical Specimens
Finally, a large scale evaluation study was conducted in order to determine the accuracy 
and reliability of the PCR test that has been developed using clinical specimens obtained 
from Hospital Universiti Sains Malaysia (HUSM) and Hospital Kota Bharu (HKB), The 
samples were collected and transported to the laboratory in sterile universal bottles. The 
clinicians involved in this collaborative study were requested to send specimens from 
cases with high and low index of suspicion for tuberculosis. The following criteria were 
used to assess the likelihood of tuberculosis in a patient:
i) Chest X-ray showing abnormal changes suggestive of tuberculosis
ii) A Mantoux reaction of >  10mm in diameter to 10 TU of PPD
iii) Prolonged coughing (>3 weeks in duration)
iv) Haemophthysis
V) Prolonged low grade fever (> 3 weeks in duration)
Vi) Weight loss
vii) Night sweats
viii) History of contact with TB patient(s)
ix) Signs and symptoms suggestive of pneumonia but with lack of response to a full 
course of antibiotics.
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The initial diagnosis of TB was confirmed if the patient showed clinical improvement in 
response to anti-tuberculous therapy.
However, to ensure impartiality in interpreting the PCR results, none of these data were 
given with the specimens and the final clinical diagnoses were only obtained at the end 
of the study.
4.6.1 Sample Processing
Upon receipt, the samples were either processed directly on the same day or stored at 
4°C for less than one week. DNA was extracted from these samples using a modification 
of the method described by Wilson et al, (1993). Sputum, urine, pus, bronchial wash 
and gastric lavage samples were homogenised and decontaminated with an equal volume 
of 0.5M NaOH, 0.05M sodium citrate at room temperature for 15 minutes, followed by 
centrifugation at 3500g for 15 minutes. The pellets were washed once with 10ml of 
phosphate buffer (pH6.8). Samples were taken, using wire loops, from each pellet for 
*  Ziehl-Neelsen (ZN) staining and culture onto Lowenstein-Jensen (LJ) media.
The remainder of the pellet was re-suspended in 1ml of 50 mM Tris pH8.3, inactivated 
by incubating in a boiling waterbath for 15 minutes and centrifuged at 12,000g for 5 
minutes. The supernatant was removed and the pellet was vortexed for 1 minute in 
lOOpl of chloroform. Distilled water (100pi) was then added and this was vortexed 
again for at least 1 minute to emulsify with the chloroform phase. The mix was 
transferred to a sterile microfuge tube and the phases were separated by centrifugation 
for 5 minutes in a microfuge. Sixteen microlitres of the aqueous phase was used for PCR 
performed according to the optimised protocol described in Section 4.4.5 and the 
products were analysed by running 20pl of the reaction mix at the end of the 
amplification process in a 1.5% agarose gel.
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Cerebrospinal fluid (CSF) and pleural fluid (PF) samples were treated slightly differently 
from that described above. CSF and PF were first spun down at 3500g for 10 minutes 
and the supernatant was removed. After taking samples from each pellet for culture and 
microscopy as described above, the pellet was resuspended with 1ml of Tris pH8.3 
before proceeding with the inactivation and the rest of the extraction process.
Each specimen was tested once only. PCR was repeated only if any of the 4 controls did 
not give the expected result.
4.6.2 Interpretation of Results
Each PCR test reaction was scored as positive if:
a) both or either one of the B X  and MM product were observed on the gel, and
b) all 4 controls gave the expected results.
•
Similarly, negative results (no bands or bands of unexpected sizes) were only accepted if 
all controls gave the expected results. Although almost all positive results showed the 
presence of both bands, the presence of either one was considered sufficient to be scored 
as positive since it is possible that the B X  primer may not give a product if the strain is 
IS 6110  negative or as the result of priming site mismatches in IS 6110 single copy strain. 
Although no B9 negative strain has yet been found (Musa, 1996), it is a single copy 
element and priming site mismatches can occur.
t
This evaluation study was done to assess the accuracy and performance of the test as a 
rapid and relatively cheap confirmatory assay. Hence, Southern hybridisation was only
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done occasionally as a quality control because it would add considerably to the cost and 
the processing time of the test.
4 .7  E v alu atio n  o f P C R  in A d ult T u b ercu lo sis
4.7.1 Clinical samples for multiplex PCR
A total o f 346 samples were included in this study. 121 samples were collected from the 
Chest Clinic of HKB, 31 from various other clinics and wards of HKB, 162 were from 
various wards and clinics of HUSM and 32 samples were collected from normal healthy 
individuals. The number of each type of samples collected for this study are listed in 
Table 4.3.
4.7.2 PCR Results
The results of the PCR and bacteriological tests in comparison to the clinical diagnosis 
are shown in Table 4.4. The final clinical diagnosis were arrived at by the physician 
involved by taking into account, in addition to the information available at the initial 
point o f admission, other data that became available later such as response to 
chemotherapy and results from further clinical, bacteriological and other laboratory 
examinations. It should also be noted that in some cases the latter data were not 
available because the patient absconded or failed to keep their follow-up appointments 
and the diagnosis is very much dependent on the skill and experience of the attending 
physician.
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Table 4.3 Types of samples collected for evaluation of PCR in adult patients.
Type of sample Total
Sputum 283
Bronchial wash 19
Pleural fluid 18
Urine 9
CSF 7
Pus 6
Gastric lavage 4
Total 346
Table 4.4. Results of PCR, Culture and AFB Smear in Clinically Diagnosed TB and 
Non-TB Adult individuals
Grouo Final Clinical 
Diagnosis
Culture AFB Smear No. of cases PC R
positive
1 TB Positive Positive 86 86
2 TB Positive Negative 9 8
3 TB Negative Positive 26 24
4 TB Negative Negative 34 25
5 TB Contaminated Positive 8 8
6 TB Contaminated Negative 10 10
7 Non-TB
(Healthy
individuals)
Negative Negative 32 0
8 Non-TB
(patients)
Negative Negative 125 9
9 Non -TB 
(patients)
Contaminated Negative 14 8
10 Non -TB 
(patients)
Positive Negative 2 1
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4.7.3 Sensitivity, Specificity and Predictive Values of PCR, Culture and
AFB Smear.
Analysis of the sensitivity and specificity of the PCR test can be done in several different 
ways depending on which factor is taken as the “gold standard”. In many diseases 
culture has always been accepted as the gold standard. However, in diseases such as 
tuberculosis bacteriological methods such as culture and microscopy have many flaws. 
Culture for example takes a long time and contamination is often a problem particularly 
in specimens likely to contain normal flora such as sputum. Microscopy is rapid but 
suffers from the problem of low sensitivity and the bacteriological load in many 
specimens such as CSF is often too low for successful detection. In real life situation 
therefore clinical examination plays a crucial role in diagnosis.
A clinical diagnosis is not 100% reliable of course but nevertheless it is often based on 
several different lines of investigations and coupled with the clinical skill and experience 
of the physician can be remarkably accurate.
In this study therefore, the final clinical diagnosis is taken as the gold standard. The data 
from Table 4.4 are reorganised as shown in Table 4.5.
In order to perform the necessary statistical analyses the following definitions (Park, 
1988) were used:
a =  the total number of true positives that were also positive with the respective
laboratory test.
b =  the total number of true positives that were negative with the respective
laboratory test.
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c =  the total number of true negatives that were positive with the respective
laboratory test.
d =  the total number of true negatives that were also negative with the respective
laboratory test.
The following definitions and formulae (Park, 1988) were then used:
Sensitivity
Sensitivity is defined as the proportion of true positives which are test positive and is 
calculated using the formula:
Sensitivity =  [a/(a+b)j x 100%
Specificity
Specificity is defined as the proportion of true negative which are test negative and is 
calculated using the formula:
Specificity =  [d/(c+d)] x 100%
Positive Predictive Value fPPVl
PPV is defined as the likelihood of a positive test result being a genuine positive and is 
calculated using the formula:
PPV = [a/(a+c)] x 100%
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Negative Predictive Value (NPV)
NPV is defined as the likelihood of a negative test result being a genuine negative and is 
calculated using the formula:
NPV =  [d/(b+d)] x 100%
The sensitivity, specificity and predictive values of each test, calculated using the above 
formulae, are shown in Table 4.6
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^  Table 4.5 Comparison of PCR, Culture and AFB smear results to True Positive and
True Negative.
PCR
+ve
PCR
-ve
Culture
+ve
Culture 
-ve or 
contam.
Smear
+ve
Smear
-ve
True Positive 
(n=173) 161 12 95 78 120 53
True
Negative
(n=173)
18 155 2 171 0 173
Contam = Contaminated, +ve = positive, -ve = negative 
Note:
True positives and negatives are cases where the final clinical diagnosis are TB and non- 
TB respectively.
Table 4.6: Sensitivity, Specificity, PPV andNPV of PCR, Culture and AFB Smear.
PCR Culture Smear
Sensitivity 93.1% 54.9% 69.4%
Specificity 89.6% 98.8% 100%
PPV 89.9% 97.9% 100%
NPV 92.8% 68.7% 76.6%
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4.7.4 Comparison of Sensitivity of PCR, Smear and Culture
S en sitiv ity  o f  PC R
I t  should be noted th a t in  cases w here the c lin ica l diagnosis, cu ltu re  and smear are in  
com plete agreem ent (G roup 1, see Table 4 .4), the PC R  detection  rate was 100% . 
A lth o u g h  th is  gives a good ind ica tion  o f the re lia b ility  o f the PC R  test th a t has been 
developed, there w ere a s ign ifican t num ber o f cases where such agreem ent was n o t seen.
The results presented in  Table 4 .6 show th a t PC R  has the highest sen s itiv ity  fo llo w e d  by 
smear and cu ltu re  respectively. The high sensitiv ity  o f  PC R  is expected and the ra te  o f  
93.1%  is com parable to  m any previous studies (Forbes e t a h , 1993; W ilson  e t a l,  
1993; T o tsch  e t a l., 1994; B eige e t a l,  1995).
The d ifference in  sensitiv ity  between PC R  and m icroscopy o f A F B  smear, the m ost rap id  
conventional d ire c t labora to ry test cu rren tly  available, is sign ifican t. The results suggest 
th a t add itio n  o f  the PC R  test w o u ld  s ign ifican tly  increase the detection  ra te  o f  the  
organism  a llow in g  rap id  com m encem ent o f the appropriate treatm ent.
I t  should also be noted th a t PC R  was able to  provide  con firm ation  o f  tuberculosis in  35 
o u t o f 44 cases (79 .6% ) w here b o th  conventional bacterio log ica l m ethods fa iled  to  do so 
(G roups 4 and 6)  and the diagnoses w ere made solely on c lin ica l grounds. In  add itio n , 
P C R  was able to  p rovide  rap id  con firm ation  in  8 ou t o f 9 cases (8 8 .9% ) w here  
conventional con firm a tion  was provided only by cu ltu re  w h ich  in  contrast w o u ld  have 
taken m ore than a w eek fo r the results to  become available.
The d ifference in  sensitiv ity  between PC R  and cu ltu re  is even m ore s ign ifican t com pared 
to  P C R  and smear. The sens itiv ity  o f  cu ltu re  in  actual fact is unexpectedly lo w  b u t th is  
cou ld  be explained by the fa c t tha t m any o f the patients m ay already be on an ti-
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tubercu lous treatm ent. The negative cu ltu re  results obtained w ere probab ly due to  the  
fa c t th a t m ost o f  the organism s w ere already dead.
In  add ition , the negative cu ltu re  results in  these cases could also be due to  a lo g is tica l 
problem . A ll samples fro m  H K B  could on ly be collected once a w eek. Thus samples 
fro m  H K B  w ere kep t at 4°C before co lle ction  and some w ill have been stored fo r  m ore  
than 2 days before cu ltu re  was perform ed. This may have resulted in  the negative cu ltu re  
results seen in  G roup 3 and probably also account fo r the re la tive ly  h igh num bers o f  
contam inated cu ltures seen in  th is  study (G roups 5, 6, and 9).
•
P C R  False N egative
T w e lve  o u t o f  the 173 cases c lin ica lly  diagnosed as T B  w ere P C R  negative g iv in g  a false  
negative ra te  o f 6.9% .
In  G roup 2 (Table 4 .4 ), 1 ou t o f  the 9 samples was negative by PC R  w h ile  the cu ltu re  
was p os itive  bu t the smear was negative. The negative PC R  resu lt m ay be due to  the  fa c t 
*  th a t the num ber o f  organism s in  the sample (p leura l flu id  in  th is  case) was to o  lo w  to  be
detectable even by PCR. I t  should be noted tha t although the se ns itiv ity  o f  th is  P C R  test 
was determ ined to  be lp g  o f D N A , it  was done using p u rifie d  D N A . In  a real c lin ica l 
specim en, o ther b io log ica l m aterials are present w h ich  m ay be in h ib ito ry  to  the  
e xtra c tio n  process and reduce the sensitiv ity  o f the test. A lte rn a tive ly , the  negative resu lt 
m ay be due to  the presence o f PC R  inh ib ito rs in  th is pa tien t’ s sample o r th a t the  
in fe c tio n  was due to  a typ ica l m ycobacteria.
In  G roup 3, 2 ou t o f 26 samples w ere PCR negative. In  one o f  these cases the  sputum  
sample received was heavily b lood  stained and the PCR cou ld  have been inh ib ite d  by  
heme w h ich  is a poten t in h ib ito r o f  PC R  (Inn is  e t a l, 1990, M e rc ie r e t a l, 1990, K o lk  e t 
a l,  1994).
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In  the second case, a second sputum  specimen was received b u t the results obtained
w ere iden tica l to  the firs t specimen. Thus the negative resu lt m ay be due to  the presence 
o f  P C R  in h ib ito rs  in  th is  p a tien t’ s samples o r tha t the in fectio n  was due to  a typ ica l 
m ycobacteria.
In  G roup 4, 9 samples w ere PC R  negative. In  one case, the sample received (bronch ia l 
w ash) was heavily contam inated w ith  b lood  bu t a second sample sent la te r fro m  th is  
pa tien t was PC R  positive  suggesting tha t the negative resu lt obtained in  the firs t sample 
cou ld  have been due to  inh ib itio n . This patient was also a confirm ed case o f T B
0  reactiva tion .
R eview  o f  the data available fo r the 12 cases showed tha t the c lin ica l presentations o f  
these cases w ere consistent w ith  tuberculosis and the PC R  results are genuine false  
negatives. The m ost lik e ly  cause o f  the false negative results is in h ib itio n  o f  the  PC R  
reaction  (a lthough the p o ss ib ility  o f  in fe ction  due to  atypical m ycobacteria  m ay account 
fo r  some o f these cases).
•  D e te c tio n  o f in h ib itio n  was no t incorporated in to  the PC R  test because o f  several
reasons such as the  po ten tia l problem  o f PC R  com petition  w h ich  m ay reduce the  
se n s itiv ity  o f  the  test. The results obtained here suggest th a t the in h ib itio n  rate is lo w  
enough such th a t detection o f  in h ib itio n  need no t be b u ilt in to  the test.
A d d itio n a l samples was obtained in  on ly 2 o f the 12 false negative cases and one was 
P C R  positive . T esting 2 o r m ore samples fro m  a single pa tien t m ay help resolve  
discrepant results p a rticu la rly  i f  the patient has a h igh index o f  suspicion o f  tubercu losis  
as has been suggested by C larridge e t a l., (1993). Indeed, the value o f  m u ltip le  samples 
w as also seen in  th is  study. F o r exam ple, m u ltip le  samples w ere obtained fro m  m ost o f  
the  PC R  positive  cases in  G roups 4 and 6 where the c lin ica l diagnoses w ere based sole ly
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on c lin ica l grounds. The positive  PC R  results obtained w ith  the add itiona l samples added 
to  the confidence in  the PC R  test and also the c lin ica l diagnosis.
A lte rn a tive ly , the  use o f a m ore e ffective  m ethod o f D N A  e xtra ction  and rem oval o f  
in h ib ito rs  m ay also resolve th is  problem .
4.7.5 Comparison of Specificity of PCR, Smear and Culture
S p e c ific ity  o f  PC R
The P C R  results obtained in  G roup 7 (a ll negative) in  w h ich  the sputum  samples w ere  
taken fro m  32 healthy ind iv idua ls gave a good ind ica tion  o f the  sp e c ific ity  o f  the  PC R  
test and is consistent w ith  data obtained fro m  studies during the  developm ent o f  the  
m u ltip le x  PCR. H ow ever, 18 PC R  positive  results w ere obtained in  the o ther categories 
o f  non-T B  cases g iv in g  an actual spe cific ity  o f  89.6% .
The sp e c ific ity  o f  PC R  obtained in  th is study is com parable to  those reported in  o the r 
studies w h ich  ranged fro m  74%  to  100%  (Eisenach e t a l., 1990; H erm ans e t a l,  1990; 
B risso n -N o e l e t a l,  1991; Forbes e t a l,  1993; Jones e t a l., 1993) A lth o u g h  the  
sp e c ific ity  o f  89.6%  is no t as h igh as th a t obtained by cu ltu re  and smear, th is  resu lt 
should be seen in  the  context o f  the  m uch higher sensitiv ity  o f  PC R  in  com parison to  the  
o th e r tw o  tests.
P C R  False P ositive
P C R  false positives w ere detected in  10.4%  (18 ou t o f 173) o f cases. The false p ositive  
ra te  found  in  th is  study is reasonably lo w  and compares favourab ly w ith  o the r studies 
(N oo rdh oe k e t a l., 1993; N oordhoek e t a l., 1994; D oucet-P opula ire  e t a l,  1996).
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G iven the extensive evaluation o f  the spec ific ity  o f IS 6110 (C la rrid ge  e t a l., 1993, 
Forbes e t a l., 1993; W ilson  e t a l,  1993) and B 9  sequences (M usa e t a l.„  1994; M usa, 
1996) as targets fo r PC R  and the m u ltip lex  PC R  test during th is  study, the false pos itive  
results th a t occurred are lik e ly  to  be due to  contam ination o f the samples. C ontam ination  
o f  samples p a rticu la rly  by am plicons fro m  previous rounds o f am p lifica tio n  is a w e ll 
know n problem  (Persing, 1991). A lthoug h  contro ls w ere included in  each run  o f  
am p lifica tio n  to  detect such contam ination and precautions w ere taken to  reduce it, 
measures taken are no t com plete ly fo o lp ro o f. In  fu tu re  developm ents o f the  test, 
contam ina tion m ay be reduced by fu rth e r im provem ent on various technical aspects to  
elim inate cross-over contam ination and by incorpora ting  the use o f u ra c il N -glycosylase  
(U N G ) in  the  test (K o ik e / a l, 1992; A be e t a l, 1993; K o x  e ta l, 1994).
In  add ition  to  contam ination, some o f the 18 false positive  cases m ay actua lly be due to  
m isdiagnoses. The c lin ica l and labora to ry data o f these 18 cases w ere review ed.
N in e  o u t o f  125 cases in  G roup 8 (Table 4 .4) w ere PC R  positive . A  second specim en 
was obtained in  on ly 1 o f  the 9 false positive  cases in  th is group b u t PC R  was also 
p ositive  w ith  the  second sample and it  seems lik e ly  tha t th is  case was a m isdiagnosis. N o  
fu rth e r in fo rm a tio n  w ere available fo r the other 8 cases.
In  G roup 9 (Table 4 .4), 8 ou t o f 14 cases in  th is  group w ere PC R  positive . A d d itio n a l 
samples w ere no t obtained fo r m ost o f  the 8 cases bu t a review  o f  the c lin ica l data  
yie lded some useful in fo rm a tio n  fo r 5 o f  these cases.
One pa tien t was a confirm ed case o f  pulm onary tuberculosis w ho was supposed to  have 
com pleted his treatm ent and thus the  PC R  m ay either have detected dead M T B  o r the  
treatm ent was ine ffective . In  the second case, the 75 year o ld  pa tien t had a M an tou x  
reaction  o f  15mm and an ESR  resu lt o f  115. In  the th ird  case, the patient was diagnosed 
as having bronch ia l asthma bu t a second specimen received fro m  th is  pa tien t was also
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P C R  positive . The fo u rth  case was a 65 year o ld  patient w ith  collapsed rig h t lung and an 
E S R  o f 120. The fifth  patient was a 69 year o ld  man w ith  p roductive  cough o f  3 m onths 
duration . T herefore the actual diagnoses, c lin ica l h is to ry  o r the  observed c lin ica l 
m anifestations do n o t ru le  ou t the po ss ib ility  o f tuberculosis in  5 o f  the 8 cases o f PC R  
false positives in  G roup 9.
L a s tly , the  tw o  cases in  G roup 10 (Table 4 .4 ) appear lik e ly  to  be m isdiagnoses as 
cultu res w ere positive  and PC R  fo r one o f these cases was also positive .
R eview  o f  the 18 false positive  cases suggests th a t some appear to  be obvious  
m isdiagnoses whereas the po ss ib ility  o f tuberculosis cannot be ru led  o u t in  some others. 
I f  such cases w ere taken in to  account the spec ific ity  o f the PC R  test w o u ld  a ctua lly  be 
higher than the calculated fig u re  described above.
4.7.6 Comparison of Predictive Values of PCR, Smear and Culture
P red ic tive  values are dependent on the ra tio  o f tru e  positives to  tru e  negatives (u n like  
the  se n s itiv ity  and sp ec ific ity  values). Thus the values obtained w ill depend on the leve l 
o f  T B  in  the specimens exam ined, w h ich  in  a re a l-life  s itua tion  w ill depend on the  level 
o f T B  in  the popu la tion  and on the w ay the clin ic ian  choose the specimens to  be 
analysed.
The P P V  o f PC R  o f 89.9%  com pares favourab ly w ith  those p reviously  reported  in  the  
lite ra tu re  (D ’A m ato  et. a l., 1995). A lthoug h  P P V  o f PC R  is less than tha t obtained fo r  
cu ltu re  and smear, the fig u re  is fa irly  h igh and seen in  the context o f  its  h igh sens itiv ity  
suggest tha t th is  test w o u ld  be a useful add ition  to  T B  d iagnostic m ethods. P P V , in  
s im ila rity  to  spec ific ity , is affected by false positive  results. Thus in  a s im ila r m anner to
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^  sp ec ific ity , P P V  o f PC R  w o u ld  be h igher i f  the m isdiagnosed cases w ere taken in to
account.
In  con trast to  P P V , N P V  o f  PC R  is the highest com pared to  cu ltu re  and smear and is 
expected g iven the h igh sensitiv ity  o f PCR. Thus, the high P P V  and N P V  obtained w ith  
P C R  suggest th a t th is  test w ou ld  be useful in  a T B  endem ic co un try  such as M alaysia  
and w o u ld  grea tly assist in  resolving cases w hich  are d iffic u lt to  diagnose especially 
w hen the  presenting signs and sym ptom s are unclear.
^  In  add itio n , the sens itiv ity  and ra p id ity  o f  the test (w h ich  could  perhaps be im proved
upon) m ay assist the c lin ic ian  to  detect tuberculosis during the firs t v is it a llo w in g  the  
appropria te  treatm ent to  be institu ted  as soon as possible and th a t the necessary 
in fo rm a tio n  are obtained fo r the health authorities to  ensure pa tien t com pliance. This  
w o u ld  help to  reduce the num ber o f cases lo s t th rough fa ilu re  o f  the  patients to  attend  
th e ir fo llo w -u p  appointm ents.
4.8 E v alu atio n  o f  P C R  In  P a e d ia tr ic  T u b ercu lo sis
The recent increase o f  tuberculosis w o rld -w id e  both in  industria lised and developing  
countries has stim ulated in terest in  childhood tuberculosis. In  the  U n ite d  States alone, it  
has been reported  tha t there was a 35%  increase in  n o tifica tio n  cases in  ch ild ren less 
than 15 years o ld  fro m  1985 to  1992 (C D C  rep o rt 1993). In  the developing countries, 
the  incidence o f ch ild  tuberculosis is o ften  d iffic u lt to  estim ate and the  on ly  gu ide is the  
num ber o f  ch ild ren referred to  tuberculosis centre fo r treatm ent.
In  M alaysia, a study o f ch ildhood tuberculosis by the M in is try  o f  H ea lth  showed th a t the  
ove ra ll num ber o f  incidence have no t shown an increasing trend fro m  1987 to  1995
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(Tab le  4 .7 ). A  m ore detailed analysis appear to  show an increasing trend  in  incidence in  
the E ast M alaysian state o f Sabah bu t no t in  the state o f Sarawak and the  states in  W est 
M alaysia.
The ris k  o f  tuberculosis in  exposed ch ildren is quoted as up to  42%  in  those less than 1 
year o ld , 24%  in  ch ildren aged between 1-5 years and 15% in  adolescents (age 11-15 
years o ld ) com pared to  5-10%  o f im m unolog ica lly norm al adults (S tarke  e t a l., 1992). 
Tuberculosis in  ch ildren are m ore o ften  extrapulm onary w ith  a h igh  m o rta lity  ra te  due to  
dissem inated disease and m eningitis (S tyb lo  and Sutherland, 1982). In  contrast to  adu lt 
tuberculosis, bacte rio lo g ica l tests in  childhood tuberculosis are o ften  negative. 
C on firm a tion  by sputum  smear o r cu ltu re  is uncom m on except in  o ld e r ch ildren, and 
exam ination o f  gastric aspirates is usually reserved fo r problem  cases, fo r  exam ple, H IV -  
in fected  ch ild ren w ith  negative tubercu lin  tests o r where drug resistance is suspected. In  
develop ing countries, im m unosuppression associated w ith  o the r in fections and 
m a ln u tritio n  m ake the diagnosis in  ch ildren m uch m ore d iffic u lt to  assess. P revious B C G  
vaccination, and po o r q u a lity  chest X -rays also added to  the d iffic u lty  in  in te rp re ta tio n  
o f  the  disease (H a rt e t a l,  1996). Thus paediatricians o ften  have to  reso rt to  a tr ia l o f  
chem otherapy (H a rt e t a l, 1996).
The d iffic u lty  in  establishing rapid diagnosis o f  tuberculosis in  general and in  the  
paedia tric popu la tion  in  pa rticu la r, has led to  considerable in terest in  the  developm ent o f  
rap id  tests fo r T B . The PC R  test tha t was developed was there fo re  evaluated using  
samples fro m  paedia tric cases.
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Table 4.7 Childhood tuberculosis cases in Malaysia from 1970 to 1995
W e st M a la y s ia E ast M a la ys ia
Y e a r P e n in s u la r
M a la y s ia
Sabah S a ra w a k T o ta l in  M a la y s ia
1970 104 111 18 232
1975 100 74 56 230
1980 75 125 60 260
1985 76 145 181 402
1986 81 140 183 404
1987 73 186 51 310
1988 94 165 62 321
1989 111 135 70 316
1990 98 140 63 301
1991 113 140 47 284
1992 89 148 47 284
1993 98 148 44 288
1994 84 184 43 275
1995 84 161 42 287
* 4.8.1 Samples from Paediatric Cases
The fo rm a t and technical procedures used in  th is  evaluation study w ere iden tica l to  tha t 
used fo r  the  adu lt cases a lthough na tu ra lly  the p ro p o rtio n  o f each type o f  sample sent fo r  
P C R  d iffe r som ewhat m ostly due to  the d iffic u lty  in  obtain ing sputum  samples fro m  
paedia tric  patients. Table 4.8 shows the numbers received fo r each type  o f sample.
A  to ta l o f  68 paedia tric cases w ere used in  th is  evaluation study o f  w h ich  25 cases w ere  
c lin ic a lly  diagnosed as T B  w h ile  43 w ere cases though t to  be non-T B .
*
Table 4 .8 : Types and num bers o f samples collected fo r the evaluation o f  PC R  in  
paedia tric  tuberculosis.
Type of sample Total
Sputum 17
B ronch ia l wash 1
P leural flu id 3
U rin e 8
CSF 2
G astric lavage 37
Total 68
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# 4.8.2 Test Results
The results o f  the PC R  and bacte rio log ica l tests obtained in  th is  study are show n in  
Table 4.9.
4.8.3 Sensitivity, Specificity and Predictive Values of PCR, Culture and
AFB Smear.
The data fro m  Table 4.9 are reorganised as shown in  Table 4.10
Based on the figures in  Table 4.10 the sensitiv ity, spec ific ity  and p red ic tive  values o f  
each test w ere calculated and are shown in  Table 4.11
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Table 4.9 R esults o f  c lin ica l diagnosis, bacterio log ica l and PC R  tests in  ch ildhood  
tuberculosis
Grouu Final Clinical 
Diagnosis
Culture AFB Smear No. of cases PC R
nositive
1 T B P ositive P ositive 2 2
2 T B P ositive N egative 7 6
3 T B N egative N egative 12 7
4 T B Contam inated P ositive 1 1
5 T B Contam inated N egative 3 3
6 N on  -T B
(patients)
N egative N egative 41 11
7 N o n  -T B  
(patients)
C ontam inated N egative 2 1
Table 4.10: True  positive  and T rue negative value
PCR
+ve
PCR
-ve
Culture
+ve
Culture 
-ve or 
contam.
1
Smear
+ve
Smear
-ve
True Positive 
(n=25) 19 6 9 16 3 22
True
Negative
(n=43)
12 31 0 43 0 43
Contam = Contaminated, +ve= positive, -ve = negative
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T a b le  4 .11: S ensitiv ity, S pecific ity  and P red ictive  Values o f PCR, C u ltu re  and A F B  
Smear calculated based on figures in  Table 4.10.
PCR Culture Smear
Sensitivity 76% 36% 12%
Specificity 72.1% 100% 100%
PPV 61.3% 100% 100%
NPV 83.8% 72.9% 66.2%
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4.8.4 Comparison of Sensitivity of PCR, Smear and Culture in Paediatric
cases
S en sitiv ity  o f  PC R
Table 4.9  shows th a t PC R  was positive  in  9 ou t o f 10 cases (90% ) w here the c lin ica l 
diagnoses o f T B  w ere supported by one o r bo th  bacterio log ica l tests (G roups 1, 2, and 4  
respective ly). A  review  o f  the c lin ica l records show tha t the organism  iso la ted fro m  the  
one patient in  w h ich  PC R  was negative (Table 4.9, G roup 2 ) was id e n tifie d  as an 
atyp ica l M ycobacte rium . Thus, i f  th is  pa rticu la r case is excluded, the actual agreem ent 
betw een the  PC R  and bacte rio log ica l tests is 100% .
These 10 cases also illu s tra te  the p o in t tha t in  contrast to  adu lt cases, conventional 
lab o ra to ry  con firm a tion  o f tuberculosis o ften  relies m ore on cu ltu re  (9  o u t o f  10 cases) 
ra the r than smear exam ination (3 ou t o f  10) w h ich  is consistent w ith  o ther reports in  the  
lite ra tu re  (F auville -D afaux e t a l., 1996). The excellent agreem ent betw een PC R  and 
cu ltu re  h igh lig h ts the u tility  o f PC R  in  diagnosis o f T B  in  paedia tric patients p a rticu la r as 
i t  is a m uch m ore rap id  test than cu lture.
The sens itiv ity  o f  PC R  in  paedia tric cases is low e r than th a t found  in  adults. H ow ever 
the  num ber o f  paedia tric cases are m uch lo w e r than in  adults w h ich  m ay a ffect the  
accuracy o f  the  result. O n the other hand the differences in  sens itiv ity  o f PC R  w hen  
com pared to  cu ltu re  and smear are even m ore significant.
P C R  False N egative
False negative PC R  occurred in  24%  o f cases diagnosed as T B . The false negative PC R  
resu lt obtained in  one o f the cases in  G roup 2 has already been explained. H ow ever, 5
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cases (o u t o f  12) in  G roup 3 w ere also negative by PCR. The fo llo w in g  data (Table  
4 .12)  w ere obtained fo llo w in g  a review  o f the c lin ica l and additiona l la bo ra to ry  records:
Three patients in  th is  group (N os. 1, 2 and 3 respectively) had 5 samples sent fo r  
analysis and a ll w ere consistently negative except patient 1 w ho had one sample pos itive  
w ith  PCR. Thus the samples fro m  these 3 patients appear to  consistently conta in  PC R  
in h ib ito rs  o r the bacteria l load is to o  lo w  even fo r PC R  o r the pathogens invo lved  are 
atyp ica l m ycobacteria. P atient 4 had one additional sample w hich  was P C R  positive . The  
c lin ica l record  fro m  the last patient in  th is group did no t contain fu rth e r details.
The data seem to  suggest th a t m u ltip le  samples may no t necessarily im prove  the  
se n sitiv ity  rate. H ow ever, it  should be noted tha t sensitiv ity  m ay be h igher i f  a m ore  
appropria te  specimen was sent fo r PCR. F o r example, in  cases o f  lym phadenopathy, the  
num ber o f  organism s in  a lym ph biopsy m ight be higher than in  a gastric  lavage (the  
m ost com m on specimen sent regardless o f the m ajor site o f in fe c tio n ) and thus easier fo r  
P C R  to  detect.
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Table 4.12 R eview  o f  the c lin ica l and additional labora to ry records o f  5 cases (o u t o f  
12) in  G roup 3.
«
N o P atient C lin ica l data A d d itio n a l labora to ry  results
1 K K S Lym phadenopathy, ca lc ified  cavity  on  
chest X -ra y , M an toux reaction o f  
14mm diam eter
5 add itiona l samples sent; a ll w ere  
smear and cu ltu re  negative but 
one was PC R  positive
2 L C F Fever, breathlessness, abnorm ality  
seen on chest X -ra y , M antoux  
reaction o f 18mm
5 add itio na l samples sent; a ll w ere  
cu ltu re , smear and P C R  negative
3 N P rolonged fever, H illa ry  
lym phadenopathy, M an toux reaction  
o f 20mm in  diam eter and h isto ry o f  
contact w ith  T B  patient
5 add itiona l samples sent; a ll w ere  
cu ltu re , smear and PC R  negative.
4 W N I Lym phadenopathy, fever, cough, n ight 
sweats, h is to ry  o f T B  contact and 
M a nto ux reaction  o f 15mm
1 add itiona l sample sent; cu ltu re  
and smear w ere negative bu t PC R  
was positive
5 M A “ T B ” . N o  o ther additional data N one
i
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4.8.5 Comparison of Specificity of PCR, Smear and Culture
S p e c ific ity  o f PC R
The sp e c ific ity  o f  PC R  obtained in  th is  study (72.1% ) compares qu ite  w e ll w ith  some o f  
the  studies p reviously reported in  the lite ra tu re  w h ich  ranges fro m  74%  to  100%  
(B risson-N oe l e t a l., 1989; Eisenach e t a l., 1990; Herm ans e t a l,  1990; Forbes e t a l., 
1993; Jonqs e ta l., 1993).
The sp e c ific ity  o f  PC R  though is low e r w hen com pared to  both  cu ltu re  and smear (bo th  
100% ). H ow ever, as in  the case o f adu lt T B , th is  result needs to  be seen in  the  con text 
o f  the  se ns itiv ity  o f PC R  w h ich  is m uch higher than both cu ltu re  and sensitiv ity.
P C R  False P ositive
P C R  w as p ositive  in  12 o u t o f 43 cases w hich w ere c lin ica lly  diagnosed as non-T B  
(T ab le  4.10, G roups 6 and 7) g iv ing  a false positive  rate o f 27.9% . The resu lt is m uch  
higher than 7%  reported by D oucet-P opula ire  et. a l., (1996). The false p os itive  rate  
obtained in  th is  evaluation study is also no t consistent w ith  the m uch lo w e r rates 
obtained during  the  developm ent o f  the test and in  the adu lt study. The data fro m  
patients w ith  PC R  false positive  results w ere review ed and are shown in  Table 4.13
Three cases appear to  be obvious cases o f  false positive  PC R  even w ith  repeat samples 
(P atients 9, 10 and 11 respectively). These appear to  be cases o f  non-T B  since the  
patients responded to  norm al a n tib io tic  treatm ent (patients 9 and 11 respective ly) o r 
recovered w ith o u t any an ti-m icrob ia l therapy (patient 10). A  rev iew  o f  the labora to ry  
record  shows th a t in  each respective case, the m u ltip le  samples fro m  the pa tien t w ere
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received, processed and tested at the same tim e. Thus contam ination cou ld  have 
occurred at an early stage during  processing resulting in  the false pos itive  resu lt in  
m u ltip le  samples fro m  each patient. These cases also suggest th a t m u ltip le  samples fro m  
a single patien t should n o t be processed at the same tim e.
P atien t 4 had no add itiona l samples bu t th is  appear to  be a genuine case o f  P C R  false  
p o s itive  since the patient responded to  a norm al course o f  antib io tics.
P a tien t 7 also clearly appear to  be a case o f  genuine PCR false pos itive  (firs t sam ple) as 
C ryptococcus was isolated and the patient responded to  an ti-funga l treatm ent. T w o  
add itiona l samples (taken and processed at d iffe ren t tim es fro m  the firs t) w ere PC R  
negative w h ich  h igh ligh ts the  value o f  repeated samples.
H ow ever, 4 cases had add itiona l samples th a t w ere also PC R  positive  and th e ir c lin ica l 
presentations do n o t ru le  o u t T B  (patients 3, 5, 6, and 8). In  the case o f  P atien t 5 one o f  
the  add itiona l samples was also cu ltu re  positive. U n fo rtuna te ly, no fu rth e r details  
regard ing treatm ent and response could be e lic ited  fro m  the records. N o  fu rth e r details  
w ere available fro m  the o ther three patients (patien t 1, 2 and 12 respective ly).
The data described above show tha t in  a num ber o f cases the p o ss ib ility  o f T B  cannot be 
ru led  out. Thus i f  these cases w ere taken in to  account the sp e c ific ity  o f  the PC R  test in  
paedia tric  cases w o u ld  actually be higher than the calculated figu re .
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Table 4.13 Review of the data from patients with PCR false positive.
No Patient Clinical data Additional laboratory results
1 M I “ N o n -T B ” . N one
2 S N H “ N o n -T B ” . N one
3 K B H Pneum onia, pro longed cough, 
fever, cerebral palsy, 
abnorm ality seen in  chest X -ra y
2 additiona l samples sent w ere also P C R  
positive
4 RS C onfirm ed pneum onia. P atient 
responded to  standard course o f  
antib io tics
N one
5 M IQ Subdural e ffusion 2 additiona l samples sent; P C R  was 
positive  in  b o th  second and th ird  
samples, cu ltu re  was p ositive  in  the  th ird  
sample
6 CS B ronchopneum onia, fever, 
cough, shortness o f breath, 
cerebral paralysis
2 additiona l samples sent; b o th  cu ltu re  
and smear negative bu t P C R  w ere  
positive
7 N M Pneum onia, no h is to ry  o f T B , 
chest X -ra y  norm al, 
C ryptococcus was isolated
2 additiona l samples sent; b o th  cu ltu re , 
smear and PC R  negative
8 A B B roncho  asthma 2 add itiona l samples sent; b o th  cu ltu re  
and smear negative b u t P C R  w ere  
positive
9 M F P leura l effUsion, fever, cough, 
S taphylococcus aureus isolated. 
P atient im proved on norm al 
antib io tics.
2 add itiona l samples sent; b o th  cu ltu re  
and smear negative b u t PC R  w ere  
positive
10 SF V ira l fever, m alnourished, 
patient w e ll on fo llo w  up a fte r 3 
m onths
1 additiona l sam ple sent; cu ltu re  and 
smear negative bu t PC R  was p ositive
11 N H A cute  laryngo trach itis , 
resolved on a n tib io tic  therapy
2 add itiona l samples sent; bo th  cu ltu re  
and smear negative b u t PC R  w ere  
positive
12 M S “ N o n -T B ” N one
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# 4.8.6 Comparison of Predictive Values of PCR, Smear and Culture
The re la tive ly  h igh  PC R  false positive  cases na tu ra lly  affected the  P P V  o f  P C R  (61.3% ). 
H ow ever, th is  should also be seen in  the context o f the h igher se ns itiv ity  o f  PC R  
com pared to  the o the r tests. Furtherm ore the P P V  w ou ld  be h igher i f  cases o f  possible  
m isdiagnoses w ere taken in to  account.
N P V  o f PC R  how ever is highest am ongst the three tests com pared. T h is suggests th a t 
P C R  w o u ld  g rea tly  help the c lin ic ian  to  reduce the risk  o f unnecessary an ti-tubercu lous  
am ongst paedia tric patients p a rticu la rly  i f  m u ltip le  samples and the use o f m ore rigo ro us  
procedures to  elim inate cross contam ination and reduce in h ib itio n  o f  PC R  are 
incorpora ted  in to  fu tu re  developm ents o f the test. This w o u ld  lik e ly  resu lt in  increased 
se n sitiv ity  and sp e c ific ity  and thus be tte r p red ictive  values.
4 .9  D iscussion
S ensitiv ity
The results obtained indicated th a t the m u ltip le x  PC R  developed in  th is  study show  
good se nsitiv ity  in  bo th  adu lt (93 .1% ) and paediatric cases (76 % ). The results obtained  
in  th is  study are consistent w ith  o ther reports in  the lite ra tu re  (A lta m iran o  e t a l 1992, 
W ilso n  e t a l, 1993, Totsch e t a l, 1994, F auville -D ufaux e t a l., 1996). The sensitiv ities  
in  b o th  types o f cases w o u ld  be higher in  fact i f  the cases w here obvious m isdiagnoses 
(such as cases diagnosed as non-T B  bu t w ith  subsequent cu ltu re  pos itive  results o r 
w here PC R  w ere consistently positive  in  m u ltip le  specimens fro m  the same pa tien t) have 
occurred are taken in to  account.
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The lo w e r se nsitiv ity  obtained in  paedia tric cases is to  a certa in  extent affected by the  
m uch sm aller num ber o f  cases used fo r the analysis. Inappropria te  samples sent fo r PC R  
m ay also p lay an im portan t ro le . Three o f the 4 genuine false pos itive  paedia tric cases 
(T ab le  4 .12 ) fo r exam ple had lym phadenopathy bu t m u ltip le  samples o f  gastric lavage 
w ere sent, m ost o f  w h ich  w ere PC R  negative. M a te ria l fro m  b iopsy o f  the affected  
lym ph node in  each case m ay have yie lded positive  results.
In h ib itio n  o f PC R  is a recognised problem  (B risson-N oel et. a t., 1991; N o lte  e t a l., 
1993; C la rridge  e t a l., 1993; H aw key, 1994). The in h ib itio n  m ay account fo r  some o f  
the  false negative PC R  results found  in  th is study. The add ition  o f  a in h ib itio n  detection  
system  was no t included in  the study fo r fo u r reasons. F irs t, such a system w h ich  w ou ld  
enta il sp ik ing  the sample w ith  a ta rge t am plifiab le by the same set o f  prim ers, w o u ld  
resu lt in  com petition  th a t m ay affect sensitiv ity. Second, the detection  o f  in h ib itio n  does 
n o t actua lly  resolve the question o f w hether the specimen contained M  tu b e rcu lo s is  o r 
not. T h ird , the add itiona l step w o u ld  add to  the chances o f in tro d u c in g  contam ination. 
F o urth , in  cases w here T B  are s trong ly suspected, additiona l samples can be easily 
collected and tested. The best so lu tion  is actually to  develop o r use D N A  extra ction  
m ethods th a t can rem ove in h ib ito rs  w ith  a high degree o f e ffic iency w ith  m inim al 
add itio n  to  cost.
One o the r possible reason fo r false negative results are lo w  num bers o f  organism s in  the  
specimens o r in fe c tio n  caused by atypical m ycobacterium  w h ich  w ill n o t be detected by  
the prim ers used in  th is  study. This needs to  be addressed in  fu tu re  developm ents o f  the  
P C R  assay.
A n  im po rtan t p o in t gained fro m  th is  evaluation study was th a t m u ltip le  samples fro m  
each pa tien t are o ften  useful in  resolving discrepant results and is consistent w ith  the  
find ing s o f  C larridge e t a l (1993) and D eva llo is et. a l,  (1996). Thus m u ltip le  samples (3
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o r m ore) should be tested i f  the assay is to  be incorporated as pa rt o f  ro u tin e  lab o ra to ry  
diagnosis.
A d d itio n  o f  a hybrid isa tion  step may im prove sensitiv ity  bu t M anjunath  e t a l (1991), 
reported  th a t hyb rid isa tion  a fte r PC R  neither increased the sens itiv ity  no r the sp e c ific ity  
o f  th e ir assay over agarose gel electrophoresis detection o f the am plified  p roduct. Th is  
suggestion is con tra ry to  m ost o the r reports (N o lte  e t a l, 1993; Shawar e t a l., 1993 ) 
w h ich  found  increased sensitiv ity  w ith  hybrid isa tion  bu t the re la tive ly  h igh  leve l o f  
se n s itiv ity  found  w ith  the m u ltip le x  PC R  used in  th is study perhaps do n o t w arran t 
add itio na l steps tha t w ou ld  increase the cost and processing tim e o f  the assay.
O ther m ethods to  increase sensitiv ity  such as nested PC R  (M iya za k i e t a l,  1993), re- 
a m p lifica tio n  o f negative samples (P ierre  e t a l., 1991), reverse hybrid isa tion  (M angiapan  
e t a l,  1996), ca lo rim e tric  detection (W ilson  e t a l, 1993), m ore e ffic ie n t D N A  e xtractio n  
m ethods and rem oval o f in h ib ito rs  (B u ck  e t a l, 1992, K ocagoz e t a l 1993, Perera e t a l., 
1994, A m icosante e t a l,  1995) and many others w ere no t tested bu t cou ld  be 
incorpora te d  in  fu tu re  developm ents o f th is  m u ltip lex  assay.
The sensitiv ity  o f the m u ltip le x  PC R  assay in  both  adult and paedia tric cases w ere higher 
than th a t o f  e ither cu ltu re  o r smear. The difference is p a rticu la rly  m arked in  paed ia tric  
cases w h ich  are w e ll know n to  be d iffic u lt to  con firm  by conventional la bo ra to ry  
m ethods. Thus, th is  assay w ill be a very useful add ition  to  clin icians in  the  fu tu re  in  the  
diagnosis o f  tubercu losis p a rticu la rly  i f  prim ers to  detect some o f  the c lin ica lly  im po rtan t 
atyp ica l m ycobacteria are included.
S p ec ific ity
The sp e c ific ity  o f  IS 6I70-based am p lifica tion  assays has recently been questioned (K e n t 
et. a l,  1995, H e llye r et. a l, 1996). Prim ers fro m  IS 6110  used in  th is  m u ltip le x  system
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was ca re fu lly  designed to  avoid the regions reported earlier. B y  using know n cu ltures  
fro m  9 species o f  m ycobacteria o ther than M . tu b e rcu lo sis , there w ere no false positives  
in d ica tin g  the  h igh sp ec ific ity  o f the PC R  assay described here (section  4.4, fig . 4.11a,b). 
H ow ever, in  the c lin ica l com parison tria l, the specific ity  o f  the m u ltip le x  PC R  was found  
to  be 89.6%  and 72.1%  in  adu lt and paediatric cases respective ly com pares w e ll w ith  
those obtained in  o ther studies, w h ich  are between 74%  to  100%  (B risson -N oe l e t a l., 
1989; Eisenach e t a l., 1990; Herm ans e t a l,  1990; Forbes e t a l., 1993; Jones e t a l., 
1993).
M u ch  higher sp e c ific ity ’ s w ere expected based on the results o f m any studies regard ing  
the  sp e c ific ity  o f 186110 (C la rridge  e t a l., 1993; Forbes e t a l., 1993; W ilson  e t a l, 
1993) and B 9  (M usa, 1996) sequences and prim ers (determ ined by lab o ra to ry  studies 
using p u rifie d  D N A  o f  num erous species o f m icro-organism s as tem plates). A  sp e c ific ity  
o f  100%  was indeed seen w hen samples fro m  32 healthy ind iv idua ls (Table 4 .4 ) w ere  
tested.
H ow ever, false pos itive  results w ere observed in  both  adu lt and paedia tric  cases. This  
how ever is no t unexpected and false positive  PC R  have been reported  in  m any studies 
(B risson-N oe l e ta l., 1989; Eisenach e ta l., 1990; Herm ans e ta l, 1990; Pao e t a l., 1990; 
Persing, 1991; Cousins e t a l,  1992; Forbes e t a l., 1993).
G iven the  h igh specific ities o f the targets to  members o f  the M  tu b e rcu lo s is  com plex  
and the use o f ve ry s tringent am p lifica tion  param eters, false positive  results m ust be due 
to  contam ination o f samples o r reagents by chrom osom al D N A  o r m ore lik e ly  by  
am plicons fro m  previous am plifica tions (Persing, 1991).
In  add itio n  to  adhering to  procedures to  m inim ise cross contam ination, m any 
labora to ries use an am plicon d igestion system by using inco rp o ra tio n  o f  dU TP  instead o f  
dTTP  and d igestion o f the U TP  contain ing am plicon by uracil-N -g lucosylase  (K o lk  e t
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a l, 1992; Abe e l a l, 1993; K o x  e t a l, 1994). H ow ever, N oordhoe k e t a l, (1994 and 
1996 respective ly) reported th a t in  th e ir b lind  studies conducted am ong several 
laboratories, h igh levels o f  false p o s itiv ity  w ere found even in  labora to ries using th is  
system.
G ood la bo ra to ry  practice, standardisation o f reagents, m on ito rin g  o f the perform ance o f  
the  w ho le  assay there fo re  p lay very crucia l central roles in  ensuring h igh sp e c ific ity  o f  
the  test w h ile  o ther m ethods o f contam ination prevention should be used on ly  to  
com plem ent them . A d d itio n a lly , testing  o f 3 o r m ore samples o f  the  appropria te  type  
fro m  each pa tien t should also ensure accuracy o f the results and reduce the chances o f  
fa lse p o s itiv ity .
P red ic tive  Values
The re la tive ly  h igh p red ic tive  values (P P V  89.9% , N P V  92.8%  in  adults and P P V  
61.3% , N P V  83.8%  in  ch ildren respectively) suggests tha t th is  m u ltip le x  PC R  assay w ill 
be a useful add ition  to  rou tin e  labora to ry diagnosis o f  tuberculosis even in  endem ic 
countries. H ow ever, fu rth e r technical and procedural im provem ents need to  be done to  
increase sen s itiv ity  and p a rticu la rly  spec ific ity  i f  the test is to  be included as pa rt o f  
ro u tin e  diagnostics.
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C h a p t e r  5
Chapter 5
Conclusion and Future W ork
5.1. Characterisation of IS 6110 in Malaysian single copy strains of
M. tuberculosis
E a rlie r studies have shown th a t IS M  10 in  m ost single copy strains is located in  the same 
p o s itio n  on the chrom osom e (Fom ukong et. a l., 1994). I t  was th oug h t th a t the  IS  
elem ent in  these organism s is defective in  transposition w hich  occurred in  a stra in  at the  
ve ry  early stage in  the evaluation process o f  the M . tub e rcu lo s is  com plex and the single  
copy stra in  are actua lly  the d irect descendants o f th is “ ancient stra in” . C om parison o f  
published sequence o f IS 95(5 and IS 957  shows tha t ORFa is the fundam ental reg ion  o f  
the  IS . The aim  o f th is  study was to  characterise the sequence o f  the O RFa reg ion  in  
M alaysian M  tu b e rcu lo s is  single copy strain. The results fro m  th is  study suggest
1. The inse rtion  sequence on the M alaysian single copy strains M . tu b e rcu lo s is  w ere  
iden tica l to  IS 957.
2. A  com parison o f  th is  sequence and a sequence fro m  a recently active copy o f  th is  
elem ent showed th a t the sequences w ere identica l. This led to  a re-exam ination o f  the  
o rig in a l cloned copy o f IS 986 and showed tha t the sequences o f  a ll the elem ents w ere  
iden tica l and th a t the differences between the published sequences o f  IS95<5 and 
IS 95 7  w ere due to  sequencing errors.
3. These results suggest th a t the elements in  B C G  and in  single copy strains are actua lly  
fu lly  capable o f  transposing and the m o b ility  o f  the IS  elem ent depends on the  
tran scrip tion a l a c tiv ity  o f the flank ing  chrom osom al reg ion  and n o t w ith in  the IS  
itse lf.
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# 5.2. Multiplex PCR system
A  m u lti-p rim e r P C R  system  perm ittin g  the am plifica tio n  o f  tw o  d iffe re n t m ycobacteria l
sequences, IS 6110 and the BP sequences, was developed and evaluated in  these studies.
The m u ltip le x  PC R  was show n to  be h igh ly e ffic ien t in  detecting D N A  o f  M .
tu b e rcu lo s is  fro m  c lin ica l samples. P otentia l advantages o f the m u ltip le x  PC R  system
m e rit m ention :-
1. The IS  6110  is present in  one to  tw en ty  copies in  M . tu b e rcu lo s is  strains a lthough  
0  strains lacking  IS 6110  have been reported. In  contrast, the BP sequence appears to  be
present in  a ll strains o f  M  tu b e rcu lo s is  tested and strains no t conta in ing  th is  sequence 
have n o t ye t been found. The m u lticopy nature o f  IS 6770 provides a good ta rg e t fo r  
a m p lifica tio n  and the BP sequence provides a good backup fo r  the  detection  o f  the  
unusual IS 6110-negative strains.
2. C om bination o f BP and IS 6770 derived prim ers in  the m u ltip le x  P C R  p ro v ide  a h igh  
degree o f confidence in  the results as both  are h igh ly specific fo r  M T B  com plex.
0
3. E va lua tio n  study o f  the m u ltip lex  PC R  using c lin ica l samples showed th a t th is  system  
is sensitive (93.1%  in  adu lt cases and 76%  in  paediatric cases) and specific (89.6%  in  
adu lt cases and 72.1%  in  paedia tric cases)
4. The experience gained fro m  th is  study suggests tha t at least 3 o r m ore specimens 
should be sent fo r PC R  to  reduce the rate o f false p o s itiv ity  and false negativ ity .
5. The sp e c ific ity  o f  IS6770-based am plifica tio n  assays has recently been questioned  
(K e n t et. a l., 1995, H e llye r et. a l, 1996). Prim ers fro m  IS 6770 used in  th is  m u ltip le x  
system  w ere ca re fu lly  designed to  avoid the regions reported earlier. F u rth e r PC R
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g w ith  various species outside the M . tu b e rcu lo sis  com plex w ere tested and the prim ers
show n to  be specific.
In  conclusion, th is  m u ltip le x  PC R  assay provides an e ffic ie n t stra tegy to  detect and 
id e n tify  M . tu b e rcu lo s is  fro m  c lin ica l samples and perform s w e ll in  com parison w ith  
cu ltu re .
5 .3 . F u tu re  w o rk
#
1. T o  study the flan k ing  regions o f  IS 6110  and the postulated fram esh ift reg ion  o f  
O R Fa-O R Fb in  order to  determ ine the factors w h ich  regulate transposab ility  o fIS 6 7 7 0 .
2 . T o  im prove  the sensitiv ity  and spe cific ity  o f the m u ltip le x  PC R  test by inco rp o ra tin g  
m ore e ffic ie n t m ethods o r procedure fo r extracting  D N A , rem oval o f  in h ib ito rs  fro m  
c lin ica l specimens and prevent contam ination.
157
C h a p t e r  6
Chapter 6 
References
Abe, C ., H osojim a, S. &  Fukasawa, Y . (1992) Com parison o f  M B -C he ck, B A C T E C  
and egg-based m edia fo r recovery o f m ycobacteria. J. C lin . M ic ro b io l. 30: 878-881.
A be, C ., H irano , K ., W ada, M ., K azm i, Y ., Takahashi, M .,Fukasaw a, Y ., Y oshim ura, 
T ., M iya g i, C ., and G oto , S. (1993) D etection  o f M ycobacte rium  tu b e rcu lo s is  in  
c lin ica l specim en by Polym erase Chain R eaction and G ene-Probe am plified  
M yco b a cte riu m  tu b e rcu lo s is  d irect test. J. C lin . M ic ro b io l. 31:12; 3270-3274.
A lbergh ina, M ., N ic o le tti, G ., &  T o rris i (1973) G enetic determ ination o f  am inoglycoside  
resistance in  strains o f M ycobacte rium  tu b e rcu lo sis . C hem otheraphy. 19: 148-160.
A lta m ira no , M ., K e lly , M .T ., W ong, A ., Besscille, E .T ., B lack, W .A ., &  Sm ith, J.A . 
(1992) C haracterisation o f  a D N A  probe fo r detection o f  M yco b a cte riu m  
tu b e rcu lo s is  com plex in  c lin ica l samples by polym erase chain reaction. J. C lin . 
M ic ro b io l 30: 8; 2173-2176.
A m icosante, M ., P icheld i, L ., T re n ti, G ., Paone, G ., Campa, M ., B is e tti, A ., &  S a ltin i, 
C. (1995) In a c tiva tio n  o f polym erase inh ib ito rs  fo r M yco b a cte riu m  tu b e rcu lo s is  
D N A  a m p lifica tio n  in  sputum  using capture resin. J. C lin . M ic ro b io l. 33: 3; 629- 
630.
A nargyros, P ., A s till, D .S .J., &  L im  L .S . (1990) Com parison o f  im proved B A C T E C  
and Low enstein-Jensen m edia fo r cu ltu re  o f m ycobacteria fro m  c lin ica l specimens. J. 
C lin . M ic ro b io l 28: 1288-1291.
Andersen, A .B ., Thybo, S., G odfrey-Faussett, P., &  S toker, N .G . (1993) Polym erase  
chain reaction  fo r detection o f M ycobacte rium  tu b e rcu lo sis  in  sputum . E u r. J. C lin . 
M ic ro b io l In fe c t. 12: 12; 922-921.
A nnual R e po rt (1995) M in is try  o f  H ea lth  M alaysia.
A th w a l, R .S ., D eo, S.S., &  Im aeda, T ., (1984) D N A  relatedness am ong
M yco b a cte riu m  lep rae , M ycobacte rium  lepraem urium  and selected bacteria  by do t 
b lo t and spectrophotom etric D N A  hybrid isa tion  assays. In t. J. Syst. B a c te rio l. 34: 
371-375.
158
Baess, I. &  M ansa B . (1978) D eterm ina tion  o f  genome size and base ra tio  fro m  
deoxyribonucle ic acid o f m ycobacteria. A cta  P ath . M ic ro b io l. S c a n d B 86, 309- 
312.
Banerjee, A ., Dubnau, E ., Q uem ard, A ., Balasubram anian, V ., U m , K .S ., W ilson , T ., 
C o llins, D ., de L is le , G. &  Jacobs, W .R . Jr. (1994) inhA , a gene encoding a ta rge t 
fo r  ison iazid  and ethionam ide in  M ycobacte rium  tu b e rc id o sis. S cience  : 263; 227- 
230.
Beam , E .R . &  K ubica, G.P. (1986). S tim u la to ry effects o f  carbon d io x id e  on the  
prim ary  iso la tion  o f tubercle  b a c illi on agar contain ing m edium . Am . J. C lin . P a th . 
50: 395-397.
B eck-S ague, C ., D oo ley, S .W ., H u tto n , M .D ., Breeden, A ., C ra w fo rd , J .T ., P itchen ik,
A .E ., W oodley, C ., Cauthen, G. &  T arris, W .R . (1992) O utbreak o f m u ltid ru g  
resistant M ycobacte rium  tu b e rc id o s is  in fections in  a hosp ita l: transm ission to  
patients w ith  H IV  in fe c tio n  and staff. JA M A . 268: 1280-1288.
B eige, J., L o k ie s, J., Schaberg, T ., F inckh, U ., Fischer, M ., M auch, H ., Lode, H ,, 
K o h le r, B . &  R o lfs , A . (1995) C lin ica l evaluation o f M yco b a cte riu m  tu b e rcu lo s is  
P C R  assay. J. C lin . M ic ro b io l 33: 1 ; 90-95.
B h a tti, N ., L a w , M .R ., M o rris , J .K ., H a lliday, R. &  M o o re -G illo n , J. (1995) Increasing  
incidence o f tuberculosis in  England and W ales: a study o f  lik e ly  causes. B M J. 310: 
967-969.
B ishop, P.J. &  N eum ann, G. (1979) The h is to ry  o f  Z iehl-N eelsen stain. T ubercle  51: 
196-206.
B lo om , B .R . &  M u rra y  C .J.L . (1992) Tuberculosis: C om m entary on a re-em ergent 
k ille r. S cience 257: 1055-1064.
B oddinghaus, B ., R oga ll T ., F lo h r, T ., B lo cke r H . &  B o ttg e r E .C . (1990) D e te c tio n  
and id e n tifica tio n  o f  m ycobacteria by am p lifica tion  o f  rR N A . J. C lin . M ic ro b io l 28: 
1751-1759.
B rad ley, S.G. (1973) R elationships am ong m ycobacteria and N orcadiae based upon  
deoxyribonucle ic acid re-association. J. B a d . 113:645-651.
B risson-N oe l, A ., Lecossier, D ., N assif, X ., G icquel, B ., Levy-F rebau lt V . &  H ance A .J.
(1 989) R apid diagnosis o f  tuberculosis by am plifica tion  o f m ycobacteria l D N A  in  
c lin ica l samples. L a n ce t i i : 1069-1072.
159
B risson-N oe l, A ., A znar, C. Chureau, C ., N quen, S., P ierre, C ., B a rto li, M ., B onete, R ., 
O alloux, R .G ., G icquel, B . &  G arrighe G. (1991) D iagnosis o f tubercu losis by D N A  
a m p lifica tio n  in  c lin ica l practice evaluation. Lancet. 338: 364-366.
B ro w n , P. (1992) The re tu rn  o f  the b ig  k ille r. New S cie n tis t. 10: 30-37
B u ck, G .E ., L ila , C. O ’H ara &  James, T.S . (1992) R apid, sim ple m ethod fo r tre a ting  
c lin ica l specimens conta in ing M ycobacte rium  tu b e rcu lo sis  to  rem ove D N A  fo r  PCR. 
J ; C lin . M ic ro b io l. 30: 5; 1331-1334.
B uesching, W ., Solom on, M ., &  Puchalski, T . (1991) Id e n tifica tio n  o f  c lin ica l isolates  
o f m ycobacterium  by gas chrom atography. In : A b stra c ts  o f the 91st a n n u a l m eeting  
o f the A m erican  S ocie ty fo r  M ic ro b io lo g y ; M ay 1991; D allas, A b stra ct 144.
Carpels, G ., F issetle, K ., Lim bana, V ., van D eun, V anderbulke, W ., P ortaels, F. (1995) 
D ru g  resistant tuberculosis in  Sub-Sahara A frican : an estim ation o f  incidence and 
cost fo r  the year 2000. Tuber &  L u n g D is . 76: 6 : 480-486.
Cave, M .D ., Eisenach, K .D ., Salfinger, M ., Bates J.H . &  C ra w fo rd  J.T . (1992) 
U sefulness o f 186110 in  fin g e rp rin tin g  D N A  o f M yco b a cte riu m  bovis. M ed. 
M ic ro b io l. L e tt. 1 : 96-102.
C entre o f  Disease C o n tro l [C D C ] (1990) N osocom ial transm ission o f  m u ltid ru g  
resistance tuberculosis to  healthcare w orkers and H IV -in fe c te d  patients in  an urban  
hospita l. F lo rid a M M W R  39: 718-722.
C entre o f  Disease C o n tro l [C D C ] (1991) N osocom ial transm ission o f  M D R  am ong 
H IV -in fe c te d  person-F lorida  and N e w  Y o rk  1988-1991. M M W R  40: 585-591.
C entre o f  Disease C o n tro l [C D C ] (1992) Transm ission o f  M D R  am ong im m uno­
com prom ised persons in  a correctiona l system -N ew  Y o rk . M M W R  41: 507-507
C entre o f  Disease C o n tro l [C D C ] (1993) Tuberculosis m o rb id ity  - U n ite d  States 1992. 
M M R W . 42: 696-704.
C irillo , J.D ., B arle tta , R .G ., &  Jacob, W .R . Jr. (1991) A  novel transposon trap  fo r  
m ycobacteria: iso la tion  and characterisation o f  IS 1096. J. B a c te rio l. 173: 7772- 
7780.
C la rk-C urtiss , J.E. Jacobb, W .R . Jr, D ocherty, M .A ., R itch ie , L .R . &  C urtis , R . I l l  
(1985) M o le cu la r analysis o f D N A  and construction  o f  genom ic lib ra ries o f  
M yco b a cte riu m  le p ra e . J. B a c te rio l, 161:1093-1103.
160
C lark-C urtiss , J.E ., &  D ocherty, M .A . (1989) A  species-specific sequences in  
M yco b a cte riu m  lep rae  D N A . J. In fe c t D is . 159: 7-15.
C la rridge , J.E. I I I . ,  Shawar, R .M ., Shinnick, T .M ., &  P likaytis , R .B . (1993) Large-scale  
use o f  P C R  fo r detection o f M ycobacte rium  tu b e rcu lo s is  in  a rou tin e  
m ycobacterio logy laborato ry. J  C lin . M ic ro b io l. 31: 2094-2056.
C o llins, C .H ., Yates, M .D . &  Grange, J.M . (1982) S ub-d ivision o f  M yco b a cte riu m  
tu b e rcu lo s is  in to  fiv e  variants fo r epidem io logical purposes: M ethods and 
nom enclature. J o u rn a l o f H yg iene. 89:235-242.
C o llins, D .M . &  D E  Lissle, G .W . (1984) D N A  re s tric tio n  endonuclease analysis o f  
M yco b a cte riu m  tu b e rcu lo s is  and M ycobacte rium  bovis  B C G . J. C lin . M ic ro b io l. 
130: 1019-1021.
C o llins, D .M ., &  D e L issle, G .W . (1985a) D N A  re s tric tio n  endonuclease analysis o f  
M yco b a cte riu m  bovis  and other members o f  the tuberculosis com plex. J. C lin . 
M ic ro b io l 21; 4: 562-564.
C o llins, C .H ., Grange, J.M ., &  Yates, M .D . Eds(1985b) O rg a n isa tio n  a n d  P ra c tic e  in  
T ubercu losis  B a c te rio lo g y . Publ: B u tte rw o rth  &  Co. L td ., England.
C o llins, D .M ., G abric, D .M . &  D e Lissle, G .W . (1990) Id e n tifica tio n  o f  tw o  groups o f  
M ycobacte rium , p a ra tu b e rcu lo s is  strains by re s tric tio n  endonuclease analysis and 
D N A  hybrid isation. J. C lin . M ic ro b io l 28; 1591-1596
C o llins, D .M . &  Stephens, D .M . (1991) Id e n tifica tio n  o f an insertion  sequence, IS 1081, 
in  M ycobacte rium  bovis. F E M S M ic ro b io l L e tt, 83: 11-16,
C o llins, F .M . (1993) Tuberculosis: The re tu rn  o f an o ld  enemy. C ritic a l R eview  in  
M ic ro b io lo g y . 19: 1-16.
C o ld itz , G .A ., B rew er, T .F ., B erkey, C .S., W ilson, M .E ., B u rd ick , E ., F ineberg, H .V . &  
M o ste lle r F. (1994) E ffica cy  o f B C G  vaccine in  the prevention  o f  tubercu losis : 
m eta-analysis o f  the published lite ra tu re . J. Am er. M e d ic. Assos. 271; 698-702.
C onnie, R ., M . &  W illia m , F. N . (1993) Tuberculosis: The U ltim a te  H ea lth  R isk? C lin . 
La b . S ci. 6; 2 : 94-97.
C ooper, G .L ., G range, J .M ., M cG regor, J.A . &  M cFadden, J.J. (1 989) The po ten tia l 
use o f D N A  probes to  id e n tify  and type strains w ith in  the  M yco b a cte riu m  
tu b e rcu lo s is  com plex. L e tte r in  A p p lie d  M ic ro b io lo g y . 8; 127-130.
161
^  Cousins, D .V ., W ilto n , S .D ., Francis, B .R ., &  G ow , B .L . (1992) U se o f  polym erase
chain reaction  fo r rap id  diagnosis o f tuberculosis. J. C lin . M ic ro b io l. 30: 1; 255-258.
C raw fo rd , J .T ., &  Bates, J.H . (1979) Iso la tio n  o f plasm id fro m  m ycobacteria  In fe c t. 
Im m uno l. 24; 978-981.
C ra w fo rd , J.T ., &  Falkinham , J.O. I I I .  (1990) Plasm ids o f the M yco b a cte riu m  avium  
com plex. In : M o le c u la r B io lo g y  o f the M yco b a cte ria . M cFadden, J.J. Ed. London, 
Surrey U n ive rs ity  Press. 97-119.
D ale, J.W . (1995) M o b ile  genetic elements in  m ycobacteria. E u r. R esp ir. Jo u r. 633- 
648.
D ’ A m ato  R .F ., W illia m , A .A ., H ochstein, L .H ., C olaninno, P .M ., Scardam aglia, M .,
•  A rd ila , E ., G houri, M ., K im , K .M ., Patel, R .C ., &  M ille r, A . (1995) R apid  diagnosis
o f  pu lm onary tuberculosis by using R oche A m p lico r M yco b a cte riu m  tu b e rcu lo s is  
P C R  Test. J. C lin . M ic ro b io l 33: 7; 1832-1834.
D anie l, T .M ., &  DeBanne, S .M . (1987) The serodiagnosis o f  tubercu losis and o ther 
m ycobacteria l disease by enzym e-linked im m unosorbant assay. Am . Rev. R esp ir. 
D is . 135: 1137-1151.
D anie l, T .M  .(1989) R apid diagnosis o f tuberculosis: La bo ra to ry  techniques applicable  
in  developing countries. R eview  o f In fe c tio u s  D iseases. 2. Suppl. 2, 471-478.
0  Das, S., Chan, S L., A leen, B .W ., M itch iso n , D .A . &  L o w rie , D .B . (1993) A p p lica tio n
o f  D N A  fin g e rp rin tin g  w ith  IS 956  to  sequential m ycobacterial isolates obtained fro m  
pulm onary tuberculosis in  H ong K ong  before, during and a fte r short-course  
chem otherapy. Tuber. &  L u n g  D is  ; 74: 47-51.
D avies, P .D .O . (1995) Tuberculosis and m igration. J. R. C o ll Phys. Lond . 29: 113- 
118.
D e  W it, L . Steyn, S. Shoem aker &  Sogin, M . (1990) D ire c t de tection  o f  
M yco b a cte riu m  tu b e rcu lo s is  in  c lin ica l specimens by D N A  am p lifica tion . J. C lin . 
M ic ro b io l. 28: 11: 2437-2441.
> D eva llo is , A . Legrand, E  &  R astogi, N . (1996) E valuation o f  A m p lico r M T B  Test as
adjunct to  smears and cu ltu re  fo r d irect detection o f M ycobacte rium  tu b e rcu lo s is  in  
the  French Caribbean. J. C lin . M ic ro b io l. 34: 5; 1065-1068.
i 162
D oucet-P opula ire , F ., Lalande, V ., C arpentier, E ., B ourgo in , A ., D a illo u x , M .} B o lle t, 
C ., Vachee, A ., M o ina rd , D ., Texier-M angien, J., Carbonneke, B . &  G rosset, J. 
(1996) A  b lind  study o f  the polym erase chain reaction fo r  the  detection  o f  
M yco b a cte riu m  tu b e rcu lo s is  D N A . Tubercle & L u n g D is . 77: 358-362.
D o lin , P .J., R avig lione, M .C . &  K och i, A . (1994) G lobal tuberculosis incidence and 
m o rta lity  during  1990-2000. B u ll W o rld  H e a lth  organ. 72: 213-220.
D rum m er, M . &  Szabo, V . (1992) R apid non-rad iom etric id e n tifica tio n  o f  
M yco b a cte riu m  tu b e rcu lo s is  and M . a v iu m -in tra c e llu la re  using A ccuprobe and 
S epti-check A F B  system. In : A b s tra c t o f the 92th  A n n u a l m eeting  o f the A m erican  
S ocie ty fo r  M ic ro b io lo g y , M ay 1992: N e w  Orleans. A bstract U 35.
E d lin , B .R ., J .I. Tokars, J .I., G rieco, M .H ., C raw ford , J.T ., W illiam s, J., S o rd illo , E .M ., 
O ng, K .R ., K ilb u m , J.O ., D oo ley, S.W . &  H olm berg, S.D. (1992) A n  outbreak o f  
m ultid rug -resistan t tuberculosis am ong hospitalised patients w ith  the  acquired  
im m unodeficiency syndrom e. N . E ng. J. M ed. 326: 1514-1521.
E isenach, K .D ., C raw fo rd , J.T ., &  Bates, J.H . (1988) R epetitive  D N A  sequences as 
probe For M ycobacte rium  tu b e rcu lo sis. J. C lin . M ic ro b io l. 2240-2245
Eisenach, K .D ., Cave, D ., Bates J.H . &  C raw ford , J.T. (1990) Polym erase chain 
reaction  o f  a rep e titive  D N A  sequence specific fo r M ycobacte rium  tu b e rcu lo s is . J. 
In fe c t. D is . 161: 977-981.
E lln e r, J.J., &  W a llis , R .S. (1989) Im m unolog ica l aspects o f  m ycobacteria l in fection . 
R ev. In fe c t. D is  11 Suppl. 2: S455-S459.
E lln e r, J.J., H inm an, A .R ., D ooley, S .W ., F ischl, M .A ., S epkow itz, K .A ., G oldberger, 
M .J ., Shinnick, T .M ., Iseman, M .D ., &  Jacobs Jr., W .R .. (1993) Tuberculosis  
sym posium : E m erging problem s and prom ise. J. In fe c t. D is . 168: 537-551.
E narson, D . (1992) Tuberculosis forgotten? Tuber. &  L u n g  D is . 73: 69-70.
E rlic h , H .A . E d .(1989 ) PC R  Technology -  P rin c ip le  and  A p p lic a tio n  fo r  D N A  
a m p lific a tio n : S tockton  press.
Falkinham , J.O ., &  C raw fo rd , J.T. (1994) Plasmids. In :. T u b e rcu lo sis : P athogenesis, 
P ro te c tio n  an d  C o n tro l. B lo om  B .R . Ed. W ashington D C , A S M  Press; pp. 185-198.
F auville -D u fa u x, M ., W aelbroeck, A ., D e M o l, P ., V anfle te ren, B ., Le vy , L ., 
Debusschere, P. &  Farber, C .M . (1996) C on trib u tio n  o f  the polym erase chain  
reaction  to  the  diagnosis o f  tuberculosis in fectio n  in  children. E u r. J. P a d ia tr. 155: 
106-111.
Fom ukong, N .G ., D ale, J.W ., O sborn T .W . &  Grange, J.M . (1992) U se o f  gene probes 
based on the insertion  sequence IS 9#6  to  d iffe ren tia te  between B C G  vaccine strains. 
Jo u r. A p p l. B a d . 72, 126-133.
Fom ukong, N .G . &  D ale, J.W . (1993) Transpositional a c tiv ity  o f  IS 956  in  
M yco b a d e riu m  sm egm atis. Gene; 130: 99-105.
Fom ukong, N .G ., Tang, T .H ., A l-M am aary, S., Ib rahim , W .A ., Ramayah, S., Y ates, M ., 
Z ainudd in  Z .F . &  D ale, J.W . (1994) Inse rtion  sequence typ in g  o f  M yco b a d e riu m  
tub e rcu lo sis '. C haracterisation o f a w idespread subtype w ith  a single copy o f  IS 9#6: 
Tuber. & L u n g D is . 75, 435-440.
Forbes, B .A . &  H icks, K .E .S . (1993) D ire c t detection o f M ycobacte rium  tu b e rcu lo s is  
in  re sp ira to ry  specimens in  c lin ica l labora to ry by polym erase chains reaction. J. C lin . 
M ic ro b io l. 31: 1687-1694.
F o rd , E .G ., Snead, S .J., T odd, J. &  W arren, N .G . (1993) S trains o f M yco b a cte riu m  
te rra e  com plex w h ich  react w ith  D N A  probes fo r M yco b a d e riu m  tu b e rcu lo s is  
com plex, J. C lin . M ic ro b io l. 31: 10; 2805-2806.
F orm ico la , V ., M ilanesi, Q. &  Scarsini, C. (1987) Evidence o f  spinal tubercu losis at the  
beginning o f  the fo u rth  m illennium  B C  fro m  Arene Candide Cave (L ig u ria , Ita ly ) 
Am . J. Phys. A n th ro p o l. 72: 1-6.
Galas, D .J. &  C handler, M ., (1989) B acteria l Inse rtion  Sequences. In : M o b ile  D N A . pp 
109-162. B erg  D .E . and H ow e M .M . Eds A m erican S ociety fo r  M ic ro b io lo g y , 
W ashington D .C . 209-162.
G range, J.M . (1980) M y c o b a c te ria l D isease. London: E dw ard A rn o ld
G range, J.M . (1982) The G enetics o f M ycobacteria  and M ycobacteriophages In  The 
B io lo g y  o f M yco b a cte ria , v o l 1: J. S tam ford and C. R atledge. Eds. Academ ic Press
G range, J.M . E d .(1988 ) M y c o b a c te ria l an d  H um an D isease. P ub l.: E dw ard  A rn o ld
G range, J.M . (1989) The rapid diagnosis o f  paucibacillary tuberculosis. T ubercle . 70: 
61-64.
G rassi, C. &  Peona, V . (1995) N ew  drugs fo r tuberculosis. E u r. R esp ir. S uppl. 
(D enm ark) 20: 714s-718s.
164
Green, E .P ., T izard ., M .L .V ., M oss, M .T ., Thom son., J., W in te rboum e, D .J., 
M cFadden, J.J. &  H erm on-T aylo r, J.(1989) Sequence and characte ristic  o f  IS 900, 
an inse rtion  elem ent iden tifie d  in  a human chron’ s disease isolated o f  M yco b a cte riu m  
p a ra tu b e rcu lo s is . N u c le ic  A c id  R esearch. 17, 9063-9073.
G rosskinsky, C .M ., Jacob, W .R ., C la rk-C urtiss, J.E. &  B loom , B .R . (1989) G enetic 
re la tionsh ips am ong M ycobacte rium , le p ra e , M ycobacte rium  tu b e rcu lo s is  and 
candidate leprosy vaccine strains determ ined by D N A  hybrid isa tion ; id e n tifica tio n  o f  
an M ycobacte rium  le p ra e -specific  repe titive  sequence. In fe c tio n  a n d  Im m u n ity , 57, 
1535-1541
G uerrero, C ., B em sconi, C ., B u rk i, D ., B odm er, T . &  Te lenti, A . (1995) A  novel 
inse rtion  elem ent fro m  M ycobacte rium  avium , IS 7275, is a specific  ta rg e t fo r 
analysis o f stra in  relatedness. J. C lin . M ic ro b io l. 33: 304-307.
G u ilh o t, C ., G icquel, B ., D avis, J. &  M a rtin , C. (1992) Iso la tio n  and analysis o f  
IS 6720, a new  IS  fro m  M ycobacte rium  sm egm atis. M o l M ic ro b io l 6 : 107-113.
Hance, A .J., Grandcham p, B . &  Levy-F rebau lt (1989) D e tection  and id e n tifica tio n  o f  
m ycobacteria l D N A . M o l M ic ro b io l. 3: 843-849.
H a rt, C .A ., Beeching, N .J. &  D uerden, B .L  (1996) Tuberculosis in to  the  next century. 
J. M ed. M ic ro b io l. 44: 1-34.
H aw key, P .M . (1994) The ro le  o f polym erase chain reaction  in  the  diagnosis o f  
m ycobacteria l in fections. Rev. M ed. M ic ro b io l. 5: 1; 21-32.
H e llye r, T .J., D esJardin, L .E ., A s s a f, M .K ., Bates, J.H ., Cave M . D . &  Eisenach, K .D . 
(1996) S pecific ity  o f  IS6770-based am plifica tion  assays fo r M yco b a cte riu m  
tu b e rcu lo s is  com plex. J. C lin . M ic ro b io l 34: 2843-2846.
Herm ans, P .W .N ., van Soolingen, D ., D ale, J.W ., Schuitem a, A .R ., M cA dam , R .A ., 
C atty  D . &  van Em bden, J .D .A  (1990) Insertion  elem ent IS 986 fro m  
M yco b a cte riu m  tu b e rcu lo s is : A  useful to o l fo r diagnosis and ep idem io logy o f  
tuberculosis. J. C lin . M ic ro b io l 28: 2051-2058. J. C lin . M ic ro b io l. 34: 2843-2846.
H erm ans, P .W .M ., van Soolingen, D ., B ik , E .M ., D e Hass, P .E .W ., D ale, J.W . &  van  
Em bden, J.D .A . (1991) Inse rtion  elem ent IS 957  from  M yco b a cte riu m  bo vis  B C G  is 
located in  a ho t-spo t in teg ra tio n  reg ion fo r insertion elem ents in  M yco b a cte riu m  
tu b e rcu lo s is  com plex strains. In fe c tio n  an d  Im m u n ity, 59, 2695-2705.
H ernandaz Perez, M ., Fom ukong, N .G ., H e llyer, T ., B row n , I  N . &  D ale, J.W . (1994) 
C haracterisation o f  IS 7770, a h igh ly  m obile genetic elem ent fro m  M yco b a cte riu m  
avium . M o l M ic ro b io l 1 2 : 717-724.
165
0 H orsburg , C .R . &  Selik, R .M . (1989) The epidem io logy o f dissem inated non­
tubercu losis m ycobacterial in fe ctio n  in  acquired im m une deficiency syndrom e. Am  
R ev R e sp ir D is . 139:4
H u ll, S .I., W allace, R .J., &  B obey, D .G . (1984) Presence o f  am inoglycoside  
acetyltransferase and plasm ids in  M ycobacte rium  fo rtu itu m . Am . Rev. R esp ir. D is . 
129: 614-618.
Inn is , M .A ., G elfand, D .H ., Sninsky, J.J. &  W hite , T.J. E ds.(1990) PC R  p ro to c o ls  : a  
gu id e  to  m ethods a n d  a p p lic a tio n . Academ ic Press, In c ., N ew  Y o rk .
Jonas, V ., A lden, M .J. &  C urry, J.I. (1993) D etection  and id e n tifica tio n  o f  
M yco b a cte riu m  tu b e rcu lo s is  d ire c tly  fro m  sputum  sediments by a m p lifica tio n  o f  
rR N A . J. C lin . M ic ro b io l. 31: 2410-2416.
1
K e n t, L ,  M cH ugh, T .D ., B illin g to n , 0 ., D ale J.W . &  G illesp ie , S .H . (1995) 
D em onstra tion  o f  hom ology between 186110 and D N A s o f  o the r m ycobacterium  
species. J. C lin . M ic ro b io l. 33: 3: 2290-2293.
K ocagoz, T ., Y ilm az, E ., O zkara, S., K ocagoz, S., H ayran, M ., Sachedera, M ., and
Chambers, H .F . (1993) D etection  o f M ycobacte rium  tu b e rcu lo s is  in  sputum  by  
P C R  using a s im p lified  procedure. J. C lin . M ic ro b io l. 31: 6; 1435-1438.
K o ch i, A . (1991) The g lobal tuberculosis s itua tion  and the new  co n tro l stra tegy o f  the  
W o rld  H ea lth  O rganisation. T ubercle. 72: 1-6.
I
K o lk , A .H .J ., A .R .J. Schuitem a, A .R .J.,. K u ijp e r, S., van Leeew en, J.,. Herm ans, 
P .W .M  ., van Em bden J.D .A . &  H artskeerl, R .A . (1992) D e tection  o f  
M yco b a cte riu m  tu b e rcu lo s is  in  c lin ica l samples by using polym erase chain reaction  
and a non-rad ioactive  detection system. J. C lin . M ic ro b io l. 30: 2567-2575.
K o lk , A .H .J ., N oordhoe k G .T ., D e Leeuw , O. &  van Em bden, J .D .A . (1994) 
M yco b a cte riu m  sm egm atis strain fo r detection o f  M ycobacte rium  tu b e rcu lo s is  by  
PC R  used as in terna l co n tro l fo r in h ib itio n  o f am p lifica tio n  and q u a n tifica tio n  o f  
bacteria. J. C lin . M ic ro b io l. 32: 5; 1354-1356.
K o x , L .F .F ., R hienthong, D ., M edo M .A ., U dom santisuk, N ., E llis , K ., van Leeuw en, J., 
k van Heusden, S., K u ijp e r S. &  K o lk , A .H .J  (1994) A  m ore re liab le  PC R  fo r
detection  o f  M ycobacte rium  tu b e rcu lo s is  in  c lin ica l samples. J. C lin . M ic ro b io l. 32; 
3 :6 7 2 -6 7 8 .
i 166
K rits k i, A .L ., M argnes, M .J., Rabahi, M .F ., Andrade, L .M ., V ie rra , M A ., W erneck- 
B arroso , E ., C arvalho, C .E ., Andrade, G. de N ., B ravo-de-S ouza, R ., G o n tijo , P .P., 
R ile y, L .W . (1996) Transm ission o f tuberculosis to  close contacts o f  patients w ith  
m u ltid ru g  resistant tuberculosis. Am . J. R esp ir. D is . 153: 1: 331-335.
K unze, Z .M ., W a ll, S., A ppleberg, R ., S ilva, M .T ., Portaels F. &  M cFadden, J.J (1991) 
IS 907, a new  m em ber o f a w idespread class o f a typ ica l inse rtio n  sequences is 
associated w ith  pathogenicity in  M ycobacte rium  avium . M o l M ic ro b io l 5; 9: 2265- 
2272.
K unze, Z .M ., P ortaels, F. &  M cFadden, J.J. (1992) B io lo g ica l d is tin c t subtypes o f  
M yco b a cte riu m  avium  d iffe r in  possession o f insertion sequence IS 907. J. C lin . 
M ic ro b io l. 30: 2366-2372.
L a b id i, A ., D augnet, C ., G oh, K .S . &  D avid , H .L . (1984) P lasm id p ro file s  o f  
M yco b a cte riu m  fo rtu itu m  com plex isolates. C u rre n t M ic ro b io lo g y . 11: 235-240.
Lecossier, P .C .D ., Boussougant, Y ., B ocart, D ., Joly, V ., Y em i P. &  Hance, A .J. (1991) 
U se o f  a re -am p lifica tio n  p ro to co l im proves sensitiv ity  o f  de tection  o f  
M yco b a cte riu m  tu b e rcu lo s is  in  c lin ica l samples by am p lifica tio n  o f  D N A . J. C lin . 
M ic ro b io l. 29: 712-717.
M angiapan, G ., V o ku rka , M ., Schouls, L ., Cardranel, J., Lecossier, D ., van Em bden, J. 
&  Hance, A .J. (1996) Sequence capture-P C R  im proves de tection  o f  m ycobacteria l 
D N A  in  c lin ica l samples. J. C lin . M ic ro b io l. 34: 5; 1209-1215.
M angtan i, P ., Jo lley, D .J., W atson, J.M . &  R odrigues, L .C ., (1995) S ocio-econom ic  
depriva tion  and n o tifica tio n  rates fo r tuberculosis in  Londo n during  1982-91. B M J. 
310: 963-966.
M anjuna th , N ., Shankar, P ., Rajan, L ., Bhargava, A ., Saluja, S., &  S hriniw as (1991) 
E va lu a tio n  o f  a polym erase chain reaction fo r the diagnosis o f  tuberculosis. T ubercle  
72: 21-27.
M a rtin , C ., Ranes, M ., &  G icquel, B . (1990a) P lasm ids, a n tib io tic  resistance  a n d  
m ob ile  g e n e tic  elem ents in  m ycobacteria '. In  M o le c u la r B io lo g y  o f the  
M y co b a c te ria : M cF a dde n  J.J. E d. Surrey Press. 121-129.
M a th a i, A ., Radha K rishnan, V .V . &  Thom as, M . (1991) R apid diagnosis o f  
tuberculosis m eningitis w ith  D o t Enzym e Im m unoassay to  detect an tibody in  
cerebrospinal flu id . E u r. J. M ic ro b io l In f. D is . 10: 440-444.
167
M cA dam , R .A ., Herm ans, P .W .M ., van Soolingen, D ., Zainuddin, Z .F ., C a tty , D ., van  
Em bden J.D .A . &  D ale J. W . (1990) C haracterisation o f a M ycobacte rium  
tu b e rcu lo s is  insertion  sequence belonging to  the IS 3 fam ily. M o l M ic ro b io l 4 :9; 
1607-1613.
M cA dam , R .A ., W eisbrod, T .R ., M a rtin , J., Scuderi, J.D ., B row n , A .M ., C irillo , J.D ., 
B loom , B .R . &  Jacob, W .R . Jr (1995) In v iv o  g ro w th  characteristics o f  leucine and 
m ethionine auxo troph ic m utants o f M ycobacte rium  bovis  B C G  generated by  
transposon m utagenesis. In fe c t. Im m un. 63; 1004-1012.
M cFadden, J.J., B utcher, P .D ., Thom pson, J., C h iodin i, R ., &  J. H erm on -T aylo r 
(1987a) The use o f D N A  probes iden tify in g  re s tric tio n  fragm ent length  
polym orphism  to  exam ine the M ycobacte rium  avium  com plex. J. C lin . M ic ro b io l. 1; 
3 :2 8 3 -2 9 1 .
M cFadden, J.J., B utcher, P .D ., C h iod in i, R ., &  J. H e rm o n -T y lo r (1987b) C rohn ’ s 
disease-isolated m ycobacteria are identica l to  M ycobacte rium  p a ra tu b e rc u lo s is , as 
determ ined by D N A  probes tha t d istingu ish between m ycobacterial species. J. C lin . 
M ic ro b io l. 25; 5: 796-801.
M cFadden, J.J., K unze, Z . &  Seechurn, P. (1990) D N A  p ro b e s fo r  d e te ctio n  a n d  
id e n tific a tio n . In : M o le c u la r B io lo g y  o f the M yco b a cte ria . M cFadden J.J. Ed. 
London, Surrey U n ive rs ity  Press. 1990: 139-172.
M cP herson, M .J ., Q uirke, P. &  T aylo r, G .R . E ds.(1991) PC R -A  P ra c tic a l A pp roach . 
IR L  press. 184-185.
M e d ica l Research C ouncil [M R C ] U n ited  K ingdom  (1972) B C G  and vo le  bacillus  
vaccines in  the  prevention o f tuberculosis in adolescence and early adults life . 
B u lle tin  o f the W o rld  H e a lth  O rg a n isa tio n . 46: 381.
M end io la , M .V ., M a rtin , C ., O tal, I. &  G icquel, B . (1992) Analysis o f the  regions 
responsible fo r  186110 R FLP  in  a single M ycobacte rium  tu b e rcu lo s is  strain. Resp. 
M ic ro b io l. 143: 767-772.
M e rc ie r, M ., Gancher, C ., Feugeas O. &  M azurie r, C (1990) D ire c t polym erase chain  
reaction  fro m  w hole  b lood  w ith o u t D N A  extraction. N u c le ic  A c id  Res. 18: 5908.
M ille r, N ., S.G. Hernandes, S.G. &  C leary, T.J. (1994) E va lua tion  o f  G ene-Probe  
am plified  M ycobacte rium  tu b e rcu lo s is  d irect test and PC R  fo r  d ire c t detection  o f  
M yco b a cte riu m  tu b e rcu lo s is  in  c lin ica l specim ens./ C lin . M ic ro b io l. 32: 393-397.
168
M iya za k i, Y ., K oga, H ., K ohno, S. &  K aku, M . (1993) N ested polym erase chain 
reaction  fo r detection o f  M ycobacte rium  tu b e rcu lo sis  in  c lin ica l samples. J . C lin . 
M ic ro b io l. 31: 8; 2228-2232.
M o rb id ity  &  M o rta lity  W eekly R eport [M M R W ] (U n ited  States) (1996) M u ltid ru g  
resistant tuberculosis outbreak in  a H IV  w ard -M adrid , Spain, 1991-1995. 45 (16 ) 
330-333.
M o r, N ., Sim on, B ., M ezo, N . &  H eife ts, L . (1995) C om parison o f a c tiv itie s  o f  
rifapem tine  and rifa m p in  against M ycobacte rium  tu b e rcu lo s is  resid ing in  hum an 
m acrophages. A n tim ic ro b ia l agents C hem otheraphy. 39: 9; 2073-2077.
M oss, M .T ., M a lik , Z .P ., T izard , M .L .V ., Green, E .P ., Sanderson, J.D . &  H erm on- 
T a y lo r J. (1992) IS 902, an insertion  elem ent o f  the chron ic-en te ritis-causing  
M yco b a cte riu m  avium  subspecies: S ilvaticum . J. C lin . M ic ro b io l 138: 139-145.
M u llis , K ., F rancois Ferre B . &  G ibbs R .A . E ds.(1994) The P olym erase C ha in  
R eaction . Publ. B irkhauser B oston.
M u rra y , C .J.L ., S tyblo, K . &  R om illon , A . (1990) Tuberculosis in  develop ing countries: 
burden, in te rve n tio n  and cost. B u lle tin  In s titu te  o f T ubercu losis. 65: 6-24.
M usa, M ., Z ainuddin, Z .F . &  Ramayah S (1994) A  new  D N A  probe fo r  id e n tifica tio n  
and d iffe re n tia tio n  o f M ycobacte rium  tu b e rcu lo s is  C om plex. A s ia  P a c ific  J o u rn a l o f 
M o le c u la r B io lo g y  a n d  B io te ch n o lo g y. 2 : 353-360.
M usa M . (1996) PhD  Thesis. U n ive rs ity  Sains M alaysia
N o lte , F .S ., M e tchock, B ., M cG ow an Jr. J.E ., Ew ards, A ., O kw um abua, O ., Thurm ond, 
C., M itc h e ll, P .S ., P likay tis  B . &  S hinnick, T  (1993) D ire c t de tection  o f  
M yco b a cte riu m  tu b e rcu lo s is  in  sputum  by PC R  and D N A  hybrid isa tion . J. C lin . 
M ic ro b io l. 31: 1777-1782.
N oordhoe k, G .T ., van Em bden, J .D .A  &  K o lk , A .H .J. (1993) Q uestionable re lia b ility  o f  
the  polym erase chain reaction in  the detection o f tuberculosis. N . E ng . J . M e d  329: 
2036.
N oordhoe k, G .T ., K o lk , A .H .J ., B june, G ., C atty, D ., D ale, J.W ., F ine, P .E .M ., 
G odfrey-Faussett P ., Cho, S .N ., Shinnick, T ., Svenson, S .B ., W ilson , S. &  van  
Em bden, J .D .A . (1994) S ensitiv ity  and specific ity  o f  PC R  fo r  detection  o f M . 
tube rcu lo sis '. A  b lind  com parison study am ong seven laboratories. J. C lin . 
M ic ro b io l. 32: 277-284.
N oordhoe k, G .T ., van Em bden, J .D .A ., &  K o lk , A .H .J. (1996) R e lia b ility  o f  nucle ic  
acid am p lifica tio n  fo r detection o f M ycobacte rium  tu b e rcu lo s is : an in te rna tio na l 
co llabo ra tive  q u a lity  co n tro l study am ong 30 laboratories. J. C lin . M ic ro b io l. 34: 
10; 2522-2525.
N orm an, E ., D e llangostin , O ., M cFadden, J.J. &  D ale, J.W . (1995) H om ologous  
recom bination and gene replacem ent in  B C G . M o l M ic ro b io l. 16: 755-760.
O ta l, I . ,  M a rtin , X ., Levy-F rebault, V ., T h ie rry  D . &  G icqual B . (1991) R e stric tio n  
length  polym orphism  analysis using IS 6770 as an ep idem io logica l m arker in  
tuberculosis. J. C lin . M ic ro b io l. 29: 1252-1254.
P ablo, J.B ., P likaytis , B .B ., K apur, V ., S tockbauer, K ., Pan, X ., L u tfe y , M .L ., 
M oghazeh, S .L ., E isner W ., D anie l, T .M ., Kaplan, M .H ., C raw fo rd , J.T .,. M usser, 
J.M . &  K re is w irth  B .N . (1996) O rig in  and in tersta te  spread o f  a N e w  Y o rk  c ity  
m ultid rug -resista n t M ycobacte rium  tube rcu lo sis. JA M A  276: 6; 452-457.
Pao, C .C ., B enedict, C ., Yen, T .S ., Y ou, J.B ., M aa, J.S., Fiss, E .H . &  Chang, C .H .
(1990) D e tectio n  and id e n tifica tio n  o f  M ycobacte rium  tu b e rcu lo s is  by D N A  
am plifica tio n . J. C lin . M ic ro b io l. 28: 9; 1877-1880.
P ark T .E . E d .(1988 ) T ext B ook o f P reven tive  an d  S o c ia l M e d ic in e . P ub l.: M7S. 
Banarsidas B hanot. Ind ia ; 248-254.
P atel, R ., K vach, J.T. &  M ounts, P. (1986) Iso la tio n  and re s tric tio n  analysis o f  
m ycobacteria l D N A . J. G en. M ic ro b io l. 132: 541-551.
P atel, R .J., Fries, J.W .U ., Piessens, W .F . &  W irth , D .F . (1990) Sequence analysis and 
a m p lifica tio n  o f  a cloned D N A  fragm ent fo r id e n tifica tio n  o f  M yco b a cte riu m  
tu b e rcu lo s is . J. C lin . M ic ro b io l. 28: 3; 513-518.
Pearson, M .L ., Jereb, J.A . &  Frienden, T .R . (1992) N osocom ia l transm ission o f  
m u ltid ru g  resistant M ycobacte rium  tu b e rcu lo s is : A  ris k  to  patients and healthcare  
w orkers. A nn. In te rn . M e d ic . 117: 191-196.
Perera, J., Chandrasekharan, N .V ., &  Karunanayake, E .H . (1994) PC R  based detection  
o f M ycobacte rium  tu b e rcu lo s is : e ffect o f  sample preparation. Southeast Asian J. 
T ro p . M ed. P ub lic H ealth . 25: 4; 693-697.
P ersing, D .H . (1991) Polym erase chain reaction: Trenches to  benches. J. C lin . 
M ic ro b io l 29: 1281-1285.
P fa lle r, M .A . (1994) A p p lica tio n  o f new  technology to  the detection, id e n tific a tio n  and 
an tim icrob ia l susceptib ility  testing  o f m ycobacterial. C lin . M ic ro b io l. In fe c t. D is . 
101: 329-337.
P fy ffe r, G .E ., K iss ling , P., W irth , R. &  W eber, R. (1994) D ire c t de tection  o f  
M yco b a cte riu m  tu b e rcu lo s is  com plex in  resp ira to ry specimens by ta rge t am plified  
test system. J. C lin . M ic ro b io l 32: 918-923.
P ierra , C ., Lecossier, D ., Boussongant, Y ., B ocart, D ., Joly, V ., Y en i, P. &  Hance, A .J.
(1991) U se o f a re -am p lifica tio n  p ro to co l im proves se nsitiv ity  o f  de tection  o f  
M yco b a cte riu m  tu b e rcu lo s is  in  c lin ica l samples by a m p lifica tio n  o f  D N A  J. C lin . 
M ic ro b io l 29: 712-717.
P o rtillo , P .D ., M u rillo , L .A . &  P atarroyo, M .E . (1991) A m p lific a tio n  o f  a species- 
specific  D N A  fragm ent o f  M ycobacte rium  tu b e rcu lo s is  and its  possible use in  
diagnosis. J. C lin . M ic ro b io l. 29: 2163-2168.
P o rtillo , P .D ., Thom as, M .C ., M artinez, E ., M aranon, C ., Valladares, B ., P atarroyo, 
M .E . &  Lopez, M .C . (1996) M u ltip rim e r PC R  system fo r d iffe re n tia l id e n tifica tio n  
o f  m ycobacteria l in  c lin ica l samples. J. C lin . M ic ro b io l. 34. 324-328.
R atnam , S., &  Chandrasekhar, S. (1976) The pathogenicity o f  spheroplast o f  
M yco b a cte riu m  tu b e rcu lo sis. Am . Rev. R esp ir. D is . 114: 549-554.
R eddi, P .P ., Ta lw a, G ..P &  Khandekar, P.S. (1988) R epe titive  D N A  sequence o f  
M yco b a cte riu m  tu b e rcu lo s is : A nalysis o f d iffe ren tia l hybrid isa tion  patte rn  w ith  o ther 
m ycobacteria l. In t. J. Leprosy. 592-597.
R o iz , M .P ., Palenque, E ., G urrero, C. &  G arcia, M J . (1995) U se o f re s tric tio n  
fragm ent length polym orphism  as a genetic m arker fo r typ in g  M yco b a cte riu m  avium  
strains. J. C lin . M ic ro b io l. 33: 1389-1391.
S aiki, R .K . (1989) The design a n d  o p tim isa tio n  o f the PC R . In : PC R  T echno logy: 
P rin c ip le  a n d  A p p lic a tio n  fo r  D N A  A m p lific a tio n . E rlic h  H .A ., Ed. N e w  Y o rk : 
S tockton  Press, 7-16.
Sam brook, J., F ritsch , E .F ., &  M aniatis, T . Eds (1989) M o le c u la r C lo n in g  : A  
la b o ra to ry  m anua l, C old  Spring H arbour L abora to ry Press, C o ld  S pring H arbour, 
N e w  Y o rk .
Schaefer, W .B . (1968) Incidence o f  the serotypes o f  M ycobacte rium  avium  and atyp ica l 
m ycobacteria in  human and anim al disease. Am . R esp ir. D is . 97: 18-23.
0, Schouls, L ., Kam erbeek, J., van A g te rve ld  M ., van Soolingen, D ., Bunschoten, A . K o lk ,
A ., K u yp e r S. &  van Em bden, J. (1995) R apid sim ultaneous detection  and 
d iffe re n tia tio n  o f M ycobacte rium  tube rcu lo sis. K eystone m ee ting : M o le c u la r 
m echanism  in  tu b e rcu lo s is . Tam arron, C olorado, February 19-25 1995. A b stract B3  
(419), 96.
S elw yn, P .A ., H a rte l, D ., Lew is, V .A ., Schoenbaum, E .E ., V erm und, S .H ., K lie n , R .S ., 
W alker, A .T . &  Friedland, G .H . (1989) A  prospective study o f  the ris k  o f  
tubercu losis am ong intravenous drug users w ith  human im m unodefiency v iru s  
in fe ctio n . N . E ng. J. M ed. 320: 545-550.
Shawar, R .M ., E l-Z a a ta ri, F .A ., N atara j, A . &  C larridge, J.E. (1993) D e te ction  o f  
M yco b a cte riu m  tu b e rcu lo s is  in  c lin ica l samples by tw o-step  polym erase chain 
reaction  and non-iso top ic  hybrid isa tion  m ethods. J. C lin . M ic ro b io l 31: 1 ; 61-65.
Shankar, P ., M anjunath, N ., M ohan, K .K ., Prasad, K ., B ehari, M ., Shriniw as, G .K . &  
A huja , T . (1991) R apid diagnosis o f  tubercle  m eningitis by polym erase chain 
reaction. L a n ce t 337: 5-7.
S incla ir, K ., Challaus, J .A ., Kazw ada, R .R ., H ew inson, R .G . &  Sharp, J.M . (1 995) A  
m u ltip le x  PC R  fo r d istingu ish ing M ycobacte rium  tu b e rcu lo s is  fro m  M yco b a cte riu m  
tu b e rcu lo s is  com plex. M o le c u la r &  C e llu la r P robes. 9: 291-295.
S jobring , U .L .F , M eckelenburg, M ., Andersen, A .B . &  M io rn e r, H . (1 990) Polym erase  
chain reaction  fo r detection o f  M ycobacte rium  tub e rcu lo sis . J. C lin . M ic ro b io l. 28: 
H 10; 2200-2204.
Snider, D .E . &  R oper, W .L . (1992) The new tuberculosis. N . E ng. J . M ed. 68: 548- 
556.
Spargo, C .A ., Haaland, P .D ., Jurgensen, S.R ., Shank, D .D . &  W a lke r, G .T . (1993) 
C hem ilum inescent detection o f  strand displacem ent am plified  D N A  fro m  species 
com prising o f M ycobacte rium  tu b e rc id o s is  com plex. M o le c u la r &  C e llu la r P robes. 
7: 395-404.
Starke, J.R ., Jacobs, R .F. &  Jereb, J. (1992) Resurgence o f tuberculosis in  ch ildren. J. 
P e d ia tr. 120: 839-855.
Steady, W .W . (1981) Tuberculosis am ongst the e lderly person: A n  outbreak in  a 
nursing home. Am . In te r. M ed . 94: 606-618.
S tover, C .K ., D e la  C ruz, V .F ., Fuerst, T .R ., B urle in , J.E ., Renson, L .A ., B ennett, L .T ., 
Bansal, G .P., Y oung, J.F., Lee, M .H . &  H a tfu l, G .F. (1991) N e w  use o f B C G  fo r  
recom binant vaccines. N atu re . 351: 6326; 456-460.
172
S tyb lo , K . &  Sutherland, 1.(1982) E p idem io logy o f tuberculosis in  ch ildren. B u ll. In t. 
U n io n  Tuber. 57: 133-139.
S tyb lo , K . (1991) E p idem io logy o f tuberculosis. R oyal N etherlands Tuberculosis  
A ssocia tion  selected papers. The Hague. V o l 24.
T e len ti, A ., Im boden P. &  M archesi F. (1993) D etection  o f  rifam picin-resistance  
m uta tion  in  M ycobacte rium  tu b e rcu lo sis . Lance t. 341: 647-650.
T h ie rry , D ., Cave, M .D ., Eisenach, K .D ., C raw ford , J.T ., Bates, J.H ., G icquel B . &  
G uesdon J.L. (1990a) IS 6770, an IS -lik e  elem ent o f M yco b a cte riu m  tu b e rcu lo s is  
com plex. N u c le ic  A c id  R esearch. 18: 188
T h ie rry , D ., B risson-N oe l, A ., Levy-F rebau lt, V ., N gayen, S., Jean-Luc, G. &  G icquel,
B . (1990b) C haracterisation o f a M ycobacte rium  tu b e rcu lo s is  inse rtion  sequence, 
IS 6770, and its  app lica tion  in  diagnosis. J. C lin . M ic ro b io l. 2668-2673.
T otsch, M ., Schm id, K .W ., B rom m el Kam p, E ., S tucker, A ., Puelacher, C ., S id o ro ff, 
G ., M ik u z , G ., B ocke r, W . &  D ockhorn-D w om iczak, B . (1994) R apid de tection  o f  
m ycobacteria l D N A  in  c lin ica l samples by m u ltip le x  PCR. D ia g . M o l. P a th . 3: 4; 
260-264.
van Em bden, J .D .A ., Cave, M .D ., C raw ford , J.T ., D ale, J.W ., E isenach, K .D ., G icquel,
B ., Herm ans, P .W .M ., M a rtin , C ., Shinnick, R .M . &  Sm all, P .M . (1993) S tra in  
id e n tifica tio n  o f M ycobacte rium  tu b e rcu lo sis  by D N A  fin g e rp rin tin g : 
recom m endations fo r a standardised m ethodology. J. C lin . M ic ro b io l 31: 2; 406- 
409.
van Soolingen, D ., Herm ans, P .W .M ., D e Hass, P .E .W ., S oil, D .R . &  van Em bden, 
J.D .A . (1991) The occurrence and s ta b ility  o f  inse rtion  sequences in  
M yco b a cte riu m  tu b e rcu lo s is  com plex strains; evaluation o f  IS -dependent D N A  
polym orph ism  as a to o l in  the epidem io logy o f  tuberculosis. J. C lin . M ic ro b io l. 29: 
2570-2586.
van Soolingen, D ., Herm an, P .W .M ., D e Haas, P .E .W . &  van Em bden, J .D .A . (1992) 
In se rtio n  elem ent IS70#7-associated R FLP in  M ycobacte rium  tu b e rcu lo s is  com plex  
species: a re liab le  to o l fo r recognising M ycobacte rium  bovis  B C G . J. C lin . 
M ic ro b io l. 30: 1772-1777.
van Soolingen, D ., D e  Haas, P .E .W ., Herm an, P .W .M ., G roenen, P .M .A . &  van  
Em bden, J .D .A . (1993) C om parison o f various repe titive  D N A  elem ents as genetic  
m arkers fo r stra in  d iffe re n tia tio n  and epidem io logy o f  M yco b a cte riu m  tu b e rc id o s is . 
J. C lin . M ic ro b io l. 31: 1987-1995.
173
W ayne, L .G . (1986) The atyp ica l m ycobacterial - R ecognition  and disease association: 
C RC C rit. R ev. M ic ro b io l. 12: 85-222.
W e il, A ., P lika ytis , B .B ., B u tle r, W .R ., W oodley, C .L . &  S hinnick, T .M . (1996) The  
m tp40 gene is n o t present in  a ll strains o f M ycobacte rium  tu b e rcu lo s is . J. C lin . 
M ic ro b io l. 32: 9; 2309-2311.
W e lls tood , S .A . (1993) D iagnostic  m ycobacterio logy: C urren t challenges and 
technologies. L a b . M e d ic in e  24: 6; 357-361.
W H O /T ubercu losis/techn ica l G uide 67.7 (1967)
W illiam s, D .L ., G illis , T .P ., B o o th , R .J., C ooker, D . &  W atson, J.D . (1990) The use o f  
a specific D N A  probe and polym erase chain reaction fo r  the detection  o f  
M yco b a cte riu m  leprae . J. In fe c t. D is . 162 :193-200.
W ilk in s , S. &  Thorpe, T . (1992) R ecovery and detection o f  m ycobacteria w ith  the  
B a c T /A le rt system. In : A bstracts o f the 92nd annual m eeting o f  the A m erican  
S ociety fo r  M ic ro b io lo g y , M ay 1992, N e w  Orleans.
W ilson , S .M ., M cN em y, R ., Pamela, M . N ., G odfrey-Faussett, P .D , S toker N .G . &  
V o lle r, A . (1993) Progress tow ard  a sim plified  PCR and its  app lica tion  to  diagnosis 
o f  tuberculosis. J. C lin . M ic ro b io l. 31; 4: 776-782.
Y ang, M ., Ross, B .C . &  D w yer, B . (1993) Id e n tifica tio n  o f  an IS -lik e  elem ent in  a 
subspecies o f M ycobacte rium  kansasii. J. C lin . M ic ro b io l. 31: 2074-1079.
Y uen, L .K .W ., Ross, B .C ., Jackson, K .M . &  D w yer, B . (1993) C haracterisation o f 
M yco b a cte riu m  tu b e rcu lo s is  strains from  Vietnam ese patients by S outhern b lo t 
h y b rid is a tio n /. C lin . M ic ro b io l. 31: 1615-1618.
Zainudd in , Z .F . &  D ale, J.W . (1989) P olym orphic re p e titive  D N A  sequences in  
M yco b a cte riu m  tu b e rcu lo s is  detected w ith  a gene probe fro m  M yco b a cte riu m  
fo rtu itu m  plasm id. J. Gen. M ic ro b io l, 135: 2347-2355.
Za inudd in , Z .F . &  D ale, J.W . (1990) Does M ycobacte rium  tu b e rcu lo s is  have plasm ids? 
T ubercle . 71: 43-49.
Zhang, Y . (1993) G enetic basis o f  Ison iazid  resistance o f M yco b a cte riu m  tu b e rcu lo s is . 
R esp ir. M ic ro b io l. 144: 143-149,
